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Abstract
Endochondral ossification is the process of cell proliferation and differentiation leading 
to bone formation. It requires temporal and spatial coordination of the actions of 
various cell types and is mediated by many signaling molecules amongst which Ihh and 
PTHrP are included. A novel gene product identified recently as SAP (Small Acidic 
Protein) has also been proposed to play a major role in endochondral ossification. The 
main aim of this study is to characterize the functional roles of SAP that are potentially 
associated with new bone formation. The embryonic chick sternum has been rarely 
used in the previous studies of the development of cartilage. Thus, both tissues (tibia 
and sternum) from 17 days old embryonic chicks are included in this project. The areas 
of investigation are as follows: (1) Localising the expression of SAP, Ihh and type X 
collagen using an in situ hybridisation technique. (2) To investigate whether the 
expression of SAP is associated with the Ihh/PTHrP loop. (3) Studying the over 
expression of SAP in chick sternal chondrocytes using Replication-Competent 
Retrovirus.
Tibia and sternum show a close similarity in terms of their cell growth structure as 
confirmed by histological investigation. The tissues are composed of three 
characteristic zones (caudal, middle and cephalic) distinguishable by their respective 
chondrocyte phenotypes: proliferative, prehypertrophic, and hypertrophic. As revealed 
by in situ hybridisation, SAP is predominantly localised in the proliferative 
chondrocytes of both, tibia and sternum, although low intensity of expression is also 
observed in the prehypertrophic and hypertrophic cells. Ihh is highly expressed in the 
prehypertrophic chondrocytes in both tissues and its expression continues throughout 
this transitional zone where the majority of cells are stained strongly, but the reactivity 
becomes less pronounced throughout the hypertrophic part of the tissues. Unlike SAP 
and Ihh, type X collagen is found to accumulate exclusively in the hypertrophic zone.
Under normal culture conditions where the samples are not treated with cyclopamine, 
the proliferative chondrocytes show high levels of SAP, PTHrP and Patched 
expression, but do not express Ihh and type X collagen. When treated with 
cyclopamine, the proliferative chondrocytes no longer express SAP and PTHrP but 
unexpectedly show the expression of Ihh and type X collagen. The initiation of the 
expression of Ihh and type X collagen by the proliferative chondrocytes following 
cyclopamine treatment is also accompanied by a decline in the production of GAG and 
hydroxyproline, suggesting the onset of cell differentiation. Cyclopamine is a naturally- 
occurring chemical that belong to the group of steroidal jerveratrum alkaloids. It has 
been shown that cyclopamine blocks the hedgehog signalling pathway by influencing 
the balance between active and inactive forms of the Smoothened protein (Taipale et 
al, 2002) Cyclopamine inhibits SAP and PTHrP expression in the prehypertrophic and 
hypertrophic chondrocytes where Ihh and type X collagen remains unaffected. As SAP 
expression is predominantly found in the proliferative zone and downregulated in 
prehypertrophic and hypertrophic chondrocytes, this may indicate its involvement in 
endochondral ossification as a promoter of cell proliferation and as a transcription 
regulator preventing the cells from reaching hypertrophy or maturation. An attempt to 
investigate the biological role of SAP by over expressing the SAP gene in cell cultures 
has not been successful and it remains to be confirmed whether SAP is an integral part 
of the Ihh/PTHrP feedback control loop.
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Chapter 1 General Introduction
1 Introduction
Cartilage is one of the major components of the vertebrate skeleton. This is a type of 
connective tissue closely associated with bone; it is tough, semi-transparent, elastic 
and flexible (Price et al, 1994). This tissue contains chondrocytes that are embedded 
in a matrix composed of collagens, proteoglycans and glycoproteins. Covered by a 
dense fibrous membrane and perichondrium, the cartilage matrix has no nerve and 
blood vessels. According to their histological appearances and the biochemistry of the 
extracellular matrix, there are three types of cartilage: hyaline, elastic and fibro 
cartilage. The present work focuses on the hyaline cartilage since this tissue is known 
to be associated with endochondral ossification.
Two different mechanisms are known to be involved in the formation of the vertebrate 
skeleton. One of these is known as intramembranous ossification during which 
mesenchymal cells directly differentiate into osteoblasts. According to Ortega et al 
(2004), some of the skeletal elements, mainly craniofacial bones, are formed by this 
process. The second mechanism is known as endochondral ossification (EO), which 
involves the initial formation of a cartilage template from aggregated mesenchymal 
cells, and then the subsequent replacement of this cartilaginous template by bone.
1.1 Endochondral Ossification
This process of bone formation is highlighted in the formation of the long bone in 
Figure (1.1).
1.1.1 Formation of the Cartilage Template
During the initial stage of long bone formation, mesenchymal cells condense in the 
region where the bone is to be formed and they differentiate into chondrocytes. The 
second stage involves proliferation of the chondrocytes and secretion of a cartilage 
extracellular matrix which subsequently formed the shape of the future long bone. The 
third stage is the phase during which the chondrocytes in the main shaft of the anlagen 
stop dividing but increase their volume dramatically and are differentiated into mature 
hypertrophic chondrocytes. These large hypertrophic chondrocytes alter the
2
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composition and organisation of the matrix and enable it to become mineralized by 
calcium hydroxyapatite deposition. The last stage involves the invasion of the calcified 
cartilage model by blood vessels and osteoprogenitor cells (Ortega et al, 2004). At this 
last stage, the hypertrophic chondrocytes become apoptotic, leaving spaces which 
eventually turn into bone marrow. Osteoprogenitor cells then migrate to the mineralised 
cartilage and differentiate into mature osteoblasts which lay down an unmineralised 
bone matrix (osteoid). The osteoid is eventually mineralised to form woven bone but 
this structure is not mechanically strong enough to support the weight of the growing 
vertebrate (Cheung et al, 2003). The woven bone is eventually remodelled by the 
concerted efforts of osteoblasts and osteoclasts to more rigid and compact bone. This 
strictly regulated process leads to the replacement of cartilage with bone (Hunziker et 
al, 1987; Gibson, 1998; Steven and Lowe, Human Histology, 1996).
1.1.2 The Secondary Ossification Centre
The secondary ossification centre arises within the epiphysis (Figure 1 .IF). The 
mechanism of this process is similar to that of the ossification of the metaphysis but the 
ossification propagates radially instead of longitudinally. As the embryo grows, the 
diaphysis (Fig 1.1) is eventually separated from the secondary ossification centre by a 
thin plate of cartilage known as the epiphyseal growth plate (Roach et al, 1995; 2004; 
Steven Lowe, Human histology, 1996; Gartner and Hiatt, Atlas of histology, 2000) 
(Figure 1.2). This region of cartilage is the focal point of the present study and a good 
understanding of its histology is helpful in the investigation.
3
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Figure 1.1: Diagram showing the formation of a long bone. The process starts as a 
condensation of mesenchymal cells in the place where the long bone will be formed 
(A). These mesenchymal cells differentiate into chondrocytes, forming a cartilaginous 
template. The cells surrounding this cartilage template differentiate into perichondrial 
cells producing the perichondrium (B). The cells of the cartilage template proliferate 
and secret a proteoglycan-rich matrix which eventually form the shape of the long bone 
and the surrounding perichondrium becomes the periosteum forming a bony collar 
around the shaft of the developing long bone (C). At the middle region of the diaphysis, 
vascularisation occurs in the periosteum and grows through the bony collar. This 
process also brings the osteoprogenitor cells into the diaphysis (D). The bony trabeculae 
produced by mature osteoblasts spread throughout the primary ossification centre to 
occupy the entire diaphysis (E). The formation of the secondary ossification centre (F). 
(Adapted from Human histology, Steven and Lowe, 1996).
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Figure 1.2: Photomicrograph of a longitudinal section of a human digit showing the 
distal inteiphalangeal joint. In this photomicrograph, the diaphysis (D) of the lower 
phalanx is replaced by bone and the marrow cavity is filled with marrow (M). The 
secondary ossification centre (2°) is shown developing within the epiphysis (E). The 
epiphyseal growth plate (ED) is the thin cartilaginous band between the diaphysis (D) 
and the epiphysis (E). Woven bone is formed as the result of ossification process (Taken 
from Color atlas of histology, Gartner and Hiatt, 2000).
5
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1.2 The Epiphyseal Growth Plate
The epiphyseal growth plate is responsible for the longitudinal growth of long bones by 
providing a population of chondrocytes that undergo proliferation to give new cartilage 
at the ends of the diaphysis. Due to the biological sequence of their development, the 
chondrocytes within the epiphyseal plate can be histologically divided into five distinct 
zones. As shown in Figure 1.3, the morphological and histological appearances of 
chondrocytes within these zones are different. These zones are: (1) the resting zone 
which is close to the articular cartilage; (2) the proliferative zone; (3) the transitional 
zone (prehypertrophic zone); (4) the zone of terminal chondrocyte differentiation 
(hypertrophic zone); and (5) the ossifying zone (Kember, 1978; Gibson, 1998).
1.2.1 Resting Zone
The chondrocytes of this zone are round and small as compared to the other zones of the 
growth plate. These chondrocytes are surrounded by an abundant amount of 
extracellular matrix (Figure 1.3b). Morphologically, the resting zone appears as a 
narrow region at the top of the growth plate and the chondrocytes are not mature and 
non-dividing. This zone is a very important zone as recent evidence has shown that it 
contains mesenchymal stem cell (MCS) which can differentiate into other connective 
tissue cell types (Dowthwaite et al, 2004; Veronica et al., 2005).
1.2.2 Proliferating Zone
In this zone, the chondrocytes divide rapidly and form columns of disc-shaped cells 
whose long axes are perpendicular to the longitudinal axis of the growth plate. The 
chondrocytes proliferate in response to a number of regulatory factors that mediate their 
division. These factors include retinoic acid, thyroid hormone, vitamin D and growth 
factors such as FGFs, TGF, and BMPs (Tsumaki et al., 2002). The chondrocytes in this 
zone appear slightly larger than those in the resting zone. On the other hand, the 
proliferating zone is responsible for providing a stream of chondrocytes for cell 
differentiation, therefore maintaining the constant width of the epiphyseal growth plate 
throughout the growth of the bone (Hunziker et al., 1987; 1989; Goldring et al., 2006).
6
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Figure 1.3: The Growth Plate.
(a) Diagram showing the initial enlargement of the secondary ossification centre 
within the epiphysis. The epiphyseal plate is located between the secondary 
ossification centre at the top and the diaphysis at the bottom.
(b) Diagram showing a magnified view of a section of the epiphyseal plate (box). 
Chondrocytes in the epiphyseal plate proliferate in columns towards the 
diaphysis, becoming hypertrophied as they deposit a hypertrophic matrix. The 
matrix becomes mineralised before osteoblasts deposit osteoid on the calcified 
cartilage (Taken from Steven and Lowe, 1996).
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1.2.3 Prehypertrophic Zone
The chondrocytes in this zone appear oval and some are still actively dividing. 
However, some cells in this zone have started to differentiate but have not yet acquired 
the hypertrophic morphology. The extracellular matrix produced by these transitional 
chondrocytes is compositionally and biochemically different from that of the previous 
two zones (Hunziker et al, 1987; Veronica et al, 2005).
1.2.4 Hypertrophic Zone
The chondrocytes of the hypertrophic zone are larger than those in the prehypertrophic 
zone and secrete extracellular matrix rich in collagen type X and reduced amounts of 
types II and IX collagen (Provot and Schipani, 2005). A high level of alkaline 
phosphatase has also been found to associate with these cells, suggesting an active role 
in mineralisation of the cartilage matrix during endochondral ossification (Schimd et al, 
1985; Shum, 2003; Goldring et al, 2006).
1.2.5 Ossifying Zone/Mineralised Cartilage
One of the most important processes is mineralisation that begins after chondrocyte 
differentiation. Mineralisation is considered to be a prerequisite to osteoprogenitor 
invasion (Figure 1.4). The major mineral phase is hydroxyapatite (HAP), [Caio (PO4) 6 
(OH) 2] (Figure 1.4) which is a member of the family of apatite minerals. However, 
biological minerals are not pure hydroxyapatite and many other constituents are also 
included such as carbonate, citrate, magnesium and sodium (Russell et al, 1986). Also 
this is the zone where the hypertrophic chondrocytes undergo cell degeneration and 
apoptosis (Cheung et al, 2003). On the other hand, the fate of these cells is currently a 
topic of much debate. Some evidence has suggested that some hypertrophic 
chondrocytes in this zone can trans-differentiate into osteoblasts (Roach, 2004). 
However, this observation has not been substantiated by other researchers. It has been 
documented that a number of morphological, physiological and biochemical changes 
take place in this zone (Russell et al, 1986).
8
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It has been observed that terminal hypertrophic chondrocytes occur as condensed cells 
with their plasma membrane attached asymmetrically to the last transverse septum 
(Cheung et al., 2003). Morphological and biochemical evidence of apoptosis includes 
retraction from the pericellular matrix, cytoplasmic and nuclear condensation, and DNA 
fragmentation. Gibson et al (1997) proposed that in the avian system, cell commitment 
to hypertrophy itself could be the initiator of apoptosis. An increasing number of 
proteins are known to regulate chondrocyte apoptosis (Chung, 2004; Shum et al, 2003). 
Expression of the apoptosis inhibitor, bcl-2 is up-regulated in proliferating and maturing 
chondrocytes, while expression of the apoptosis inducer, box, increases progressively 
towards the hypertrophic zone of the growth plate. In the same region vascularisation 
begins by the migration of vascular endothelial cells from the marrow cavity. 
Vascularisation within the growth plate allows the supply of hormones and nutrient to 
the growth plate. Recent studies have shown that many factors are associated with the 
vascularisation and reabsorption of cartilage such as VEGF, IGF-1, EGF, and PDGF-A) 
(Gerber et al, 1999; Provot and Schipani, 2005). It has also been demonstrated that 
osteoprogenitors can migrate to the ossifying zone and differentiate into mature 
osteoblasts which lay down new bone matrix (Gibson, 1998).
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Figure 1.4: A schematic diagram of a longitudinal section of the epiphyseal growth 
plate. Morphological regions and cell types are highlighted.
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1.3 Mineralisation o f the Growth Plate
1.3.1 Deposition of Minerals
According to Johnstone et al (2000) these minerals are deposited primarily in the 
extracellular matrix that is specifically localised between the adjacent columns of the 
prehypertrophic and hypertrophic chondrocytes in the growth plate. The process of 
mineralisation is not fully understood but is thought to involve calcium binding 
proteins, enzymes and membrane ion transport mechanisms. The initial site of calcium 
deposition is confined to the matrix of the longitudinal septae and appears as small 
vesicles or particles of approximately 50 nm in diameter. These structures are known as 
the matrix vesicles (Anderson, 1995). The release of these matrix vesicles from 
hypertrophic chondrocytes may be a result of increased cytosolic calcium concentration, 
contributed to by annexins forming calcium channels in the plasma membrane (Wang 
and Kirsch, 2002).
1.3.2 Matrix Vesicles
The mineralisation process takes place in the extracellular matrix starting with small 
organelles known as matrix vesicles (MVs). According to Anderson (1995 & 2003), 
these organelles initiate the first step of mineralization by creating a specific 
environment where deposition of initial amorphous mineral complexes (nucleation) 
occurs. As a result, hydroxyapatite is produced and form needle-like crystals on the 
inner surface of the MV membrane. In fact, the MVs serve as a site for Ca2+ and 
inorganic phosphate (Pi) accumulation. These elements are essential to sustain the 
nucleation process and to propagate the mineralisation (Anderson, 2003).
The second step of mineralisation starts with the release of the hydroxyapatite crystals. 
After reaching a critical length, the needle-like hydroxyapatite crystals are released from 
the MVs into the extracellular matrix. These crystals serve as a template for the 
formation of crystalline arrays, leading to tissue calcification (Anderson, 2003). As 
Balcerzak et al (2003) has speculated, the mechanism by which the hydroxyapatite 
crystals are propagated, may affect the MV membrane fluidity. The mineral formation 
occurs between the matrix vesicles. The crystals then grow towards the vesicles and
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eventually enter their membrane. The outward growth of the crystals depends on the 
levels of calcium and phosphate in the extra-vesicular matrix which should allow 
continued nucleation of the hydroxyapatite (Anderson, 2003). In addition, Wu et al 
(1991) suggested that the outward propagation of the crystals results in mineralisation 
of the type II and type X collagen pericellular matrix. Matrix vesicles isolated from 
chicken growth plate cartilage were found to contain MMP-2,-9 and -13 (D’Angelo et 
al., 2001). These vesicles also contain TGF-p whose reaction is activated by MMP-13 
(D’Angelo et al., 2001). In a later study made by Maeda et al., (2002), MMP-3 found 
in the matrix vesicles was implicated in the release of the large latent complex from 
TGF-pl.
1.3.3 Annexins
The annexins are a structurally conserved family of proteins characterized by reversible 
Ca2+ dependent intracellular membrane binding. Annexins comprise a large family with 
more than 100 sequenced proteins from over 45 species (Wang et al, 2005). There are 
twelve members of the annexin family have been identified. Three were identified in 
MVs. These members are annexins II, V and VI. Annexin can be associated with both 
outer and inner leaflets of the MV membrane. Annexins affect membrane stability in a 
Ca2+ dependent manner. In addition, they could be involved in the Ca2+ transport, as ion 
channels inserted within the MV membrane (Balcerzak et al, 2003). Furthermore, 
Kirsch et al (2000) have suggested that type X collagen is able to bind to annexin V and 
that it would anchor matrix vesicles in the extracellular matrix and also activate the 
annexin V channel properties. These finding suggest that annexin V may not only form 
calcium channels in growth plate chondrocytes and matrix vesicles but may also 
mediate cell-vesicle-matrix interaction (Wang et al., 2005).
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1.3.5 Proteoglycans
Proteoglycans are thought to play a role in the calcification process, but the nature of 
that role is still unknown. Perhaps, aggrecan binds calcium via their chondroitin sulfate 
chains in vivo and the reaction could promote hydroxyapatite formation. Proteoglycans 
seem to promote calcification and this hypothesis is supported by the observation that 
calcification is not always initiated within matrix vesicles but rather in discrete focal 
sites containing aggrecan and chondrocalcin (a glycoprotein derived from the C- 
terminal propeptide of type II collagen). The ability of chondrocalcin to bind to annexin 
V and accumulate in calcifying cartilage has been noted by Kielty and Grant (1992). 
However, a contradictory report of in vitro studies on hydroxyapatite formation 
suggests that proteoglycans are inhibitors rather than promoters of the calcification 
(Hunter, 1991).
1.4 Extracellular Matrix (ECM)
The extracellular matrix (ECM) is a complex structure surrounding and supporting 
various types of cells within connective tissues. The ECM is composed of three major 
classes of molecules. These are: Collagen and Elastin, specialized glycoproteins 
(fibrillin, fibronectin and laminin) and proteoglycans which are all composed of a 
protein core with long chains of repeating disaccharide units named 
glycosaminoglycans (GAGs) (Schmal et al., 2006).
Collagen fibres strengthen and help organize the matrix, while the elastin is fibres give 
its resiliency. The adhesive glycoproteins help cells to attach to the extracellular matrix. 
For example, fibronectin promotes the attachment of fibroblasts and other cells to the 
ECM via extracellular domains of members of the integrin family, and laminin 
promotes the attachment of epithelial cells to the basal lamina, again via the 
extracellular domains of integrins.
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1.4.1 Components o f  the Extracellular Matrix
1.4.1.1 The Collagen Family
This family of collagens include major proteins of the bone and cartilage extra cellular 
matrix and is essential for the determination of size, shape and strength of these tissues. 
Twenty seven members are found to belong to this super-family of proteins which can 
be grouped according to their molecular structures and the supra-molecular assemblies 
which they adopt. Apart from showing a variety of structures, they have different 
biological roles and are expressed in different tissues (Canty and Kadler 2005). These 
collagens are listed in (Table 1.1).
Collagen type Localisation Supermolecular assembly
Type I Skin, Tendon, Bone and 
Dentin
Fibrillar collagen
Type II Cartilage Fibrillar collagen
Type III Skin, Muscles, Blood vessels Fibrillar collagen
Type IV Basement membrane 
associated collagen
Short chain collagen, hexagonal network
Type V Fetal tissue, Placenta and 
Interstitial tissues
Fibrillar collagen
Type VI Ubiquitous Beaded filaments
Type VII Dermo-epidermal junction Anchoring fibrils
Type VIII Basement membrane 
associated collagen
Short chain collagen, hexagonal network
Type IX Cartilage, Vitreous Humour Fibril-associated collagen
TypeX Hypertrophic cartilage Short chain collagen, hexagonal network
Type XI Cartilage Fibril-associated collagen
Type XII Embryonic skin and tendons Fibril-associated collagen
Type XIII Epidermal cell-matrix Type II membrane protein
Type XIV Fetal skin and tendons Fibril-associated collagen
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Type XV Basement membrane 
associated collagen
Multiplexin, supermolecular assembly 
unknown
Type XVI Associated with cartilage 
hypertrophic
Fibril-associated collagen
Type XVII Membrane collagen Type II membrane protein
Type XVIII Basement membrane 
associated collagen
Multiplexin, supermolecular assembly 
unknown
Type XIX Epithelial basement 
membrane zone and muscle 
cells
Fibril-associated collagen
Type XX Corneal epithelium Fibril-associated collagen
Type XXI Vascular walls and fetal 
development
Fibril-associated collagen
Type XXII Tissue junctions Fibril-associated collagen
Type XXIII Membrane collagen Type II membrane protein
Type XX3V Bone and cornea Fibrillar collagen
Type XXV Membrane collagen Type II membrane protein
Type XXVI Ovary, testis Supermolecular assembly unknown
Type XXVII Cartilage Fibrillar collagen
Table 1.1: A table summarising the different members composition structure and tissue 
distributions of the collagen family members (Ricard-Blum and Ruggiero, 2005).
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All collagens are trimeric molecules composed of three a chains. The a chains are 
defined as polypeptides that are essentially repeats of the amino acid triplet, Glycine-X- 
Y in which the position of X is frequently occupied by proline and that of Y is 
frequently by 4-hydroxyproline (Prochop and Kivirikko, 1995). The unique primary 
structure of the a-chain allows the three chains in a collagen molecule to intertwine to 
form the typical collagen triple helix. The sizes of a chains in the family vary from 600 
to 3000 amino acids and some contain non-collagenous (non Gly-X-Y) interruptions 
within and on the ends of sequences. Some of these collagens also have motifs that 
show homology with other extracellular matrix proteins (Brown and Timpl, 1995).
The most prevalent collagens in tissues are the fibrillar collagens these include types I, 
II, III, V, XI, XXIV and XXVII. In each a-chain in their triple helical domain, there are 
about 1000 amino acids (Kietly et al, 2002). Type I collagen fibrils are arranged into 
parallel bundles in tissues providing physical strength to the tissues under extensive 
forces, such as bone and tendons. Those fibrils that are formed by type II collagen are 
narrower than the type I and they are the major collagen components of cartilaginous 
tissues and vitreous humour. Elastic tissues such as the skin, intestine and aorta also 
contain Type III collagen fibrils. Type XXVII collagen has recently been assigned to the 
fibrillar collagen family (Boot-Handford et al., 2003).
As described by Myllyhaiju and Kivirikko (2001), the biosynthesis of fibrillar collagens 
consists of a series of post-translational events, a-chains are synthesised as a pre­
procollagen chain containing an N-terminal signal peptide, and a N and C-terminal 
propeptide linked by the triple helical domain. First of all, the pre-procollagen chains 
having a signal peptide are translocated into lumen of the rough endoplasmic reticulum 
(RER). According to Hendershot et al (2000), formation of the collagen triple helix 
occurs in the C-N direction and requires modification within the polypeptide chain. The 
melting temperature of the triple helix correlates with the extent of hydroxylation of 
proline residues and with the physiological temperature of an organism. Hydroxyproline 
coordinates with water molecules within the triple helix of collagen increasing the H- 
bonding between a-chains increasing the thermal stability of the triple helical molecule. 
The importance of hydroxylation is demonstrated by the disease scurvy that results from
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deficiency of vitamin C. Some lysine residues are also hydroxylated by a family of lysyl 
hydroxylases. Hydroxylysine can be further modified by the addition of galactose and 
glucose moieties. Hydroxylysyl residues are further modified to form extracellular 
collagen cross-links essential for the mechanical properties of collagen fibril. The 
control mechanisms of collagen molecular and fibril assembly are not fully understood. 
An evidence suggests that in the embryonic fibroblast at least, fibril assembly occurs 
inside the cell and then secreted through cellular invaginations termed fibropositors 
(Canty and Kadler 2005).
Contrary to the fibrillar collagens, the non-fibrillar types undergo completely different 
post-transtionla events. Some collagens have large non-collagenous domains at either 
end of their triple helix and these domains are not removed by proteinases. These 
include: IX, XII, XIV, XVI, XIX, XXI and XXII. Other types of collagen require the 
addition of either the N-linked oligosaccharides or glycosaminoglycans (GAG) chains. 
The triple helical domains of some collagens (eg. type X3II and XVII) are assembled 
from the N-terminal to the C-terminal (Myllyharju and Kivirikko, 2001).
1.4.1.2 Cartilage Collagens
1.4.1.2.1 Type II Collagen
Cartilage contains predominantly type II collagen which is composed of three identical 
a 1(H) chains that wind into the characteristic triple helix (Kielty and Grant 2002). 
Type II collagen forms heterotypic fibrils with the lesser abundant type IX and XI 
collagens. Figure (1.5) shows that the interior of these fibrils contains type XI collagen 
whereas its exterior is associated with type IX. These fibrils show highly ordered 
arrangements of regular three-dimensional network throughout the cartilage matrix, thus 
giving support to the ECM as well as interaction sites for other ECM components.
1.4.1.2.2 Type IX Collagen
Type IX collagen is a heterotrimer which has a molecular configuration of [al (IX) a2 
(IX) a3 (IX)]. The three chains are products of three distinct genes (Eyre and Wu,
1995). There are short and long forms of type IX collagen depending on the presence or
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absence of a large globular domain (NC4) at the amino terminal of the al chain. The 
short form of type IX collagen is found to be dominant in the hypertrophic cartilage of 
the growth plate whereas the long form is present mainly in articular cartilage. The 
expression of these different forms is tissue specific and also developmentally regulated 
(Olesen, 1992). The a2 chain of type IX collagen can also bear a chondroitin sulfate 
chain which allows the collagen to be classified as a proteoglycan.
1.4.1.2.3 Type XI Collagen
Type XI collagen is a heterotrimer consisting of the following chains: a l (XI), a2 (XI) 
and a3 (XI). The al and a2 are products of two separate genes. The a3 is coded by the 
same gene COL2A1 of type II collagen, but according to Burgeson (1982), it 
undergoes different post-translational hydroxylation and glycosylation. The mutated 
genes of heterotypic fibrils have been found to cause a variety of diseases with variable 
degree of severity (Mundlos et al, 1997). Mutations in the COL2A1, COL9A2 and 
the COL11A2 gene loci can lead to achondrogenesis type II, multiple epiphyseal 
dysplasia and a Stickler-like-dysplasia, respectively (Horton, 1996).
1.4.1.2.4 Type VI Collagen
Chondrocytes in the pericellular capsule known as chondron, are surrounded by a 
network of microfibrils of type VI collagen, which have an abundant amount of cell 
binding motif (RGD) sequences (Poole, 1988). In the growth plate, type VI collagen 
has been observed in the close vicinity of the resting as well as the early proliferating 
chondrocytes, but the staining was found to diffuse gradually and in many cases was 
absent at the end of the proliferating zone. According to Sherwin et al (1999) the 
pericellular staining of type VI collagen was not detected around the hypertrophic 
chondrocytes of the growth plate.
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Figure 1.5: A diagram representing schematically the arrangement of collagen 
molecules in the hypertrophic fibrils in cartilage.
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1.4.1.2.5 Type X Collagen
Collagen type X was first isolated from culture medium of chick chondrocytes 
undergoing hypertrophy and it was described as a short chain (SC) collagen (Schmid et 
al, 1983; Kielty et al., 1985), because the molecule is a homotrimer composed of three 
59 kD al(X) chains. The human type X molecule has three domains: (1) a short 38 
amino acids non-helical region at the amino-terminus known as the non-collagenous 
domain 2 (NC2); (2) a domain of 161 amino acids at the carboxyl-terminus (NCI); and 
(3) a helical domain of 463 amino acids (Kielty et al, 1985).
According to Schmid and Linsenmayer (1990); Jacenko et al (2001), type X collagen 
has a very restricted tissue distribution, and is synthesized by hypertrophic chondrocytes 
during the process of endochondral ossification. Furthermore, within the hypertrophic 
cartilage, type X collagen occurs in at least two different super molecular forms. 
Immunoelectron microscopic studies have shown that type X forms mats of filamentous 
material which surround the hypertrophic chondrocytes and along the surface of 
cartilage collagen fibrils (Schmid and Linsenmayer, 1990).
In their earlier study, Grant et al (1987) indicated that type X collagen was associated 
with the repair of fracture and human osteoarthritic articular cartilage and that its 
synthesis occurred in the fractured callus of the chicken humourus within the 
mineralised regions. This observation suggested that type X collagen is involved in the 
formation of new bone throughout development. The extracellular deposition of type X 
collagen in the hypertrophic cells of the middle zone of osteoarthritic articular cartilage 
has been demonstrated immunohistologically. The synthesis of type X collagen in 
suspension culture of chondrocytes freshly isolated from osteoarthritic cartilage has 
provided evidence to suggest that type X collagen may be involved in the pathology of 
osteoarthritis in the regions where articular cartilage is calcified (Von der Mark et al, 
1992).
Contrary to the report that the expression of type X collagen is restricted to 
hypertrophic chondrocytes of the growth plate, the study by Rucklidge et al (1996) has 
shown that the X collagen is immunolocalised to the surface of articular cartilage of
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human, pig and rat (Rucklidge et al, 1996). A small amount of type X collagen is also 
detected in the proliferating zone of the growth plate (Jacenko, 2001). Type X collagen 
has been recently localised in other regions. It has been found in the mineralised fibro 
cartilage at the ligament-bone interface of the bovine medial collateral ligament 
(Niyibizi et al., 1996). Furthermore, Roberts et al (1998) has reported that type X 
collagen is expressed in the degenerating human intervertebral discs. The above 
observations clearly suggest that the expression of type X collagen is not restricted to 
the hypertrophic zone of the growth plate, and that it can be detected in other tissues.
The actual function of type X collagen is not well understood. On the one hand, type X 
collagen is claimed to be associated with vascularisation (Schimd et al, 1985). On the 
other hand, it is thought to be involved in mineralisation of the matrix (Kielty and 
Grant, 1992). Furthermore, Wilson et al (2002) have shown that mutation of the type X 
collagen gene was involved in the pathogenesis of the inherited human skeletal disorder, 
Metaphyseal Chondroplasia type Schmid. Type X collagen null mice have also been 
shown to develop hematopoietic abnormalities and Jacenko et al (2002) and Shum L 
and Nuckolls (2002) suggested that the type X collagen deposition is important in 
establishment of bone marrow for normal hematopoiesis of the hypertrophic cartilage.
1.4.1.3 Proteoglycans
Proteoglycans are specialised glycoproteins which contain a large proportion of glycan 
relative to the amino acid content of the molecule. A proteoglycan is made up of a core 
protein to which long chains of repeating disaccharides- glycosaminoglycan (GAGs) are 
attached (see Figure 1.6).
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0 GPI
Cell membrane
Name: invariant CD44 syndecan-1 CSF-1 glypican thrombo betaglycan NG2 
Chain -modulin
GAG: CS CS/HS HS/CS CS HS CS HS/CS CS
Figure 1.6: Structure of some cell surface proteoglycans. Some have disulfide bridges, 
Syndecan-1, CD44 and betaglycan may carry both heparan sulfate (HS) and 
chondroition sulfate (CS) GAG chain. (Adapted from Elenius and Jalkanen, 1994)
22
Chapter 1 General Introduction
1.4.1.4 Aggrecan
Aggrecan is a member of the proteoglycan family that forms multimolecular complexes 
with hyaluronan. The ECM of the cartilage is rich in this protein. As shown in Figure 
1.7A, the aggregates of proteoglycans are formed as a result of the multiple binding of 
proteoglycans to a hyaluronan chain (HA) on the globular protein core. As 
demonstrated by Hardingham (1984), the PG-HA bond is stabilised by the linkage of a 
40kDa protein core (Figure 1.7 B). Also, Figure (1.7 D), shows that aggrecan is formed 
with a multi-domain protein core of 220kDa, namely Gl, G2 and G3. The G1 domain is 
located at the N-terminus and binds non-covalently to hyaluronan (Caterson et al, 
2000). There are two attachment domains, a short keratan sulfate (KS) and two 
chondroitin sulfates (CS1 and CS2). It is thought that over 100 CS and KS chains may 
be present in the GAG attachment regions. The G3 domain is at the C-terminus and its 
function remains obscure. It has properties similar to those of lectin and may interact 
with other matrix components. Roughley (2001) has speculated that the G3 may be 
involved in intracellular trafficking during aggrecan synthesis.
Based on its molecular characteristics, aggrecan has an important role to play in the 
development of cartilage. According to Iozzo (1998), each aggrecan monomer 
occupies a large hydrodynamic volume in this tissue and the water is displaced from 
individual monomers when subjected to compressive forces. Iozzo (1998) further 
described that the swelling of the tissue is dissipated readily when the compressive 
forces are removed and water molecules are drawn back into the tissue. Mundlos 
(1994) reported that aggrecan in the growth plate showed a distribution similar to type 
II collagen and that the highest rate of expression was noted in chondrocytes of the 
proliferating and upper hypertrophic zones. However, the expression of aggrecan is 
down regulated when the chondrocytes undergo hypertrophy (Wai, 1998).
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Figure 1.7: (A) representing the cartilage proteoglycan aggregate of high molecular 
weight and its components; (B) Domains of link protein; (C) Hyaluronan disaccharide 
repeat; (D) different domains of aggrecan monomer and sites of glycosaminoglycans 
(GAGs) attachment. Gl, G2 and G3 are globular domains.
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1.4.1.5 Small Leucine Rich Protoglycan (SLRP)
The small leucine rich proteoglycans belong to a large family of molecules that are 
characterised by a protein core of approximately 40kDa with a central region containing 
leucine-rich repeats (LRRs). The LRRs have been discovered in a variety of proteins 
from prokaryotes and eukaryotes. They have a wide spectrum of cellular locations and 
functions including hormone receptors, tyrosine kinase receptors, cell adhesion 
molecules, bacterial virulence factors, enzymes and ECM-binding proteins (Mastushima 
et al, 2000). The LRRs contain twenty to thirty amino acids, with asparagine (N) and 
leucine (L) residues in conserved positions in the (LxxLxLxxNxL) motif.
Their structural differences depend on whether they contain N-linked oligosaccharides, 
GAG chains such as CS, DS and KS. The members of the family are divided into three 
distinct classes based on their evolutionary protein conservation, the sequence of a 
distinct cysteine-rich region at the N-terminal, and the number of their leucine repeats 
and genomic organisation (Iozzo, 1999)
1.4.1.6 Decorin and Biglycan
Decorin and biglycan fall into class I division of the larger family SLRPs. They are 
composed of a core protein containing 10 tandem leucine rich repeat sequences which 
is flanked at either end by cysteine rich disulphide loops. The expression of decorin 
and biglycan is widespread in many types of tissues and at different stages of 
development. Decorin is found in tissues of human embryos which are rich in fibrillar 
collagens. By contrast, biglycan is expressed in more specialised cell types such as 
renal tubular epithelia, and skeletal myofibers (Bosman and Stamenkovic, 2003; 
Waddington et al, 2003).
Decorin and biglycan are found in bovine growth plate but there are variations in the 
profiles of their distribution and expression (Alini and Roughley, 2001). Decorin was 
found predominantly in the proliferating zone, and its expression was down-regulated in 
the hypertrophic zone. However, biglycan was found throughout the growth plate with a 
decrease in the intensity of expression being noticed in the proliferative and
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hypertrophic zones. Biglycan was later found to be associated with the mineralisation of 
cartilagenous matrix following a study using the developing epiphyseal cartilage of 10- 
day old Wistar rats (Takagi et al., 2000; Mochida et al, 2003).
The targeted deletion of genes encoding for decorin and biglycan within mice has 
provided a lot of valuable evidence for the role of these macromolecules in bone 
formation in vivo. The most striking effect on mineralised tissues was observed in the 
biglycan knockouts. Most notably, these mice were seen to develop an osteoporotic 
phenotype, failing to achieve peak bone mass due to decreased bone formation with 
significantly shorter femurs (Ameye and Young, 2002). Also it has been shown that the 
decrease in bone mass was more severe and developed earlier than the single biglycan 
knockout, suggesting the effects of decorin and biglycan are synergistic within bone 
(Waddington et al, 2003)
1.4.1.7 Perlecan
Perlecan was first found in basement membrane and identified as a heparan sulfate 
proteoglycan (Iozzo, 1994). Perlecan is present in the extracellular matrix of cartilage 
and has both chondroitin sulfate (CS) and heparan sulfate (HS) chains (Hassell et al, 
2002; Smith and Hassell, 2006). In cartilage, perlecan is essential for the maintenance of 
integrity of the matrix and the binding to proteins such as fibulin and fibronectin to form 
scaffolding network between the chondrocytes in order to stabilse the cartilage (Hassell 
et al, 2002). Perlecan also has a role in cell attachment to basement membrane (BM), 
where it binds to other BM components such as laminin and collagen IV (Iozzo, 1994; 
Smith and Hassell, 2006). Earlier studies localised perlecan in the pericellular matrix of 
avian, human and murine articular and growth plate cartilage cells. The perlecan 
expression has been observed in cartilage during murine embiyogenesis (Gomes et al, 
2002). These studies demonstrated that perlecan expression was intense in cartilaginous 
tissues especially those undergoing endochondral ossification (Melrose et al, 2002). 
The ability of this proteoglycan to bind key growth factors as well as cell surface 
components suggests that it helps coordinate proper cartilage growth and development.
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1.4.1.8 Syndecan
The syndecans are a family of transmembrane heparan sulfate (HS) proteoglycans and 
chondroitin sulfate (CS) which is implicated in the binding of extracellular matrix 
components and growth factors. Syndecans bind a variety of molecules via their 
heparan sulfate chains and act as receptor or co-receptors molecules. There are 4 known 
members of the syndecan family (syndecan-1,-2,-3 and -4) (Figure 1.8). The syndecans 
are ubiquitous components of the plasma membranes of cells, act as receptors for the 
extracellular matrix, and are involved in intracellular communications (Elenius and 
Jalkanen, 1994; Fuki etal., 1997).
1.4.1.8.1 Syndecan-3
The expression of Syndecan-3 is found in the distal mesenchymal cells of the limb bud 
that undergoes proliferation and as a result of the outgrowth of the apical ectodermal 
ridge (AER), which is one of the regions that control the limb bud development (Dealy 
et al, 1997). Furthermore, according to Crossely et al (1996); Vogel et al (1996); 
Kosher (1998), this apical ectodermal ridge is induced by the mesoderm and is also 
involved in the limb bud formation, a process that appears to be mediated at least in part 
by members of the FGF family of growth factor.
Syndecan-3 is transiently expressed during the onset of the limb cartilage differentiation 
in vitro (Gould et al., 1992; Fisher et al., 2005). During this process, the mesenchymal 
cells become closely juxtaposed and undergo cell-cell. Recent studies have indicated 
that syndecan-3 is intimately associated with chondrocyte proliferation and plays an 
important role in regulating this process. In situ hybridisation data have shown that 
syndecan-3 gene expression is associated with proliferating chondrocytes and the 
pattern of its expression changes according to the topographical redistribution of these 
cells with increasing age of skeletal elements (Shimazu et al., 1996; Kirsch et al., 2002; 
Fisher et al., 2005; Tkachenko et al., 2005)
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GAG attachment site
Syndecan 1 Syndecan 2 
MW 33 kD 23kD
Cell membrane 
Syndecan 3 Syndecan 4 
43 kD 22kD
Figure 1.8: Diagram is showing the structure and molecular weight of syndecan-1,-2,-3 
and -4 (Adapted from Tkachenko et al, 2005)
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1.4.1.9 Hyaluronan (HA)
Hyaluronan (hyaluronic acid) is a high molecular-mass polysaccharide found in the 
extracellular matrix ECM. About 1-10% of the cartilage glycosaminoglycans are 
hyaluronan. It is synthesized in the plasma membrane of fibroblast and other cells 
(Kundson, 2003). Its structure is the simplest of all glycosaminoglycans. Hyaluronan is 
an unsulfated glycosaminoglycan, made of repeating disaccharide units of P-l, 4- 
glucuronic acid-p-1, 3-N-acetyl-D-glucosamine, (Figure 1.7 C) and is critical for 
normal mammalian embryogenesis as suggested by Spicer et al (2002). Hyaluronan has 
been assigned various physiological functions in the intercellular matrix. The 
production of this molecule is increased in the proliferating cells and the polymer may 
play a role in mitosis (Kundson, 2003). Hyaluronan plays a structural role in cartilage 
and other tissues. The cartilage proteoglycan, aggrecan, is bound specifically to 
hyaluronan chains. A study of HA in the epiphyseal growth plate reported that 
hypertrophic chondrocytes secreted large amounts of HA into the pericellular space and 
this contributed to expansion of the lacunae (Knudson, 2003).
1.4.1.10 Matrix Metalloproteinnases (MMPs)
Matrix metalloproteinnases (MMPs) belong to a large family of zinc-dependent 
proteases involved in proteolytic degradation of the ECM. Twenty four members of the 
MMP family have been identified in humans. Ortega et al (2004) have indicated that 
degradation of the ECM is necessary for the process of endochondral ossification. The 
important role of MMPs in endochondral ossification has been pointed out in recent 
studies using deficient MMP-9, MMP-13 or membrane type 1 MMP (MT1-MMP) 
deficient mice (Ortega et al., 2004).
MMP-13 is exclusively expressed in hypertrophic chondrocytes and osteoblasts during 
the development of skeletal tissues. In the hypertrophic and calcified cartilage matrix, 
MMP-13 degrades type X collagen and aggrecan (D’Angelo et al, 2001). It has been 
found that a synthetic inhibitor of MMP-13 not only stops the MMP-13 activity in the 
culture of growth plate chondrocytes but also inhibits mineralisation. This suggests that 
matrix resorption is essential for mineralisation to occur. According to Wu et al,
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(2002), a lack of degradation products leads to suppression of MMP-13 and type X 
collagen gene expression and this emphasises the important link between hypertrophy 
and matrix resorption.
Another important member of the MMP family is MMP-9. It has been demonstrated 
that MMP-9 is a key regulator of growth plate angiogenesis and apoptosis of the 
hypertrophic chondrocytes (Vu et al., 1998). Active MMP-9 is located at the sites of the 
matrix resorption where vascular invasion occurs; its expression is found in osteoclasts, 
endothelial cells and bone marrow stormal cells. The events such as hypertrophic 
chondrocyte apoptosis, vascularisation and ossification are delayed in homozygous 
MMP-9 null mice. This delay leads to an abnormal accumulation of hypertrophic 
cartilage. MMP-9 is thought to take part in the release of angiogenic factors from the 
hypertrophic cartilage ECM during endochondral ossification (Wu et al., 2002).
1.5 Factors that Regulate Endochondral Ossification
A balance of a large number of factors is required for normal growth and development 
in the skeleton (Hering, 1999). These factors include TGF-P, BMP, Ihh, PTHrP, Sox9, 
FGF, CTGF and IGF (Hering, 1999). Also some systemic hormones, vitamins, 
cytokines were found to have important roles in cartilage formation (Moussad and 
Brigstock, 2000; Olsen et al., 2000).
1.5.1 Transforming Growth Factor-P (TGF-P)
There are two sub classes of transforming growth factors: TGF-a and TGF-p. These 
proteins were first isolated from tumour extracts (Graff et al., 1997). Amongst these two 
subclasses, TGF-a is the smaller protein with a single polypeptide chain of 5.6kDa and 
shows epidermal growth factor (EGF) like activities with the ability to compete with 
EGF. On the other hand, the TGF-P has two identical polypeptides linked by disulphide 
bonds with a size of 25kDa. The subclass TGF-P has three main isoforms (TGF-pi, p2 
and P3) which are known to be produced by chondrocytes and osteoblasts and are
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highly concentrated in skeletal tissues (Bierie et al, 2006; Machide et al, 2005; Alvarez 
etal., 2002).
1.5.1.1 Expression Sites of TGF-p
In the growth plate, TGF-p 1 expression is restricted to the proliferative and upper 
hypertrophic zones whereas TGF-p2 is found throughout the cartilage zones with the 
highest intensity of expression detected in the hypertrophic and mineralised zones. 
Meanwhile, TGF-p3 is found in the proliferative and hypertrophic zones (Moses et al, 
1996).
1.5.1.2 Functional Roles of TGF-p
The transforming growth factor-P (TGF-P) super-family of paracrine and autocrine 
signalling molecules is known to regulate the process of all embryonic developmental 
mechanisms (Wrana et al, 1994). Janssens et al (2005) suggested that TFG-pl, P2 and 
p3) are involved in the regulation of bone and its turnover. Moreover, it has been 
suggested that the transforming growth factor-P is able to regulate the proliferation and 
the activity of most types of vertebrate cells (Gumienny and Padgett, 2002).
TGFs have been shown to stimulate a number of biological processes such as bone 
resorption and cell proliferation (Ji et al, 1996). The function of TGF-p is to regulate 
chondrocyte and osteoblast proliferation and differentiation (Thorp et al, 1992) and 
may be involved in chondrocyte hypertrophy. The histological changes associated with 
chondrocyte maturation are well defined and some workers have recently reported that 
chondrocytes undergoing differentiation and hypertrophy express high level of TGF-P 
(Thorp et al, 1992; Joyce et al, 1990). The active form of TGF-p is found primarily in 
differentiating and hypertrophic chondrocytes (Joyce et al, 1990; Thorp, 1992). The 
activity of TFG-p3 is associated with the processes that result in chondrocyte 
differentiation. As pointed out by Gumienny and Padgett (2002), disruption of TGF-P 
often leads to the development of cancer and other diseases; in particular, TGF-p3 was
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found to be reduced in the prehypertrophic chondrocytes in some skeletal diseases 
(Farquharson, 1996).
Transforming growth factor-p is known to be involved in endochondral ossification in 
association with other known factors such as BMPs, PTHrP and Sox9, and in particular 
in the regulation of chondrocyte differentiation (Gumienny and Padgett, 2002). 
Interplay between TGF-p and PTHrP has been demonstrated by Serra R and Chang C
(2003) to regulate hypertrophic differentiation in embryonic mouse metatarsal organ 
culture. According to Alvarez et al (2002) TGF-p2 acts as a signal relay between Ihh 
and PTHrP in the regulation of cartilage hypertrophic differentiation. Included within 
the TGF-p super family are a subgroup known as the Bone morphogenetic proteins 
(BMPs), which are described below.
1.5.2 Bone Morphogenetic Protein (BMP)
Bone morphogenetic proteins (BMPs) belong to a conserved sub-family of the super­
family of TGF-p and have important functions in many biological tissues. BMP and 
TGF-p gene family include at least 43 members (Boden, 2005). BMPs were originally 
isolated from bovine bone and defined by their ability to induce de novo ectopic bone 
formation (Boden, 2005). According to Gooch et al (2002), they regulate many different 
biological processes including embryonic pattern formation, cell growth and cell 
differentiation. BMPs are dimeric molecules with two chains that are joined together by 
disulphide bonds. Each monomer consists of about 120 amino acids with seven cysteine 
residues (Reddi, 1998).
Bone morphogenetic proteins work through members of a larger family of serine 
threonine kinases, including the receptors of transforming growth factor-p. Massague et 
al (1994) believe that these receptors transduce the signals to the nucleus through 
pivotal interacellular mediator of TGF-P family member protein (Smad). Smad is a 
member of the MAD-related family of molecules. MAD-related proteins are a recently 
identified family of intracellular proteins that are thought to be essential components in
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the signalling pathways of the serine/threonine kinase receptor of the transforming 
growth factor beta superfamily The work of Bubnoff and Cho (2001) has identified a 
number of nuclear cofactors that cooperate with the Smads to regulate specific target 
genes depending on the cellular response. These members of the TGF-P super family 
(BMPs) bind to two different types of serine-threonine kinase receptors, Type 1 and 
Type 2 which are required for signal transduction (Chen et al, 2004). Both have a 
similar structure with a short extracellular domain, a single transmembrane domain, and 
conserved cysteine residues. The intracellular domain contains a serine-threonine kinase 
motif (Kobayashi et al, 2005).
Bone morphogenetic protein initiates the formation of bone and cartilage and regulates 
chondrocyte differentiation. In addition, BMPs promote and maintain articular cartilage 
chondrocytes phenotype in cell culture (Nishihare et al, 2003). Analysis of the BMP 
expression demonstrated that each protein has a unique tissue distribution. Seven 
related proteins were found, namely BMP-1 to BMP-7. Bone morphogenetic protein -1 
has a different structure to the other BMPs and it is thought to activate the others by 
proteolysis. Moreover, BMP-2 and BMP-4 are expressed during mesenchyme 
condensation in the early limb development (Kinglsey, 1994; Zou, 1997). Bone 
morphogenetic protein-2 also appears to induce differentiation of mesenchymal cells 
into chondrocytes (Tsumaki et al, 2002). It has been shown that BMP-2 leads to 
endochondral bone formation and other events such as mesenchymal cell infiltration, 
differentiation of cells into chondrocytes, removal of the cartilage, formation of bone, 
population of the bone with bone marrow elements and ultimately normal remodelling 
of the bone (Swarthout, 2002; Wan and Cao, 2005). Bone morphogenetic protein-6 has 
been shown to be expressed in the hypertrophic and prehypertrophic chondrocytes 
(Vortkamp, 2001).
The activity of BMP signalling in the embryo can be interrupted by several other 
secreted proteins including Noggin and Chordin. Biochemical analyses have 
demonstrated that both Noggin and Chordin bind BMP proteins directly, preventing 
them from interacting with their receptors (Tardif et al, 2006). It has also been reported
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that members of the BMP family are differentially expressed in the developing cartilage 
elements where Ihh is present. The missexpression of Ihh in the developing cartilage 
affects the expression pattern of various BMP genes (Pathi et al, 1999).
1.5.3 Indian Hedgehog (Ihh)
Embryonic development is guided by many different molecules which can be grouped 
into a relatively small number of categories; some of them act as transcription factors, 
whereas others are intercellular signalling molecules. Some of this latter group affect 
other cells rather than those that produce them. One of the most important families of 
embryonic signalling molecules is that of the hedgehog proteins (Fietz et al, 1994; 
Enomoto-Iwamoto et al, 2000).
Hedgehog has been studied in Drosophila. The studies have demonstrated that 
hedgehog is a segment polarity gene that regulates segmentation and anterior-posterior 
patterning of the blastoderm (Fietz et al, 1994; Kobayashi et al, 2005). The hedgehog 
signalling molecules induce specific pattern of differentiation in a variety of tissues and 
structures in the development of vertebrates. So far three different forms of hedgehog 
have been identified: (a) Sonic hedgehog (Shh) is expressed in areas of epithelial- 
mesenchymal interaction such as the posterior aspect of the developing limb bud and 
the developing notochord; (b) Indian hedgehog (Ihh) is expressed in the gut as well as in 
the prehypertrophic chondrocytes in the growth plates of long bones; (c) Desert 
hedgehog (Dhh) is expressed in Schwann and Sertoli cell precursors in mammalian 
tissues (Mohle and Vani, 1992). The Indian hedgehog gene (Ihh) regulates several 
aspects of development. Earlier studies seem to suggest that Indian hedgehog plays at 
least two roles in the vertebrate development. Firstly, it is involved in the development 
of endoderm. Secondly, it regulates proliferation and differentiation of the chondrocytes 
in the growth plate via a negative feedback loop. The intercellular communication is 
mediated by the secreted signalling molecules of parathyroid hormone-related protein 
(PTHrP) (Maye, 2000; Lai et al, 2005).
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Indian hedgehog undergoes autocatalytic internal cleavage, yielding C-terminal and N- 
terminal peptides (Zhang et al, 2001). The former is then released from the cell surface 
but the latter still remains associated with it. The C-terminal has been shown to display 
autoproteolytic and cholesterol transfers activity that results in the cleavage of the full- 
length protein and covalent attachment of a cholesterol moiety to the newly generated 
N-terminal domain. The N-terminal however is active in both local and systemic 
signalling and binds to the Ihh receptor patched (Patch) receptor to mediate downstream 
Ihh signalling (Stone and Shi, 1996; Zhang et al, 2001). The exact mechanisms, by 
which Ihh binds to Patched, and the involvement of Smoothened (Smo) in this process, 
are still unclear (Kalderon, 2000). Smoothened is a protein with seven transmembrane 
domains that is distantly related to G-protein coupled receptors (GPCR) (King, 2002). 
Patched has been reported to inhibit Smo activity directly whereas the Ihh binding may 
induce a conformational change within the Patched/Smo complex. This activity thus 
liberates Smo from the repressive influence of Patched, resulting in downstream 
signalling (Stone and Shi, 1996; Incardona et al., 1998). It has also been suggested that 
Patched may increase expression of Smo without directly interacting with Smo but 
through a diffusible intermediate molecule (Taipale et al., 2002). On the other hand, it 
has been observed that the binding of Ihh to Patched can alter the activity of this 
molecule, thereby resulting in the loss of the expressive effect of Patched on Smo 
activity. Further evidence has suggested that the hedgehog signalling pathway may be 
blocked by steroidal alkaloid compound, Cyclopamine (see Figure 1.9). (Clifford and 
McMahon, 1997; Cooper et al, 1998; Incardona et al, 1998 and Kim, 1998 and Taipale 
et al., 2002 and Kayed et al., 2003). Previous studies have shown that during the 
endochondral bone formation, Ihh is a key molecule responsible for the regulation of 
chondrocyte maturation (Vortkamp, et al., 1996, 1998; St-Jacques et al., 1999; Lia et 
al., 2005). As suggested by Pathi et al (1999); MacLean et al (2005), Ihh achieves its 
regulatory functions by inducing a series of downstream factors which include its 
receptor such as patched (Patched).
During the maturation of chondrocytes, Ihh expression is restricted to the lower region 
of the prehypertrophic zone. This biological function of Ihh promotes chondrocyte 
proliferation through PTHrP signalling mechanisms (McMahon et al., 2003; Vortkamp,
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1996; Hammerschmidt, 1997). A number of recent studies have indicated that 
disrupting the Ihh mechanism in mice leads to a decrease in the chondrocyte 
proliferation and changes in the expression of PTHrP, hence resulting in an abnormal 
positioning of hypertrophic chondrocytes close to the prearticular cartilage surface 
(Farquharson et ah, 2001). Mutation in Ihh may inhibit binding to its receptor and this 
kind of inhibition results in the shortening of the digits in the syndrome brachydactyly 
type A-l (Chung et ah, 2000; Shum et ah, 2003; Maclean et ah, 2005).
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Figure 1.9: Diagram of a generalized Hh-Gli signalling pathway derived from 
knowledge in model systems. The zinc-finger protein Ci (Cubitus interruptus, a member 
of the Gli family) is cleaved proteolytically to a repressor which supresses expression of 
Hh target genes. The binding of Hh with Patched blocks the cleavage of Ci and it acts as 
a transcriptional activator (Adapted from Weitzman, 2002).
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Ectopic expression of Ihh has been shown to affect the normal development of the 
cartilage growth plate, thus leading to abnormal bone formation (Jtippner, 2000; 
Razzaque et al, 2005). The expression of Ihh also induces that of Patched (Patched) and 
Gli, which are known to be associated with Ihh signalling mechanism (Vortkamp,
1996). Patched and Gli are expressed in the perichondrium adjacent to the transitional 
zone of the growth plate where Ihh is expressed.
As suggested by Long et al (1998), the expression of Ihh, stimulates its receptors in the 
perichondrium and as a result increase the production of PTHrP in the periarticular 
perichondrium. The PTHrP then binds receptors on chondrocytes in the prehypertrophic 
zone above the location where Ihh is expressed. When these cells become mature (or 
hypertrophic) they cease to express Ihh (Figure 1.10). Furthermore, it has been 
demonstrated that surgical removal of the perichondrium leads to an increased rate of 
cell proliferation and an extended hypertrophic zone and this observation suggests that 
this tissue may play an important role in the control of chondrocyte differentiation. This 
process will be described in detail later (1.5.4).
Some studies have reported that Ihh-null mutants exhibit a severe reduction in skeletal 
growth, resulting in long bones that are only one-fifth to one-third of the normal length 
at birth (St-Jacques et al, 1999). Moreover, chondrocyte differentiation in these mice is 
profoundly disturbed, as indicated by an initial delay in hypertrophy followed by rapid 
appositional hypertrophy throughout the bulk of cartilage. Ihh-null mouse embryos 
display a 50% reduction in chondrocyte proliferation (St-Jacques et al, 1999). On the 
other hand, it has been found that some members of the BMP family are expressed in 
the perichondrium flanking the Ihh expression domain suggesting a potential interaction 
with the Ihh/PTHrP signalling pathway (Zou, 1997). For example BMP 2 and BMP 4 
are expressed in the perichondrium of developing cartilage (Shum et al, 2003). 
Experiments in the chick limb indicated that expression of both molecules can be up- 
regulated by miss-expression of Ihh (Pathi et al., 1999).
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1.5.3.1 Ihh/PTHrP Interaction with FGF
It has been recently reported that FGF signals interact with the Ihh/PTHrP and the BMP 
signalling pathways to regulate chondrocyte development (Figure 1.11). As previously 
described, Ihh expressed in the prehypertrophic chondrocytes induces the expression of 
various BMPs in the adjacent perichondrium/periosteum and proliferating chondrocytes 
(Minina et al., 2001). Indian hedgehog and BMP signals act in parallel to induce 
chondrocyte proliferation, whereas FGF signalling inhibits chondrocyte proliferation 
independently of Hh signalling system. Ihh, in addition, regulates the expression of 
PTHrP in the periarticular region; the expression level of PTHrP signalling determines 
the distance from the joint where the onset of hypertrophic differentiation takes place, 
thereby indirectly regulating the chondrocytes that are undergo proliferate. 
Chondrocytes that are released from the expression level of PTHrP signalling, react to 
BMP signals with the up-regulation of Ihh expression. In contrast, FGF signals act as 
antagonists of BMP signalling and negatively regulate Ihh expression. By acting 
upstream of Ihh, the balance of FGF and BMP signals regulates the distance from the 
joint region where the hypertrophic differentiation takes place. Furthermore, when FGF 
signalling accelerates the rate of terminal hypertrophic differentiation, BMPs have been 
shown to suppress this process. By simultaneously regulating proliferation, Ihh 
expression, and the rate of terminal hypertrophic differentiation, therefore, the balance 
of FGF and BMP signals seems to control the process of hypertrophic differentiation to 
the proliferation rate through Ihh/PTHrP negative feedback loop (Figure 1.10) (Minina 
et al., 2002).
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Figure 1.10: The Indian Hedgehog and PTHrP negative feedback loop. 
(Taken from Vortkamp et al., 1996)
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Figure 1.11: Diagram showing the interaction of FGF, BMP and Ihh/PTHrP signalling 
pathway in the growth plate (Adapted from Minina et al, 2002).
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1.5.4 Parathyroid Hormone Related Protein (PTHrP)
Parathyroid hormone-related protein (PTHrP) is an autocrine/paracrine regulator of 
chondrocyte differentiation was originally identified as a pathogenic factor for 
malignancy-associated hypocalcaemia (Martin et al, 1988). According to van 
Donkelaar et al (2006), PTHrP is considered as a physiological paracrine factor 
regulating cell proliferation and differentiation in many tissues during fetal and 
postnatal growth. It has been shown that the amino terminal region of PTHrP is 
homologous with the amino terminal of the domain of parathyroid hormone (PTH) 
which is an 84 amino acid polypeptide hormone (Chung et al., 2000). This hormone 
functions as a major mediator of bone remodelling and an essential regulator of calcium 
homeostasis (Chung et al, 2000). Both PTH and PTHrP indirectly activate osteoclasts, 
hence resulting in an increased bone resorption (Swarthout et al., 2002). Some studies 
have indicated that both bind to class I PTH/PTHrP receptor found in the avian growth 
plate (Jiippner 1991). Also, it has been shown that PTHrP is a negative regulator of 
chondrocyte terminal differentiation in longitudinal bone growth (Vortkamp et al., 
1996; Farquharson et al., 2001).
In the growth plate, PTHrP is synthesized by the cells in the periarticular cartilage 
region and adjacent perichondrial cell near the ends of bones. However, PTH/PTHrP 
receptor mRNA is expressed in the chondrocytes immediately below the periarticular 
region, mostly in the proliferative region where the cells form columns and at high level 
in prehypertrophic chondrocytes (Kobayashi et al, 2002; Lee, 1996; MacLean et al, 
2005). An in situ hybridization study has demonstrated that PTH/PTHrP receptor is 
expressed by mature chondrocytes that express type II collagen, but not by hypertrophic 
chondrocytes expressing type X collagen in fetal and 4-weeks old rat femur (Figure 
1.12) (Lee et al, 1996).
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receptors in the growth plate. PTH/PTHrP is expressed by the chondrocytes in 
periarticular surface, and their receptor is expressed in the upper region of the 
prehypertrophic zone. Ihh is expressed by the cells in the lower region of the 
prehypertrophic region.
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PTHrP has been demonstrated to be a potent mitogen as well as an inhibitor of 
chondrocyte alkaline phosphatase (ALP) activity. PTHrP is known to slow down the 
rate of differentiation of prehypertrophic within the growth plate (Vortkamp et al., 
1996; Farquharson, 2001).
In embryogenesis, it has been suggested that PTHrP acts as an endogenous inducer of 
parietal endoderm differentiation (Medill et al, 2001) and that it is expressed in 
response to Ihh, which mediates its action through the membrane receptor ‘Patched’ 
(Patched). Recently, it has been shown that bone shows abnormality during its 
development when the activity of PTHrP is blocked. The differentiation of 
chondrocytes is accelerated in mice that lack PTHrP, and the bones show premature 
ossification throughout the endochondral process. Similar abnormalities occur in 
animals that lack PTH 1 receptor which plays a central role in chondrocyte proliferation 
and differentiation and which mediates the autocrine/paracrine actions of PTHrP. 
Jiippner (2000); Kobayashi et al (2002) have reported that a lack of PTHrP gene leads 
to quick death after birth with striking abnormality of endochondral bone development. 
However, an increase in PTHrP signalling also results in abnormalities of the growth 
plate. PTHrP is expressed in a wide variety of adult and embryonic cell types, including 
osteoblasts and chondrocytes (Broadus and Stewart, 1994; Suva, 1987; Lee, 1995). As 
described above, during the development of endochondral bones PTHrP is expressed in 
the periarticular perichondrium on the surface of the epiphyseal plate. Many studies 
have indicated that PTHrP is involved in the regulation of bone formation. Recent 
genetic knockout experiments have demonstrated that knocking out the PTHrP gene 
leads to an increase in the endochondral bone formation. In the PTHrP knock out 
epiphyses reveal diminished resting and proliferating zones but accelerated chondrocyte 
maturation and apoptosis (Lanske, 1996). Moreover, transgenic mice lacking either 
PTHrP or PTH/PTHrP receptors show evidence of dwarfism resulting from accelerated 
differentiation and premature hypertrophy. Also, the over expression of PTHrP in 
mouse growth plate has been shown to exhibit dwarfism (Schipani et al., 1996; Ballock 
and O'Keefe, 2003).
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Some studies suggest that the development of chicken tibial dyschondroplasia (TD) is 
associated with over expression of PTHrP (Farquharson et al, 2001). In the earlier 
studies made by Lee et al (1996); Vortkamp et al (1996) PTHrP expression was 
detected throughout the proliferative and hypertrophic zones of the juvenile chick 
growth plate but this expression was much less obvious in the embryonic tissue. In 
addition, van der Eerden et al (2000) have reported that PTHrP is distributed throughout 
the rat growth plate and suggested that the expression pattern of PTHrP differs 
markedly at the embryonic and post- stage of growth plate development. PTHrP 
expression was found to be normal in the chondrocytes of the growth plate and reduced 
within the lesion of tibial dyschondroplasia (TD) itself (Ben-Bassat et al., 1999).
1.5.5 Sox 9
Sox proteins belong to super family of DNA-binding proteins. In normal cartilage 
development, transcription factors are required to interact with other regulatory factors. 
This interaction is necessary to control the multi-step process of gene expression that 
takes place at different stages of endochondral ossification (Bell et al, 2000; Lefebvre 
et al, 2005). A number of transcriptions factors have been under investigation for two 
decades, namely those of Sox family which are known to be associated with the 
cartilage development. The Sox gene family plays a critical role in the development of a 
wide variety of tissues during embryogenesis. Twenty-seven mammalian Sox genes 
have so far been identified (Kulyk et al, 2000).
A member of the most rapidly growing family of Sox is Sox 9 which has been 
demonstrated to be involved in the regulation of embryogenesis (Marshall and Harley, 
2000). This transcription factor has been shown to be involved in the process of 
chondrocyte differentiation and chondroprogenitor condensation in the early stage of 
cartilage formation, but not in hypertrophic chondrocytes (Shibata et al, 2006). Sox 9 
has the ability to activate the transcription of some regulatory genes. The transcription 
factor is required for expression of a number of chondrocyte specific proteins such as 
type II, type IX, type XI collagens and aggrecan. It has been shown that blocking Sox 9 
gene expression influences chondrocyte differentiation. This indicates that Sox 9 plays
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an important role in the regulation and the synthesis of extracellular matrix. Also, Sox 9 
mutation has been demonstrated to cause human skeletal malformation syndrome 
campomelic dysplasia (de Combrugge et al., 2000;).
It is known that mutation of Sox 9 leads to the human genetic disease called 
Campomelic Dysplasia (CD), and is characterized by the hypoplasia of most skeletal 
elements that are derived by endochondral ossification and is caused by heterozygous 
mutations in the Sox 9 gene (Wagner et al., 1999). The disease is characterised by 
bowing and angulations of the long bone as a result of the deformation of the cartilage 
(Lefebvre et al., 1998). The knockout experiments of Sox 9 using mice have indicated 
that the mutant mesenchymal cells do not differentiate into chondrocytes, and as a result 
do not form cartilage (Marshall and Harley, 2000).
1.5.6 Fibroblast Growth factor (FGF)
Fibroblast growth factors (FGFs) regulate cell proliferation, migration and cell 
differentiation. They comprise a large family of polypeptide growth factors found in all 
organisms. The FGF family includes at least 13 members, which have been found to be 
highly conserved in both gene structure and amino-acid sequence among species 
(Hering, 1999; Govindaijan et al, 2006). FGFs and their receptors (FGFRs) play 
important roles in skeletal development and bone formation, by regulating the 
expression of various genes involved in osteoprogenitor cell replication, osteoblast 
differentiation and apoptosis. In addition FGFs have been identified to be expressed in 
many physiological and pathological processes such as embryonic development, cell 
survival, and malignant transformation (Marie, 2003).
In the early stage of skeletal development, a number of FGFs have been reported to be 
expressed locally. Fibroblast growth factor-2 and FGF9 were found to be expressed in 
mesenchymal cells and osteoblasts. Fibroblast growth factor-2 molecule has been 
demonstrated to be produced by mature osteoblasts and is eventually stored in the 
extracellular matrix in the growth plate. Recent studies have indicated that over 
expression of FGF2 induced abnormal long bone formation. In addition, FGF2 has been
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shown to be involved in the regulation of marrow stormal cells in the long bone which 
eventually induce osteoblast differentiation and matrix mineralisation. Hence, FGF 
signalling is required for the proper biological process of long bone formation (Marie, 
2003; Bioilly et al., 2000).
Fibroblast growth factor receptor-3 is one of the high affinity receptors for the FGF 
ligands. Ligand binding to FGFRs is facilitated by heparan sulfate proteoglycan (HSPG) 
and specified by alternative splicing of the Ig-like extracellular domain. Fibroblast 
growth factor receptor-3 is expressed adjacent to FGF 18 in developing cartilage and 
bone, suggesting that it may mediate some of the biological effects of this ligand in the 
developing skeleton. In human, activating mutation in FGFR3 results in 
chondrodysplatic disorder that are characterised by a reduction in proliferating 
chondrocytes and defective bone formation (Muenke and Schell, 1995). These disorders 
have been replicated in mice expressing transgenes encoding the activating mutation in 
the cartilage. Conversely, mice homozygous for targeted inactivation of FGFR3 develop 
severe kyphosis and skeletal overgrowth, which has been attributed in part to increased 
proliferation of chondrocytes and reduced turnover of mature cartilage into bone at the 
chondroosseous junction (Amizuka et al., 2004).
1.5.7 Small Acidic Protein (SAP)
In our laboratory, a novel chicken gene was isolated from embryonic cartilage using 
differential display PCR (Webster, 1999). This gene was found to be homologous to 
the mRNA of a gene that encodes a small acidic protein in the Coturinx japonica 
(Japanese quail), accession number U37722 (Gong, 1997). It has been reported that the 
small acidic protein (SAP) is upregulated in the proliferative chondrocytes of the 
embryonic chick sternum (Webster, 1999). This gene has also been shown to be 
expressed by cells from brain, eye, heart, liver, kidney and skeletal muscle of quail 
tissues (Gong, 1997). The sequence of this gene is short in quail, chick and human, with 
an mRNA of 758 nucleotides with a poly -A  tail (Webster, 1999). The mRNA and 
peptide sequence are highly conserved between species (Figure 1.14).
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The chick SAP mRNA sequence (Figure 1.13) is 92% and 60% identical to the quail 
and human SAP sequences respectively. The predicted amino acid sequences of the 
chick SAP are 95% and 74% identical to the quail and human forms respectively 
(Figure 1.14).
The quail SAP has distinct acidic and basic regions (Figure 1.16) and in the chick, the 
acidic amino acids are concentrated within the carboxyl terminus of the protein from 
approximately residue 105 to residue 158, which may point to a protein-binding 
domain. The basic region is located near to the amino terminus and the SAP protein has 
no signal peptide (Webster, 1999). The secondary structure of SAP was predicted to be 
of a basic-helix-loop-helix , with 5a - helical regions, 6 or 7 looping regions and one 
short P-sheet (Webster 1999), (Figure 1.15). From the predicted secondary structure, 
SAP appears to have distinct DNA and protein binding regions. Therefore, this protein 
may function as a transcription factor regulating transcription of genes that are involved 
in mediating chondrocyte proliferation or differentiation (Webster, 1999).
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5 '
*  2 0  *  4 0  *
TCGGCACAAGCGGCCATGAGCTCGGCCCGGGAGTCGCAGGCTCGCCACGG : 5 0
6 0  *  8 0  *  1 0 0
CCTCAAGCGAGCGGCCTCTCCCGACGGCTCCGGCAGCTGGCAGGCGGCGG : 1 0 0
*  1 2 0  *  1 4 0  *
ACCTCGGCAACGAGGAGAGGAAGCAGAAGTTCCTGAGGCTGATGGGCGCG : 1 5 0
1 6 0  *  1 8 0  *  2 0 0
GGGAAGAAAGAACATACTGGCCGCCTTGTTATCGGAGACCACAGATCAAC : 2 0 0
*  2 2 0  *  2 4 0  *
CTCTCACTTCAGGACAGGGGAAGAAGACAAGAAAATGAATGAAGAACTGG : 2 5 0
2 6 0  *  2 8 0  *  3 0 0
AGTCTCAGTACCAGCAGAGCATGGACAGCACGATGTCTGGACGAAACCGG : 3 0 0
*  3 2 0  *  3 4 0  *
CGCCATTGTGGACTGGGTTTCAGTGAGTTTCAGGAAGGTGAAGAGGAGGC : 3 5 0
3 6 0  *  3 8 0  *  4 0 0
AGCTGGGCATTCCTCTGACCATGAGAGTTCAGAGGACTCCGAAAGTGGCT : 4  0 0
*  4 2 0  *  4 4 0  *
CTGATTCAAAGCAAGATGAATCTGCAGAGGAACTGCAAGCTGCTGAAACA : 4  5 0
4 6 0  *  4 8 0  *  5 0 0
CACGATGAAGCTGCGGTCCCAGAAACCAAAAAGGAAGCAAAAAGCAATTA : 5 0 0
*  5 2 0  *  5 4 0  *
TAAAATGATGTTTGTTAAAGCCAGTGGTTCATAACTGCAGATGTAACAGC : 5 5 0
5 6 0  *  5 8 0  *  6 0 0
TTTGGATTTAAAGTACAGTAAGCCTTATTGTTACAGTGCAAAGTGGAGGA : 6 0 0
*  6 2 0  *  6 4 0  *
CTGCTACAGCACAAATCTTTGTATTATGATTTTAAAACCCCCCTGCTAGA : 6 5 0
6 6 0  *  6 8 0  *  7 0 0
TGACAAAAAGTAGTGTTTGCTTTCAGTTGCCGTGGGCACAGTGAGATTCC : 7 0 0
*  7 2 0  *  7 4 0  *
TGGTTTTTGTAAAGTGTATAAAATAATGGATGAAGAAATAAATTCTTTGT : 7  5 0
7 6 0  *
TCCTGCAAAAAAAAAAAAAA : 7 7  0
Figure 1.13: the sequence of the chick small acidic protein RNA. Assession 
number: C R 3 5 3 8 2 2 .
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Figure 1.14: Amino acid sequence homologies of chick, quail and human small acidic 
protein peptides. Black shading indicates identity between all three, and grey shading 
indicates homology between two. Chick and quail share 95% amino acid identity, chick 
and human share 72% identity, and quail and human share 74% identity. Prepared using 
GeneDoc software (KarlNicholas; www.cris.com/~ketchup/genedoc.shtml) Adapted from 
(Webster, 1999).
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Key
■  Helix 
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Figure 1.15: Predicted secondary structure of the quail small acidic protein. The 
structure consists predominantly of a repeated helix-loop-helix motif.
Predicted using NN-predict software (McClelland and Rumelhart, 1988; Kneller et 
al, 1990) and PSA (http://bmerc-www.bu.edu/psa/request.htm. Stultz et al., 1993; 
White et al., 1994; Stultz et al, 1997) (Adapted from Webster, 1999).
N 100 C
Acidic residues 
Basic residues
100
Figure 1.16: The acidic and basic amino acids within the quail small acidic protein. 
The acidic residues (red) are grouped in the carboxyl end of the protein and a 
predominantly basic region (green) exists in the amino half.
Prepared using DNA Strider software (Christian March, Service de Biochimie, 
Departement de Biologie, Institut de Recherche Fondamentale, CEA, France). 
(Adapted from Webster, 1999).
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1.8 Aims and Objectives o f the Present Project
During a recent study performed in our laboratory, a novel gene was found in the 
embryonic chick sternum (Webster, 1999) which is a highly likely candidate gene for 
the regulation of chondrocyte maturation in endochondral ossification. This gene is 
homologous to a small acidic protein found by Gong et al (1997) in the Japaneese quail 
(Coturinx japonica). It is hypothesised that SAP is a nuclear protein which may act as a 
transcription factor for genes that are involved in mediating the process of proliferation 
and differentiation of chondrocytes during EO.
1.8.1 Aims
The main aim of the present study is to determine whether SAP plays a role in the 
differentiation of chondrocytes either independently or in association with Ihh and 
PTHrP.
1.8.2 Objectives
The current work utilising both, chick sternal and tibial growth plate cartilage is 
designed to achieve a set of objectives:
(1) To ascertain that SAP is differentially expressed in the growth plate.
(2) To investigate any possible link between SAP expression and expression of the 
Ihh/PTHrP feedback loop in cartilage.
(3) To investigate the biological consequences of SAP miss-expression in 
hypertrophic chondrocytes.
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Investigation of the expression of 
SAP in embryonic chick cartilage by 
In Situ Hybridisation
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2 Introduction
The chondrocytes within the growth plate go through a series of distinctive 
developmental stages that include proliferation, maturation and hypertrophy. During 
these important stages these chondrocytes show variations in their gene expression. For 
instance, type X collagen and indian hedgehog have been known to regulate the process 
of endochondral ossification. It has been reported that type X collagen is expressed by 
the hypertrophic chondrocytes (Safarali et al., 2001; Shen, 2004). In contrast, Indian 
hedgehog (Ihh) has been shown to be expressed by transitional, prehypertrophic 
chondrocytes in the prehypertrophic zone (transition zone) of the growth plate but not 
by the hypertrophic chondrocytes. This gene (Ihh) has been reported to be involved with 
other genes to block further differentiation of proliferating chondrocytes to hypertrophy 
(Seth et al., 2000; Lia et al., 2005). According to Vortkamp et al (1996), the 
missexpression of Ihh shows a failure of chondrocyte hypertrophy.
In this study, Type X collagen and Ihh have been used as markers for prehypertrophic 
and hypertrophic chondrocytes respectively. In situ hybridisation was used to localize 
the expression of these regulatory genes in the sternum and tibia of 17-day chick 
embryo. The main aim of this series of experiments was to detect the mRNA of Small 
Acidic Protein (SAP) in these tissues. In this study I localized the SAP mRNA in the 
chick growth plate and the embryonic sternum using in situ hybridisation, and the gene 
was found to be upregulated in the transition zone of the growth plate and 
downregulated in the hypertrophic zone. Also this gene was found to be upregulated in 
the caudal region of the chick sternum and downregulated in the cephalic region in the 
same tissue. The differential display PCR result showed that this gene (SAP) appears to 
be upregulated in the proliferative chondrocyte region of the embryonic chick sternum 
and downregulated in the hypertrophic region in the same tissue.
The aim of the present study is to utilise the currently accepted knowledge in the 
expression patterns of cell differentiation markers such as Ihh, type X collagen to study 
Small acidic protein (SAP) in the sternum and tibia of 17 days embryonic chick since 
these tissues contain different phenotypes of chondrocytes. In situ hybridisation has 
been used in this investigation.
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2.1 Materials & Methods
In Situ Hybridisation techniques were performed in this project to localise the mRNA of 
Small Acidic Protein (SAP), Type X collagen and Ihh using Digoxigenin-labelled sense 
and antisense riboprobes specific for chicken SAP, Type X and Ihh mRNAs.
2.1.1 Preparation of APES-Coated Slides
Slides were sequentially washed in Lipsol for 30 minutes, 2% (w/v) SDS (Sigma) for 30 
minutes and twice in running distilled water for 10 minutes to remove the SDS. These 
slides were then washed in 95% (v/v) industrial methylated spirit (IMS) for 5 minutes 
and left to dry in a fume cupboard. They were then dipped in fresh acetone for 2 
minutes and in 2% (v/v) 3-aminopropyltriethyloxysilane (APES, Sigma) in fresh 
acetone for 2 minutes and then rinsed with acetone for 30 seconds and finally allowed to 
dry in the fume cupboard for 15-30 minutes.
2.1.2 Preparation of Embryonic Chick Sterna and tibia
For in situ hybridisations, the entire sternum of a 17-day chick embryo was dissected 
free using two pairs of sharp forceps and fixed in 4% (w/v) paraformaldehye (Sigma) in 
lOOmM PBS (Sigma) for 6 hours at room temperature. The sternum was then dissected 
into separate regions as illustrated in (Figure 2.1). Following fixation, the sternum was 
dehydrated through a series of increasing concentrations of ethanol (50, 70, 80, 90 and 
100 % v/v) in Diethylpyrocarbonate (DEPC, Sigma) treated water. The tissues were 
then cleared in xylene for 15 minutes. The fixed tissues were embedded in pure paraffin 
wax using a LEICA TP 1050 histology tissue processor. The embedded samples were 
sectioned with a LKB 2218 Historange microtome at a thickness of 8pm. The sections 
were then adhered onto APES-coated slides, dewaxed in xylene twice for 15 minutes 
and then rehydrated through a series of decreasing concentrations of ethanol. The 
sections were stained with a number of different histological stains including 
haematoxylin and eosin; Alcian blue; Masson’s trichrome (celestine blue B, Mayer’s 
haematoxylin, ponceau/acid fuchsin, 1% (v/v) phosphomolybic acid, and light green). 
The sections were mounted under cover slips with DPX (Sigma) mountant and 
examined under a LEITZ DM RB microscope.
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The tibia of 17-days chick embryos were fixed in 4 % (v/v) Paraformaldehye in 1 OOmM 
PBS for 12 hours and decalcified in 10% (w/v) EDTA (Sigma) solution for 5-7 days. 
The tibia were dehydrated through a series of increasing concentrations of ethanol in 
DEPC treated water, cleared in xylene and embedded in paraffin wax. Sections were cut 
at thickness of 8pm on a LKB Historange microtome. The sections were adhered onto 
freshly APES coated slides, dewaxed in two changes of pure xylene (each for 15 
minutes), rehydrated through a series of decreasing concentrations of ethanol and 
processed for histological studies according to the methods mentioned in the previous 
section.
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Figure 2.1: Photograph of a 17-day chick embryo sternum taken with a dissection 
microscope showing the different regions of the tissue used in the preparations of 
chondrocyte culture (Adapted from Webster, thesis 1999).
(CA) Caudal region contains proliferative chondrocytes.
(M) Middle region contains prehypertrophic chondrocytes.
(CE) Cephalic region contains hypertrophic chondrocytes.
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2.1.3 In Situ Hybridisation
2.1.3.1 Preparation of In Situ Hybridisation Slides
In order to maintain an RNase and DNase free environment, all solutions used in this 
study were prepared with 0.1% (v/v) DEPC treated water followed by autoclaving. Also 
all the glassware was baked overnight at a temperature of at least 200°C.
The prepared sections of the sternum and tibia were dewaxed in two changes of fresh 
xylene for 15 minutes, and then rehydrated through a series of decreasing 
concentrations of ethanol, 100%, 95%, 90%, 80% and 70% (v/v), each for 5 minutes. 
The fixed tissues were immersed in two changes of DEPC dEhO each for 5 minutes, 
and then incubated at 37°C with 20pg/ml Proteinase K (Sigma) in TE buffer (lOmM 
Tris/ ImM EDTA, pH8.0) for 45 minutes. The slides were post-fixed in 4% (v/v) 
Paraformaldehye in lOOmM PBS for 5 minutes and washed in two changes of DEPC 
dH20 each for 5 minutes. The slides were rinsed twice with freshly prepared 0.1M TEA 
(5.3ml of TEA 7M in 400 ml DEPC, 20ml of 0.4M HC1 /0.25% (v/v) acetic anhydride 
(Sigma) each time for 5 minutes to reduce non-specific binding of probes and then 
immersed in 5x SSC for 15 minutes.
2.1.3.2 Preparation of Sense and Antisense Riboprobes for Chicken Small Acidic 
Protein (SAP), Type X Collagen and Indian Hedgehog (Ihh)
Riboprobes of SAP, Type X and Ihh were prepared by transferring the corresponding 
cDNA, which have been generated using RT-PCR into pGEM-T™ vector (Promega) 
using the following protocol:
2.1.4 Reverse Transcription -Polymerase Chain Reaction RT-PCR
The SAP, Type X and Ihh cDNAs were amplified by oligonucleotide primers using RT- 
PCR to specific regions of chicken SAP, Type X and Ihh sequences. These primers 
were designed using Bio/Oligo software and are shown in Table 2.1. The RNA used for 
RT-PCR was isolated from the cells of 17-day old embryonic chick sterna. The sternum 
of 17 day chick embryo was dissected and the chondrocytes were isolated by digesting 
the tissue with (0.25mM trypsin/collagenase). The sternal chondrocytes were washed 
twice with DMEM (Invitrogen) 10% FCS (Gibco). The RNA of these chondrocytes was
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isolated using RNeasy kit (Qiagen). The RT-PCR was used to make cDNA from the 
chondrocyte RNA according to the method described in Chapter 3.
Primers Sequence 5' to 3 f Fragment size (bp)
Accession
numbers
Ibh
Forward 5’c a t  CAT CTT CAA GGA CGA GGA GAA C 3’ 224 1493841
Reverse
5 TAC TTG TTG CGG TCC CTG TCT GAC3
SAP
Forward 5 GCC TTG TTA TCG GAG ACC ACA G3 360 7533037
Reverse 5 TTT GGT TTC TGG GAC CGC AG3’
TypeX
collagen
Forward 5 AGC AGG AGC AAA TCA AGC3 340 2829294
Reverse 5CAG AGG AAT AGA GAC CAT3
Table 2.1: The forward and reverse sequences of the primers used for the preparation of 
the riboprobes of chick Ihh, SAP and Type X collagen.
2.1.5 Purification of PCR Product from Agarose Gel
The PCR products were purified from the agarose gel using the GenElute Minus EtBr 
Spin columns kit (Sigma) as follows:
The PCR products (bands) were cut out from the agarose gel and placed into a 1.5ml 
RNase DNase free tube. The GenElute Minus EtBr spin columns were placed into 
RNase/DNase free collection tubes. The spin columns were pre-washed by adding 
lOOpl of IX TE and then centrifuged at maximum speed (13,000 rpm) for 10 seconds. 
The elutes were discarded and the excised bands were loaded onto the pre-washed spin 
columns. The spin columns were then centrifuged at 13,000 rpm for 10 minutes, and the 
purified DNA collected in fresh RNase/DNase free collection tubes. The collected DNA 
was precipitated by adding 0.1 volumes of autoclaved 3M sodium acetate to one volume 
of the recovered DNA solutions. Then 2.5 volumes of absolute ethanol were added to 
the DNA solution and the mixtures incubated at room temperature for 2 hours. The 
mixtures were centrifuged at 13,000 rpm for 15 minutes and the DNA pellets washed 
with 70% ethanol diluted with freshly prepared DEPC treated water. The DNA pellets 
were resuspended in either 30pl of RNase/DNase free Sigma distilled water or DEPC
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treated dFLO water. The eluated cDNA (lpl) of each different sample were diluted with 
lml of DEPC dH20. The cDNA absorbance was measured by a spectrophotometer at 
A260- Then the concentration was calculated according to the equation below:
[DNA] = 50 X (A26o) pg/ml
2.1.6 Ligation of cDNAs Using pGEM®-T Vector
The ligation of SAP, Type X and Ihh cDNA using the pGEM®-T easy vectors kit 
(Qiagen) were prepared as follows:
The pGEM®-T vector circle map and sequence are shown in Figure 2.2. The tube 
containing the pGEM®-T vector and that with the control insert DNA were briefly 
centrifuged and placed on ice. The ligation reaction mixtures were set up as shown in 
Table 2.2. To give a maximum number of transformants, three different standard 
reactions for the three different genes were prepared using the following concentrations 
of the PCR products (SAP, Type X and Ihh cDNA) 50ng, lOOng and 150ng. The 
following calculation was used to convert molar ratio to mass ratio:
ng of vector * kb size of inserts _ _ t . Insert 
------------------------------------------- x Molar ratio -----------  = ng of insert
kb size of insert Vector
As it has been recommended by the manufacturers for high ligation efficiency, all 
different reactions were mixed thoroughly by pipetting 3-5 times and the reactions were 
incubated overnight at 4°C. The ligation reactions were used for transformation with
XL-1 blue E. Coli
Standard
Reaction
Positive
Control
Background
Control
2X rapid ligation buffer, T7 DNA ligase 5 pi 5 pi 5 pi
pGEM-T vector (50ng) lul lpl lpl
PCR Product Xnl * - -
Control insert DNA - 2pl -
T4 DNA ligase (3weiss units/pl) 1 JLXl lpl lpl
Deionized water to final volume of lOpl lOpl lOpl
X pi* (Molar ratio of PCR product: vector)
Table 2.2: Standard protocol for the pGEM®-T ligation
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(a)
Xmn I 1994
Nae I 
2692Sea I 1875
f1 ori 1 start
Apa I 
Aat II 
Sph I 
fls/Z I 
Mcol 
Sac II
Ampr p6EM*-T
Vector
(3000bp)
lacZ
46
Spe I 
Wot I 
BsfZ I 
Pst\ 
Sal I 
/Vdel 
Sac I 
flsfX I 
/Vs/1
103
112
126
ori
t  SP6
(b)
pGEM®-T Vector
T7 Transcription Start
5 '.  . . TGTAA TACGA CTCAC TATAG GGCGA ATTGG GCCCG ACGTC GCATG CTCCC GGCCG 
3T. . .  ACATT ATGCT GAGTG ATATC CCGCT TAACC CGGGC TGCAG CGTAC GAGGG CCGGC
T7 Promoter I l_I________I I_______ I I I
Apa I Aaf II Sph I BsfZ I
CCATG GCCGC GGGATT37 , . A ATCAC TAGTG CGGCC GCCTG CAGGT CGACC ATATG
GGTAC CGGCG CCCTA V /3'TTAGTG ATCAC GCCGG CGGAC GTCCA GCTGG TATAC
I II I__________________ I_____I LI____ U I _____II_____II____ I
Nco I Sac II Spe I 1 Not I | Pst I Sal I Nde I
BsfZ I
SP6 Transcription Start
GGAGA GCTCC CAACG CGTTG GATGC ATAGC TTGAG TATTC TATAG TGTCA CCTAA AT. . .  3' 
CCTCT CGAGG GTTGC GCAAC CTACG TATCG AACTC ATAAG ATATC ACAGT GGATT TA . . . 5'
I_______ I_I__________________ 11______ I SP6 Promoter
Sac I BstX I Nsi I
Figure 2.2: (a) pGEM®-T vector circle map and sequence reference points (b) The 
promoter and multiple cloning sequence of pGEM®-T vector (taken from Promega, 
2004).
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2.1.7 Preparation of Ultra-Competent E.Coli (XL-1 Blue strain) Cells
The XL-1 competent cells used in this project were prepared according to the methods 
described by Inoue and Okayama (1990):
The XL-1 cells were inoculated in 5ml LB (Sigma) medium and the culture was 
incubated overnight at 37°C. An aliquot (3ml) of the overnight grown culture was 
inoculated in 250ml of SOB medium as shown in Table 2.3. The culture was incubated 
at 37°C with continuous shaking (280 rpm) for 3-5 hours during which 1ml aliquots 
were taken every hour from the culture to check their absorbances. As soon as the 
optical density (OD600) reached < 0.6, the cell suspension culture was taken out and 
placed on ice for 15 minutes. The culture was then centrifuged at 2500g in a Sigma 3K- 
10 centrifuge for 10 minutes at 4°C. The cells were resuspended gently in 80ml of ice 
cold transformation buffer (TB) and placed on ice for 10 minutes (Table 2.3). The 
suspended cells were centrifuged once again at 2500g for 10 minutes at 4°C. The 
resulting pellets were resuspended gently in 20ml of ice cold TB for freezing the 
competent XL-1, then 1.4 ml DMSO (Sigma) was added to a final concentration of 7%. 
The cell suspension was placed on ice for 10 minutes and then 0.5ml aliquot was 
transferred into 1.5ml pre-chilled sterilised tubes. The tubes containing the competent 
XL-1 cells were dipped into liquid nitrogen and stored at -80°C for future use.
500ml of SOB medium 500 ml of Transformation buffer (TB)
2% (w/v) Bacto Tryptone 10 g 1 OmM Pipes 1.89g
0.5% (w/v) Yeast extract 2.5g 15mM CaCl2 110g
lOmMNaCl 0.292g 250mM KC1 9.30g
2.5mM KC1 0.093g 55mM MnCl2 5.44g
lOmM MgCl2 1.0165g * Autoclave the solution and then add the 
MnCl2lOmM MgS04 0.602g
Adjust pH at 6.7-7.0 Adjust pH at 6.7 with 5M KOH prior to 
adding the MnCl2
Table 2.3: Preparations of SOB medium and transformation buffer
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2.1.8 Transformation of pGEM®-T Vectors into XL-1 Blue
High-efficiency competent cells (XL-1 blue E.Coli strain) were used for the 
transformation of p-GEM®-T vectors containing SAP, Type X and Ihh cDNA. The XL- 
1 blue competent cells were thawed on ice for 15 minutes. All tubes containing the 
ligation reactions were centrifuged to collect contents at the bottom of the tubes. The 
competent cells were mixed gently by flicking the tube 4-5 times, and 150pl of these 
cells was added into each individual ligation tube and mixed gently. The tubes were 
placed on ice for 20 minutes, followed by a heat-shock incubation in a pre-warmed 
water bath without shaking for exactly 45 seconds at 50°C. The tubes were returned 
immediately to ice and left for 10 minutes. SOC medium (200pl) was added into each 
tube containing the cells which were transformed with ligation reactions; these tubes 
were incubated at room temperature for 25 minutes. The content of each tube was 
spread individually on the top of Luria broth (LB) ampicillin (Sigma) /IPTG 
(Promega) /X-Gal (Promega) agar plates and incubated at room temperature for 30 
minutes, and then overnight at 37°C.
2.1.9 Preparation of LB Broth Plates with Ampicillin
LB agar powder (15g) was dissolved in 500ml of dLLO and autoclaved. The LB 
medium was left to cool at room temperature for 30-45 minutes until the temperature 
dropped to approximately 40°C. Ampicillin was added into the LB medium at a final 
concentration of lOOpg/ml. Tetracycline (Gibco) was also added into the medium at a 
final concentration of 2.5pg/ml. LB medium (15ml) was poured into each plate. The 
plates then were left at room temperature for 1 hour. The surface of the agar in the 
plates was pre-coated with lOOpl of IPTG and 20pl of X-Gal (50mg/ml).
2.1.10 Isolation of Plasmids from the Transformed XL-1
The isolation of the plasmids was done using the mini prep kit (Qiagen). White 
colonies of XL-1 cells were selected for the isolation of plasmids containing SAP, Type 
X and Ihh cDNA. Some of these colonies were selected and inoculated in 5ml of LB- 
broth containing Ampicillin (100pg/ml). The cultures were grown overnight at 37°C 
with continuous shaking (250 rpm), after which 1.5 ml of each culture was transferred 
into a sterile DNase/RNase free tube. The remaining cultures of the three different
63
Chapter 2 Investigation of the expression of SAP by ISH
plasmids were frozen in liquid nitrogen and then stored at -80°C for future use. All 
prepared tubes containing the cells were centrifuged in a microcentrifuge for 5 minutes 
at 10,000 rpm. The resulting supernatant in each tube was discarded and the bacterial 
pellet resuspended in 250pl of PI buffer. P2 buffer (250pi) was added gently into the 
tubes which were then inverted 4-5 times to obtain a well mixed solution. Buffer N3 
(350pl) was added into the solution, and the tubes were inverted immediately 4-6 times 
and centrifuged for 10 minutes at 13.000 rpm. The supernatants were pipetted onto 
QIAprep spin columns and centrifuged for 60 seconds. The flow-through was discarded. 
The QIAprep spin columns were washed by adding 0.5 ml of PB buffer and centrifuged 
for 60 seconds. The resulting flow-through was again discarded and the QIAprep spin 
columns were washed by adding 0.75 ml of PE buffer and centrifuged at full speed 
(13,000 rpm) for 60 seconds. The same procedure was repeated again at the same speed 
to remove residual wash buffer. The QIAprep spin columns were placed into 
DNase/RNase free 1.5 ml microcentrifuge tubes, and then the DNA was eluted by 
adding 40pl of EB buffer (lOnM Tris-Cl, pH 8.5) to the centre of each QIAprep spin 
columns. The columns were left on the bench surface at room temperature for 1-2 
minutes. They were then centrifuged at maximum speed 13,000 rpm for 1 minute.
The DNA concentration was measured by using a spectrophotometer. The DNA elutes 
of SAP, Type X and Ihh were then used for riboprobe preparations. In order to check 
that the insert was correct 1 pi of plasmid DNA containing SAP, Type X and Ihh insert 
were separately diluted in 10 pi of dH20 (DEPC) and then they were used as a template 
for PCR reaction.
2.1.11 Restriction Digestion of SAP, Type X and Ihh Plasmids
Some of the purified plasmids from the three different inserts were linearised (Figure 
2.3) as follows:
A variable amount of the SAP, Type X and Ihh DNA plasmids were cut separately 
using the appropriate restriction enzymes with the optimum supplied buffers. These 
enzymes cut just a few base pairs beyond the sequence from both sides of the insert. 
This amount was calculated according to the absorbance reading obtained from the 
DNA/RNA spectrophotometer. The amount of each individual plasmid was calculated
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to give a final concentration of 2-3 pg in each reaction. The two different restriction 
enzymes were used individually with each different plasmid (SAP, Type X and Ihh) as 
follows:
dT^O (DEPC or Sigma) 11.8pl
Restriction enzyme Buffer D (Promega) 2pl
BSA, Acetylated (1 mg/ml) 0.2pl
Enzyme Sail or Ncol (lOU/pl) (Promega) lpl
Plasmid (DNA) 2-3 pg 5 pi
Total 20pl
Table 2. 4: Standard protocol of endonuclease restriction/digestion of the isolated
plasmid
The samples were mixed individually and incubated for 2-3 hours at 37°C. After the 
incubation, 5 pi of each sample were mixed with 2 pi of the loading dye and run on 1% 
agarose gel. The gel was stained in ethidum bromide (EB, Sigma) for 30 minutes and 
visualised under UV light.
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Type X, Ihh and SAP fragments 
generated by PCR
Linearisation of pGEM®-T 
Using restriction enzymes
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P-GEM®-T
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Cloning Vector
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Multiple cloning sites
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o f  products
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Figure 2.3: Schematic diagram of protocol for cloning and linearization of type X 
collagen, Ihh and SAP inserts into p-GEMT-T vector and restriction digestion of the 
inserts using Sail and Ncol.
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2.1.12 Purification of SAP, Type X and Ihh Inserts from the Cut pGEM®-T Vector 
Using QIAquick PCR Purification Kit
The following protocol was Adapted for the preparation:
All the solutions used in this preparation are supplied in the QIAquick PCR purification 
kit (Qiagen), five volumes of buffer PB were added to 1 volume of the DNA elute. The 
QIAquick spin column was placed in a provided 2 ml collection tube and then the DNA 
was applied into the QIAquick columns and centrifuged for 60 seconds. The flow­
through was discarded and the QIAquick columns were placed back into the same 
collection tubes. The columns were washed by adding 750pl of PE buffer and 
centrifuged for 60 seconds. The flow-through was discarded and the columns were 
placed back into the same collection tubes. The columns were centrifuged at the 
maximum speed (13,000 rpm) for 1 minute. The QIAquick columns were placed into 
new 1.5 ml microcentrifuge tubes. The DNA was eluted by adding 50pl of EB buffer 
(lOmM Tris-Cl, pH8.5) to the centre of the QIAquick membrane and centrifuged at full 
speed for 1 minute.
The DNA concentration was measured using the DNA/RNA spectrophotometer at the 
wavelength of A26o/A28o-
2.1.13 Labelling of linearised plasmids with Digoxigenin
The purified plasmids (SAP, Type X and Ihh), which were previously cut as described 
earlier with Ncol and Sail, were labelled using Digoxigenin kit (Roche) as follows: 
Digoxigenin (DIG) labelled riboprobes were synthesised from cloned PCR products and 
the DIG-labelled RNA were transcribed from SP6-T7 RNA polymerase promoter 
regions as recommended by the manufacturer.
The cloned sequences within the pGEM-T™ vector were transcribed separately with T7 
and SP6 RNA polymerase resulting in either the sense or antisense probes depending on 
the orientation of the cloned DNA insert. The two different linearised plasmids which 
were cut individually, one with Ncol (Promega) and the other with Sal 1 (Promega) of 
the three different plasmids (SAP, Type X and Ihh), were labelled as follows:
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Plasmid cut with 
Ncol
Plasmid cut with 
Sail
Plasmid (lpg/pl) Different amount Different amount
10X DIG labelling mix 2 pi 2pl
5X Transcription buffer 4pl 4pl
DTT (lOOmM) 2 pi 2pl
RNase inhibitor (Promega) 0.5pl 0.5pl
RNA Polymerase Sp6 lpl T7 lpl
DEPC dH20
- -
Total 20 pi 20pl
Table 2.5: Standard protocol of labelling the riboprobe with Digoxigenin
All tubes containing different reactions were incubated for 2-3 hours at 37°C. During 
the incubation 1 pi of the RNA polymerase (Sp6 or T7, Promega) was added. The DNA 
template of the plasmids was removed by adding 3 pi of DNase into each sample. The 
samples were mixed and centrifuged briefly and incubated for 20 minutes at 37°C. The 
reactions were stopped by adding lOpl of 0.2M EDTA. The mixtures were left at room 
temperature for 2 minutes. The RNA was precipitated by adding 2.5pi of 4M Lithium 
chloride (LiCl) followed by 75 pi of 100% ethanol. The mixtures were centrifuged at 
maximum speed (13.000 rpm) for 5 minutes to precipitate the RNA pellets. The RNA 
pellets were washed gently with 75pi of ice cold 70% ethanol. The pellets were 
centrifuged at full speed again for 5 minutes. The supernatants were removed from all 
the samples and the RNA pellets were left to dry at room temperature. The riboprobe
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pellets were resuspended in 20pl of DEPC dFhO and stored at -20°C. From the serial 
dilutions (1:10, 1:100 and 1:1000) of the prepared riboprobes 1 pi was spotted onto 
Hybond-Nylon membrane (Amersham,UK) which was then incubated with alkaline 
phosphatase conjugated DIG antibody and alkaline phosphatase activity was detected 
using nitroblue tetrazolium (NBT)/5-bromo-4-choro-3-indolyl phosphate(BCIP), 
(Roche) as described in detail in section 2.1.14
2.1.14 Blotting and Detection of DIG Labelled Riboprobes
Five different solutions were prepared in 20 ml universal tubes:
The Hybond-Nylon membrane was dipped into in 2ml blocking solution (lOOmM Tris- 
HCl/150mM NaCl pH7.5 and 1% blocking agent) for 2 minutes. The membrane was 
then transferred into 2ml blocking solution with lpl of Anti-DIG-AP antibody for 3 
minutes. The membrane was dipped again in the blocking solution for 1 minute. The 
membrane was washed with 2ml of washing buffer (lOmM Maleic acid/15mM NaCl 
pH 7.5 and 0.3% Tween-20) for 1 minute. The membrane was immersed into 2ml of 
detection buffer (lOmM Tris-HCl/150mM NaCl pH9.5) for 1 minute. The riboprobe 
spots were developed by dipping the membrane into 2ml of freshly prepared NBT/BCIP 
solution (Promega) (2ml detection buffer, 9ml NBT and 7ml BCIP) for 5 to 60 minutes, 
depending on the quality of the riboprobe preparation. The intensity of DIG labelling of 
antisense and sense riboprobe was compared, and the lowest concentration of the 
riboprobes that gave a reasonable signal was used at the hybridisation step.
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2.1.15 Hybridisation
The probes were diluted lOOx with hybridisation mixture (50% v/v formamide (Sigma) 
10% dextran sulfate (Sigma), 5x SSC) and the resulting solution was mixed by pipetting 
3-5 times. Aliquots (60pl) of the diluted probes were applied to each slide containing 
the tissue section. The slides were sealed under hybridisation plastic cover slips 
(Hybrislip, Sigma) and incubated overnight at 47°C in a humid box saturated with 5x 
SSC / 50% formamide (v/v).
2.1.15.1 Stringency Wash
Following the overnight incubation, the hybridisation cover slips were floated off in 2x 
SSC at room temperature for 30 minutes. The slides were taken through a series of 
stringency washes for 1 hour at different salt concentrations and temperatures as 
follows:
2 x SSC at 55°C and lx SSC at 55°C in a Hybaid Omnislide wash module to remove 
non-specifically bound probes. The sections were then equilibrated in (lOOmM Tris- 
HC1 / 150mM NaCl, pH7.5). Alkaline phosphatase conjugated anti-DIG-antibody 
(200ml of 1:100 dilution) in lOOmM Tris-HCl /NaCl pH 7.5 in 5% (w/v) bovine serum 
albumin (BSA) (Sigma) was added onto each slide and incubated in a humid black box 
at room temperature for 1 hour. The slides were washed twice with Tris/NaCl, pH7.5 to 
remove unbound antibodies and then in lOOmM Tris-HCl /lOOmM NaCl / 50mM 
MgCb, pH9.5 for 10 minutes; 1ml of the 50x diluted substrate (500ml Tris / NaCl/ 
MgCb, pH9.5, 2.25pl NBT 75mg/ml, 1.75pl BCIP 50mg/ml and 2.5pl of 1M 
Levamisole (Sigma) was applied onto each slide.
All the slides were left in the dark box for 2-5 hours. The colour reaction was stopped in 
TE buffer pH8.0 for 15 minutes. The slides were rinsed in running tap water for 2 hours 
and mounted under aqua-mount (Sigma). Photomicrographs were taken with a Leica 
DM RB photomicroscope fitted with a WILD MPS48 photographic system.
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2.2 Results
2.2.1 Confirmation of the Insertions of Chick Type X Collagen, Indian Hedgehog 
and SAP cDNAs in pGEMT® Cloning Vectors Using Restriction Enzyme Digests
The size of the cloned PCR products was confirmed by restriction digestion and 
electrophoresis with both the positive controls and molecular markers. The procedures 
are described in the ‘Materials and Methods’ section. Briefly, lpl of purified plasmids 
containing the appropriate inserts were cut at the appropriate restriction sites using Ncol 
& Sail. After the incubation, 5pi of each sample were mixed with 2pl of the loading 
dye and run on 1% (v/v) agarose gel. Following the staining in ethidum bromide (EB) 
for 30 minutes, the gel was then visualised under UV light. The results are shown in 
Figure. 2.4 Type X, Ihh and SAP are found to have the following respective size: 340bp 
(Lane 3; Plate A), 224bp (Lane 3; Plate B) and 360 bp (Lane 3; Plate C). The lengths of 
each inserted fragments (type X, Ihh and SAP) were PCR with the corresponding 
primers. The PCR products were matched the exact size of the primers used (Figure 2.4) 
Lane 4.
2.2.2 Immunoblotting of Type X, Ihh and SAP Riboprobe
After the preparations of the various riboprobes, the sense and anti-sense riboprobes of 
Type X collagen, Ihh and SAP were blotted on Hybond-Nylon membrane. A series of 
dilution (1:10, 1:100 and 1:100) of riboprobes were used to determine the optimum 
concentration for use in the in situ hybridisation experiments. The probes were labelled 
with alkaline phosphatase conjugated Digoxigenin (DIG) antibody and the product was 
detected with NBT/BCIP. The results indicate that 1:100 dilution is the minimum 
concentration for detection of both Ihh (Figure. 2.6) and SAP (Figure. 2.7) whereas the 
type X collagen riboprobe requires a 1:10 dilution (Figure. 2.5).
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Figure 2.4: Agarose gel (1% w/v) analysis of p-GEM-T plasmids following restriction 
digestion with SaWNcoI restriction enzyme. (A) p-GEM-T containing the type X 
collagen cDNA insert; (B) p-GEMT containing the Ihh insert; (C) p-GEM-T containing 
the SAP insert. Lane 1: -174 Hae III DNA ladder. Lane 2: dLLO control. Lane3: 
digested plasmid showing the appropriate insert that has the same electrophoresis 
mobilities/size as the standard PCR products. Lane 4: PCR product contains the cDNA 
(inserts) with the flanking sequences of the plasmid.
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1 1:10 1:100 1:1000
Sense
Anti-sense
Figure 2.5: Serial dilutions of chick Type X collagen Digoxigenin-labelled sense and 
anti-sense riboprobes blotted onto Hybond-Nylon membrane and visualized with an 
alkaline phosphatase conjugated Digoxigenin antibody and NBT/BCIP for 45 minutes. 
In both sense and anti-sense, spots are visible until about 1:100 dilution. In situ 
hybridisation was performed using 1:10 dilution of both probes in hybridisation buffer.
Sense
Anti-sense
Figure 2.6: Serial dilutions of chick Indian hedgehog Digoxigenin-labelled sense and 
anti-sense riboprobes blotted onto Hybond-Nylon membrane and visualized with an 
alkaline phosphatase conjugated Digoxigenin antibody and NBT/BCIP after 1 hour. In 
both sense and anti-sense spots are visible until about 1:100 dilution. In situ 
hybridisation was performed using 1:100 dilution of both probes in hybridisation buffer.
1 1:10 1:100 1:1000
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1 1:10 1:100 1:1000
Sense
Anti-sense
Figure 2.7: Serial dilutions of chick Small acidic protein (SAP) Digoxigenin-labelled 
sense and anti-sense riboprobes blotted onto Hybond-Nylon membrane and visualized 
with an alkaline phosphates conjugated Digoxigenin antibody and NBT/BCIP for 3 
hours. In both sense and anti-sense spots are visible until about 1:100 dilution. In situ 
hybridisation was performed using 1:100 dilution of both probes in hybridisation buffer.
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2.2.3 Histology of 17 Day Old Embryonic Chick Cartilage
Two types of tissue were examined, the sternum and the tibia. These tissues were 
sectioned longitudinally and sections were stained with Massons’ trichrom. Figure. 2.8 
shows a micrograph of a section through the caudal region of the sternum. This shows 
that this is a region packed with cells that appear round and small where some cells 
appear densely packed cytoplasmic contents and are identified as proliferative 
chondrocytes Figure. 2.11 A. Figure. 2.9 shows the middle region (M) which is wider 
than the caudal region. As shown in the higher magnification (Figure. 2.11), the cells in 
this region appear to have a diamond shape; most of these cells appear elongated (Plate 
B) as compared to those in the caudal region (Plate A) and they are known as 
prehypertrophic (or transition) chondrocytes. Moreover, it is interesting to note that 
many of the cells in the middle region exhibit clear space, the typical effect of 
cytoplasmic shrinkage and some have two nuclei, showing cell division activity. Figure 
2.10 illustrates the third region which is more expanded than the middle region and 
which consists mostly of cells that have either a flattened shape or a hexagonal shape 
most (Figure. 2.11 - Plate C). This third region is known as the cephalic region where 
most of the cells are much larger (Plate C) as compared to those in the other regions, 
and thus are considered as highly differentiated cells (Hypertrophic chondrocytes).
A longitudinal section of the tibia is shown in Figure. 2.12 highlighting the typical 
histological morphologies of cells within the epiphysis. The three different zones are 
easily distinguishable depending on cell density, size and shape: proliferative (PR), 
prehypertrophic (PH) and hypertrophic (H). The PR zone is occupied by a network of 
proliferative chondrocytes that appear slender and are arranged in columns (Figure. 2.14 
- Plate A). Adjacent to PR, is the prehypertrophic zone is composed of columnar or 
globular cells. Many cells also have a tadpole-like structure and show sign of 
enlargement and eventually become round (Figure. 2.14 - Plate B). Some cells also 
show cytoplasmic shrinking. Close to PH zone towards the diaphysis, the hypertrophic 
zone is observed and this consists mainly of much larger cells but with a much smaller 
and condensed cytoplasm. Due to the cytoplasmic shrinkage, large empty spaces are 
observed within these cells. But it is now known that the spaces are the artefacts of 
fixation.
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Figure 2.8: A typical photomicrograph of longitudinal section cut from 17-day old 
embryonic chick sternum. The tissue was histologically prepared as described in the text 
and the paraffin embedded section was stained with Masson’s trichrome. The picture 
illustrates the caudal region densely packed with proliferative chondrocytes. Scale bar, 
200pM.
(CA) Caudal region.
Figure 2.9: The same longitudinal section (as in Figure 2.8) of 17-day old embryonic 
chick sternum. The tissue was histologically prepared as described in the text and the 
paraffin embedded section was stained with Masson’s trichrome. The photograph 
reveals the middle region with prehypertrophic chondrocytes. Scale bar, 200pM.
(M) Middle region
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Figure 2.10: A longitudinal section of 17-day old embryonic chick sternum shows the 
morphology of the hypertrophic chondrocytes in the cephalic region (arrow). The tissue 
was histologically prepared as described in the text and the paraffin embedded section 
was stained with Masson’s trichrome. Scale bar, 200pM.
(CE) Cephalic region
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Figure 2.11: Photomicrograph showing the morphologies of cells within the sternum, 
Masson’s trichrome stain. (A) Proliferative chondrocytes are round and small. (B) 
Prehypertrophic chondrocytes in the middle region begin to enlarge and become round. 
(C) Hypertrophic chondrocytes in the cephalic region are larger than the other 
chondrocytes in the caudal and middle regions. Scale bar, lOOpM.
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Figure 2.12: A longitudinal section of 17-day old embryonic chick tibia showing the 
proliferative, prehypertrophic and hypertrophic chondrocytes in their respective zones. 
The tissue was histologically prepared as described in the text and the paraffin 
embedded section was stained with Masson’s trichrome. Scale bar, 200pM.
(PR) Proliferative zone (PH) Prehypertrophic zone (H) Hypertrophic zone
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Figure 2.13: A longitudinal section of 17-day old embryonic chick tibia showing the 
prehypertrophic and hypertrophic chondrocytes (arrow) in their respective zones. The 
tissue was histologically prepared as described in the text and the paraffin embedded 
section was stained with Masson’s trichrome. Scale bar, 200pM.
(PH) Prehypertrophic zone (H) Hypertrophic zone
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Figure 2.14: Photomicrograph showing the morphologies of cells within the growth 
plate. Masson’s trichrome stain. (A) Proliferative chondrocytes are flattened and 
arranged in columns. (B) Prehypertrophic chondrocytes begin to enlarge and become 
round. (C) Hypertrophic chondrocytes are larger than the cells in the other zones. Scale 
bar lOOpM.
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2.2.4 In Situ hybridisation
2.2.4.1 Type X Collagen
The results of the in situ hybridisation with a riboprobe specific to the mRNA of type X 
collagen show that the gene is expressed by the highly differentiated chondrocytes 
(hypertrophic) in the normal sternum at different areas of the cephalic region of the 17 
day chick sternum (Figure. 2.15). The same observation was detected in the 17-day 
chick tibia. However, type X collagen is not detected in the proliferative and 
prehypertrophic chondrocytes in the tibia (Figures. 2.16 & 2.17). The control slides with 
the sense riboprobe show no positive reaction and this indicates that the expression of 
type X found in the hypertrophic chondrocytes is indeed specific (Figure. 2.19). 
Although type X collagen mRNA expression appears to begin in the prehypertrophic 
zone, higher levels of expression are mainly associated with the cells in the hypertrophic 
zone. The number of positive cells appears to be decreased distally and in the region of 
calcified cartilage. The control section that was treated with the hybridisation mixture 
contained neither anti-sense nor sense showed non-reactive (Figure. 2.20).
2.2.4.2 Indian Hedgehog (Ihh)
As shown in Figure. 2.21, Ihh mRNA is present in the chondrocytes of both the middle 
and cephalic regions of the sternum. It is noteworthy that the middle region of this 
tissue is occupied by the prehypertrophic chondrocytes and that the cephalic consists of 
hypertrophic cells. Furthermore, the intensity of Ihh expression is much higher in the 
middle than in the cephalic region (Figure. 2.24). The control slides of the sternum and 
tibia tissues are non-reactive (Figures. 2.22 and 2.23).
In contrast, the in situ hybridisation of the tibia sections indicates that the expression of 
Ihh is predominant in chondrocytes in the lower region of the prehypertrophic zone 
(Figure. 2.24) and that the expression becomes less intense in the hypertrophic zone 
(Figure. 2.25). No reaction is detected in the control sections as shown in Figures. 2.26 
and 2.27 and this evidence confirms the specificity of the reaction found in the test 
sections.
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CE
Figure 2.15: In situ hybridisation of type X collagen mRNA in a longitudinal section of 
a 17-day embryonic chick sternum using Digoxigenin labelled anti-sense riboprobe. 
Type X collagen is expressed in the hypertrophic chondrocytes in the cephalic region 
(arrow). Scale bar, 200 pm.
(M) Middle region (CE) Cephalic region
CA
Figure 2.16: In situ hybridisation of type X collagen mRNA in a longitudinal section of 
a 17-day embryonic chick sternum using Digoxigenin labelled anti-sense riboprobe. The 
proliferative chondrocytes in the caudal region show no expression of type X collagen. 
Scale bar, 200 pm.
(CA) Caudal region.
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Figure 2.17: In situ hybridisation of type X collagen mRNA in a longitudinal section of 
a 17-day embryonic chick tibia using Digoxigenin labelled anti-sense riboprobe. The 
reaction was predominantly observed in the hypertrophic region occupied mainly by 
chondrocytes (arrow). The expression was obtained using the anti-sense SP6 riboprobe. 
Scale bar, 200 pm.
(PR) Proliferative zone (PH) Prehypertrophic zone (H) Hypertrophic zone
Figure 2.18: In situ hybridisation of type X collagen mRNA in a longitudinal section of 
a 17-day embryonic chick tibia using Digoxigenin labelled anti-sense riboprobe. A high 
magnification of the same Figure: 2.17 showing the expression of type X collagen in the 
hypertrophic region (arrow). Scale bar, 200pm.
(PH) Prehypertrophic zone (H) Hypertrophic Zone
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Figure 2.21: In situ hybridisation of Ihh mRNA in a longitudinal section of a 17-day 
embryonic chick sternum using Digoxigenin labelled anti-sense riboprobe. The reaction 
was mainly observed in the middle region and in the cephalic region (arrow). Scale bar, 
200pm.
(M ) Middle region (CE) Cephalic region
CE
Figure 2.22: In situ hybridisation of Ihh mRNA in a longitudinal section of a 17-day 
embryonic chick sternum using Digoxigenin labelled riboprobe. The section was treated 
with the sense riboprobe. No reaction of Ihh is observed in any of the regions. Scale bar, 
200pm.
(M ) Middle region (CE) Cephalic region
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CE
Figure 2.23: In situ hybridisation of Ihh mRNA in a longitudinal section of a 17-day 
embryonic chick sternum. Sternum of 17-days embryonic chick was treated with the 
hybridisation mixture that contained neither anti-sense nor sense riboprobes of Ihh. 
Scale bar, 200pm.
(M) Middle region (CE) Cephalic region
Figure 2.24: In situ hybridisation of Ihh mRNA in a longitudinal section of a 17-day 
embryonic chick tibia using Digoxigenin labelled antisense riboprobe. The reaction was 
mainly observed in the prehypertrophic region and in certain cells within the 
hypertrophic region. Scale bar, 200pm.
(PR) Proliferative zone (PH) Prehypertrophic zone (H) Hypertrophic zone
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Figure 2.25: In situ hybridisation of Ihh mRNA in a longitudinal section of a 17-day 
embryonic chick tibia using Digoxigenin labelled anti-sense riboprobe. A higher 
magnification micrograph is showing the expression of Ihh in the prehypertrophic 
region. Scale bar, 200pm. (PH) Prehypertrophic zone (H) Hypertrophic zone
Figure 2.26: In situ hybridisation of Ihh mRNA in a longitudinal section of a 17-day 
embryonic chick tibia. The section was treated with the sense riboprobe. No reaction is 
observed in any of the cartilage zones. Scale bar, 200pm.
(PR) Proliferative zone (PH) Prehypertrophic zone (H) Hypertrophic zone
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Figure 2.27: In situ hybridisation of Ihh mRNA in a longitudinal section of a 17-day 
embryonic chick tibia of 17-days embryonic chick was treated with the hybridisation 
mixture that contained neither anti-sense nor sense riboprobes of Ihh. Scale bar, 200pm. 
(PR) Proliferative zone (PH) Prehypertrophic zone (H) Hypertrophic zone
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Figure 2.28: In situ hybridisation of SAP mRNA in a longitudinal section of a 17-day 
embryonic chick sternum using Digoxigenin labelled anti-sense riboprobe. The reaction 
was intense in the caudal and middle regions and downregulated throughout the 
cephalic region. Scale bar, 200pm.
(CA) Caudal region (CE) Cephalic region
• '  «
Figure 2.29: In situ hybridisation of SAP mRNA in a longitudinal section of a 17-day 
embryonic chick sternum using Digoxigenin labelled anti-sense riboprobe. A high 
magnification of the same reaction shown in Figure 2.28 is showing the expression of 
SAP in the caudal region of the 17 days chick sternum. Scale bar, 200pM.
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Figure 2.30: In situ hybridisation of SAP mRNA in a longitudinal section of a 17-day 
embryonic chick sternum using Digoxigenin labelled sense riboprobe. The reaction 
showing no detection of SAP observed in the caudal region and in the middle region. 
Scale bar, 200pM.
(CA) Caudal region. (M) Middle region.
CE
Figure 2.31: In situ hybridisation of SAP mRNA in a longitudinal section of a 17-day 
embryonic chick sternum. Sternum of 17-day embryonic chick was not treated with the 
hybridisation mixture that contains neither anti-sense nor sense riboprobes of SAP. 
Scale bar, 200pM.
(CA) Caudal region (M) Middle region (CE) Cephalic region
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Figure 2.32: In situ hybridisation of SAP mRNA in a longitudinal section of a 17-day 
embryonic chick tibia using Digoxigenin labelled antisense riboprobe. SAP mRNA was 
mainly localised in the prehypertrophic region and SAP expression is downregulated 
throughout the hypertrophic region. Scale bar, 200pM.
(PR) Proliferative zone (PH) Prehypertrophic zone (H) Hypertrophic zone
PH
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Figure 2.33: In situ hybridisation of SAP mRNA in a longitudinal section of a 17-day 
embryonic chick tibia using Digoxigenin labelled anti-sense riboprobe. The reaction 
was mainly observed in the prehypertrophic region and in the hypertrophic region.
Scale bar, 200pm.
(PH) Prehypertrophic zone (H) Hypertrophic zone
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Figure 2.34: In situ hybridisation of SAP mRNA in a longitudinal section of a 17-day 
embryonic chick tibia. Tibia of 17-days embryonic chick was treated with the 
hybridisation mixture that contained neither anti-sense nor sense riboprobes of SAP. 
Scale bar, 200pM.
(PR) Proliferative zone (PH) Prehypertrophic zone (H) Hypertrophic zone
PR
Figure 2.35: In situ hybridisation of SAP mRNA in a longitudinal section of a 17-day 
embryonic chick tibia. Tibia of 17-days embryonic chick treated with the SAP T7 sense 
riboprobe. No staining is observed in the prehypertrophic and hypertrophic regions. 
Scale bar, 200pM.
(PR) Proliferative zone (PH) Prehypertrophic zone (H) Hypertrophic zone
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2.2.5 Discussion
Collagen type X and Indian hedgehog (Ihh) have been widely studied in recent years 
since they were reported to be involved in endochondral ossification. A novel gene 
recently identified as a Small Acidic Protein (SAP) has also been proposed to play a 
part in this process but there has been little information to substantiate it. The growth 
plate of the tibia is an embryonic cartilaginous tissue leading to the formation of long 
bone and has been mostly used in the earlier studies of the endochondral ossification. 
There is another type of cartilaginous tissue, the embryonic chick sternum that has been 
used for the investigation of bone development. In most cases, studies on the 
localisation of type X collagen have been conducted in both the sternum and tibia 
whereas those of Ihh have been restricted to the latter. So far there has been a lack of 
information about the localisation and function of SAP in the growth plate cartilage. 
Moreover, very little is known about the molecular structure of SAP. Earlier, Gong et al 
(1997) identified an avian cDNA encoding a small acidic protein of unknown functions 
in the quail embryo during development of the ear, using a differential display method.
My aim in this part of my PhD study is to localise type X, Ihh and SAP mRNA in the 17 
days old embryonic chick using an In situ hybridisation technique with Digoxigenin 
labelled anti-sense riboprobes. Since there had been attempts made previously to 
localise Ihh in the sternum, this prompted the present work to include the sternum as 
well as the tibia of the chick in the investigation to establish the cellular localisation of 
these three genes. The results confirm that the type X collagen gene is confined to 
hypertrophic chondrocytes in the cephalic region of normal sternum (Figure. 2.15). In 
the tibia, higher levels of expression are found to be associated with the hypertrophic 
zone but low intensity of type X labelling is also observed in the prehypertrophic 
chondrocyte zone (Figures. 2.17 and 2.18). Unlike the type X gene, Ihh is 
predominantly expressed in the prehypertrophic chondrocytes of the middle region (M) 
sternum although some light staining also takes place in the hypertrophic chondrocytes 
of the cephalic region (CE) of the tissue (Figure. 2.21). In the tibia, the high intensity of 
expression of Ihh is detected in the lower part of the prehypertrophic zone (PH). The Ihh 
expression continues throughout this transitional zone where the majority of cells are 
stained strongly but the reactivity becomes less pronounced throughout the hypertrophic
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zone (H) of the same section. With regard to the SAP mRNA, its expression is intense 
in the caudal and middle regions of the sternum but its labelling intensity is reduced in 
the cephalic region (Figure. 2.28). A high magnification micrograph shows that the 
expression of SAP is localised in the cells which have the characteristic features of the 
prehypertrophic chondrocytes (Figure. 2.29). In the tibia, the same pattern of SAP 
expression is also observed. The chondrocytes in the prehypertrophic zone are found to 
be highly expressed SAP, and downregulated throughout the hypertrophic zone 
(Figures. 2.32 and 2.33).
Most of the earlier studies have found that type X mRNA is expressed specifically by 
hypertrophic chondrocytes during bone formation (Jacenko et al, 2001)This 
observation seems to support the view of Thomas et al (1991) that type X collagen is 
one of the best characterized and unique macromolecules which help define the 
hypertrophic stage of chondrocyte phenotype. This long established view is further 
strengthened by the results obtained from the present work as well as by those from the 
earlier studies. The expression of type X collagen has been considered as a 
characteristic feature of hypertrophic chondrocytes and the transcriptional regulation of 
this gene has been thought to be dependent on cellular hypertrophy (Chung et al, 1995). 
Salo et al (1996) have successfully localised type X collagen by in situ hybridisation 
and immunohistochemistry methods in mandibular condyle of rats. Their results have 
shown that type X collagen is expressed by hypertrophic chondrocytes of condyles 
cartilage. In situ hybridisation of new-born rat condylar and angular cartilages 
undergoing endochondral ossification showed restricted labelling with the type X 
collagen probe in the hypertrophic chondrocyte layer.
As shown by the present study, the high level of Ihh expression only occurs in the 
prehypertrophic cells in both sternum and tibia. The results are consistent with the 
reported observation that the prehypertrophic chondrocytes are responsible for Ihh 
synthesis (Vortkamp, 1996). The detection of high intensity of Ihh expression in the 
prehypertrophic cells by the present investigation adds further evidence to support the 
findings of several previous studies. Indian hedgehog (Ihh) has been reported to be in 
the developing skeletal elements and in particular in the prehypertrophic chondrocytes
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of the growth plate (Bitgood and McMahon, 1995; Koyama et al, 1996; Colnot et al., 
2005). Indian hedgehog was expressed not only in cartilaginous growth plate during 
limb development but also during fracture healing in bone callus. In mice, Ihh has also 
been shown to be expressed widely within the cartilage of the long bone. However, by 
birth, it was localised in a zone of postmitotic, prehypertrophic chondrocytes, 
immediately adjacent to the zone of proliferating chondrocytes (Bitgood and McMahon, 
1995; Lanske et al, 1996; St-Jacques et al, 1999; Seth et al, 2000). By contrast, Gritli- 
Linde et al (2001); Yin et al (2002) found Ihh in both, proliferative and prehypertrophic 
zones. On the other hand, Kindblom et al (2002) detected Ihh immunoreactivity only in 
early hypertrophic chondrocytes, but not in either resting or proliferative chondrocytes. 
Indian hedgehog was primarily expressed by pre and early hypertrophic chondrocytes, 
and it also signalled to both immature chondrocytes and overlying perichondrial cells 
(St-Jacques et al, 1999; Vortkamp eta l, 1996).
Despite of the wealth of information about the molecular structure and cellular 
localisation of type X collagen, the precise function of this protein and its role in 
endochondral ossification still remain unresolved. However, it has been suggested that 
type X collagen may provide an open temporary matrix permissive to vascular invasion 
and mineralisation. Previous study has demonstrated that type X collagen is important 
for compartmentalization of matrix components in the hypertrophic zone of growth 
plate, providing the proper environment for mineralization and modelling (Barber and 
Kwan, 1996). Also, type X collagen may function as a scaffold preventing collapse of 
the matrix, since the proteoglycans and collagen II are degraded in the hypertrophic 
region of the growth plate (Sutmuller et al, 1997).
On the other hand, the localisation of Ihh in the sternum and tibia sections obtained 
from the present investigation together with those of the earlier studies support the 
observation that Ihh is involved in the early stage of chondrocyte differentiation. The 
reduced staining intensity of Ihh in the hypertrophic zone may be attributed to a process 
that either down-regulates the expression or inhibit the synthesis of Ihh or both. Many 
studies have in fact suggested that Ihh plays two important roles in chondrocyte 
proliferation, a direct stimulator and a regulator of this process. It is thought that first of
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all, through its receptor (Patched), Ihh stimulates perichondrial cells to produce PTHrP. 
Then Ihh co-ordinates with the PTHrP to regulate the rate of chondrocyte proliferation, 
and the timing for cell differentiation (Long et al, 2001; Karp et al., 2000; St-Jacques et 
al, 1999; Lanske etal., 1998; Vortkamp et al, 1996).
Earlier studies have also found that the Ihh/PTHrP interaction prevents the cells from 
reaching maturation. One of the relevant studies was made by Vortkamp et al (1999). 
They remarked that the ectopic expression of Ihh in the chick limb upregulated PTHrP 
gene expression in the perichondrium whereas the maturation and hypertrophy of 
chondrocytes in this region were inhibited. These observations have led to the proposal 
that the role of Ihh in the skeletogenesis is to serve as an inhibitor of chondrocyte 
maturation via PTHrP. Moreover, some studies have indicated that Ihh and its two 
putative downstream target genes, Patched (Ptc) (Vortkamp et al, 1998) and Gli 
(Marigo et al, 1996; Goodrich et al, 1996) are expressed in the precartilaginous 
condensation of early limb. These findings further suggest that Ihh may recruit the 
prechondrogenic mesenchymal cells and stimulate their cytodifferentiation at very early 
stages of skeletogenesis.
The effect of Ihh on chondrocyte proliferation is clearly demonstrated in the study made 
by Long et al (2001). They observed that in the growth plate of Ihh-null mouse 
embryos, the zone of chondrocyte proliferation preceding the prehypertrophic zone was 
considerably reduced. They also found that chondrocyte proliferation was less intense 
in the mouse embryos where the Ihh receptor was conditionally deleted in cartilage 
(Long et al, 2001). These observations support the view that Ihh is an important 
regulator of chondrocyte proliferation in the growth plate. As suggested by several 
workers in later years, Ihh and its putative genes have multiple roles one of which is that 
they exert influences on the proliferative zone as well as surrounding perichondrial 
tissues (Chung et al, 2000; Donklelaar and Huiskes, 2006). Studies in both chicken 
and mouse have established that Ihh controls the onset of chondrocyte hypertrophy 
primarily via PTHrP (Karp et al, 2000; Lanske et al, 1996). The Ihh knockout studies 
also reveal that Ihh is a potent positive regulator of chondrocyte proliferation (St- 
Jacques et al, 1999; Long et al, 2004).
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Most studies seem to agree that Ihh is exclusively produced in the prehypertrophic zone. 
One intriguing thought is that Ihh appears to be able to undergo long-range diffusion 
from its site of synthesis to reach target cells in other zones and surrounding tissues. 
During bone elongation, terminal differentiation of growth plate chondrocytes is an 
important prerequisite for the normal development and repair of the skeleton. Many 
transcription and soluble growth factors are involved in chondrocyte differentiation and 
these include insulin-like growth factor-1 (Darling and Athanasiou, 2005), transforming 
growth factor p (Thorp et al, 1992), fibroblast growth factor (Deng et al, 1996; Peters 
et al, 1993), Ihh (Vortkamp et al, 1996) and PTHrP (Amizuka et al, 1995; 
Farquharson et al, 2001). Such diversity of controlling molecules suggests that 
chondrocyte proliferation and differentiation are likely to be mediated through a number 
of interacting control loops.
Interestingly, there are recent reports that the Ihh/PTHrP interaction takes place in a 
negative feedback fashion. Some recent studies have found that PTHrP indirectly inhibit 
Ihh expression. Farquharson et al (2001) remarked that in the postembryonic growth 
plate, post-proliferative chondrocytes secreted Ihh which increased secretion of PTHrP 
to slowdown hypertrophy and that consequently; the slowing down of hypertrophy will 
reduce the production of cells that secreted Ihh. The presence of a functional Ihh/PTHrP 
negative feedback loop has also been reported elsewhere (Yoshida et al, 2001; 
Kindblom et al, 2002; Karp et al, 2000; Vortkamp, 1999; St-Jacques et al, 1999). 
One further example of the Ihh/PTHrP negative feedback interaction is that in fetal 
bone, Ihh stimulates the periarticular cartilage to express PTHrP, which then acts on the 
prehypertrophic chondrocytes to inhibit cell differentiation (Kindblom et al, 2002; 
Vortkamp, 1999). As pointed out by Wu et al (2001), Ihh is a key molecule that 
regulates chondrocyte proliferation and differentiation during endochondral bone 
formation. They found that when Ihh was synthesized nearer to the articular end of the 
growth plate, PTHrP synthesis was also increased. In this way, Ihh signalled the relative 
position of prehypertrophic and hypertrophic chondrocytes to the periarticular growth 
plate. They further explained that PTHrP delayed the transition from proliferation to 
hypertrophy of growth plate chondrocytes. Through PTHrP, Ihh may control the site at 
which Ihh also determines the site of formation of bone collar. Chung et al (2001) have
98
Chapter 2 Investigation of the expression of SAP by ISH
suggested that the source of Ihh protein for this signalling might be the Ihh coming from 
both the prehypertrophic and hypertrophic chondrocytes.
As far as the present work is concerned, the most important observation is that SAP is 
expressed in the prehypertrophic rather than hypertrophic cells of the embryonic chick. 
These results may suggest that the protein is involved in the early stages of 
endochondral ossification, hence the development of the growth plate cartilage. These 
findings also indicate that the expression pattern of SAP is similar to that of Ihh. 
Furthermore, the present study confirms the observations made by Webster (1999) that 
SAP expression is developmentally regulated and differentially expressed during cell 
hypertrophy. Intense expression of SAP is found to be restricted to the prehypertrophic 
zone where most cells undergo early differentiation. Although little labelling of SAP is 
occasionally found in the proliferative zone, the cells that reach full maturation in the 
hypertrophic zone are completely devoid of SAP mRNA expression. These observations 
suggest that expression of the SAP gene is specific to the prehypertrophic chondrocytes. 
Based on these results, SAP may have an important role to play in the chondrocyte 
differentiation in the cartilage template.
It is generally acknowledged that development of the growth plate involves a genetic 
cascade, that is, a programmed series of sequential gene activation and inactivation. 
Previous studies on vertebrate skeleton have also confirmed that genetic analysis of 
embryonic mutations can identify genes that are involved in the early events of 
development, for example, axis specification, segmentation, and pattern formation. 
Many of these genes are transiently expressed during embryonic development and 
encode transcription factors containing either homeodomains or paired domains. These 
transcription factors regulate the expression of many as yet unidentified target genes. 
SAP has a predominantly acidic part which is concentrated within the carboxy domain 
of the predicted peptide. This implies that SAP may have a protein-binding domain. 
However, the work of Webster (1999) has shown a high probability that the protein 
resides within the nucleus. If indeed this is a nuclear protein, it may function as a 
transcriptional regulator that is able to bind other proteins and up regulate transcription 
of one or more genes. In recent years, gene expression studies have revealed that the
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developing cells have unique patterns of gene expression that restrict some genes and 
their protein products to specific cells at critical period in the development process. In 
the context of the present study, cell differentiation may be triggered by molecular 
signals as a result of transcription activation in chondrocytes. SAP may either regulate 
directly or act indirectly as a transcription factor regulating the gene(s) that causes the 
immature cells to undergo differentiation. As its expression is upregulated only in the 
prehypertrophic and absent in the hypertrophic zone, this indicates that the protein may 
be a transcription activator involved in the activation of one of those genes that regulate 
the cell maturation. One can also argue that the gene expressed in the chondrocytes 
presumably activates the expression of additional target genes required for the 
regeneration or even repair of the damage if any, hence maintaining the continuity of 
the growth and development of the cartilage. Molecular analysis of several organ 
systems has shown that genes that are expressed during development are re-expressed 
during regeneration. It has been proved that such regeneration not only repopulates the 
immature cells but also restores its functions. As a wealth of literature has indicated, 
when the regulatory factors are deficient, the normal growth and development of the 
cartilage are adversely affected, resulting in skeletal disorders.
The assumed involvement of SAP in cell differentiation indicates that this protein could 
be one of the important proteins that play a significant role in the maintenance of the 
normal endochondral ossification. One interesting thought is that by analogy, SAP has 
shown a similar pattern expression as that of Ihh but not so with Type X collagen. In 
short, both SAP and Ihh expression only occurs in the prehypertrophic cells whereas 
type X is condensed in the hypertrophic zone. Ihh plays two important roles, a direct 
stimulator and a regulator of cell differentiation process. Furthermore, Ihh interacts with 
PTHrP to achieve these functions. It remains to be seen however whether SAP has 
combined roles with Ihh/PTHrP.
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3 Introduction
As shown in the previous experiments using in situ hybridisation method (Chapter 2), 
the novel gene known as small acidic protein (SAP) has been successfully localised in 
the sternum and tibia of the embryonic chick.
The in situ hybridisation results have confirmed that the prehypertrophic chondrocytes 
in the sternum and tibia expressed Indian hedgehog (Ihh). Earlier studies using mouse 
tibial growth plate have indicated that both Ihh and PTHrP were detected in the 
prehypertrophic chondrocytes and that they were found to interact with each other in a 
negative feedback loop (Vortkamp 1996; 1999). On the basis of these observations, it is 
interesting to find out (1) the expression of SAP in regulation to these of other genes 
known to be involved in endochondral ossification. (2) If SAP regulates the 
transcription key genes in endochondral ossification such as Ihh or PTHrP or type X 
collagen and (3) whether SAP is linked to the Ihh/PTHrP feedback control mechanism.
The aim of the present study is to ascertain if SAP plays a role in the differentiation of 
chondrocytes. Since SAP and Ihh cohabit in the prehypertrophic chondrocytes, it is 
interesting to see whether the non expression of SAP results in the up regulation or 
down regulation of Ihh. Earlier studies have used cyclopamine, a plant steroidal 
alkaloid, to disrupt cholesterol synthesis (Goodrich et al., 1998). Furthermore, 
cyclopamine is known to have the ability to inhibit cellular response to Hh signalling by 
blocking its pathway (Chen et al, 2002). The steroidal nature of cyclopamine and its 
ability to disrupt cellular response are thought to affect the signalling of Patched, which 
contains an apparent sterol-sensing domain (Goodrich et al., 1998). Based on this 
information, the present study used RT-PCR method to determine the effect of 
cyclopamine on the expression of SAP, Ihh, PTHrP, Patched and type X collagen, all of 
which a are known to regulate the differentiation of chondrocytes. Its objective is to 
ascertain (1) whether cyclopamine has an inhibitory effect on the expression of these 
genes, and (2) whether the inhibition of SAP leads to either down regulation or up 
regulation of the expression of other genes of interest. Three phenotypes of 
chondrocytes were included in the study (proliferative, prehypertrophic and
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hypertrophy); these were isolated from their respective regions (caudal, middle and 
cephalic) of the sternum and grown in cultures with or without cyclopamine.
In addition to the gene expression analysis by RT-PCR, the present study also examined 
the effect of cyclopamine on the production of sulphated glycosaminoglycans (GAGs) 
and collagen (hydroxyproline assay). The amount of GAGs produced was determined 
using Dimethylmethlene blue (DMMB) whereas that of hydroxyproline was measured 
according to the biochemical assay as described in the ‘Materials and Methods’.
103
Chapter 3 Biochemistry Analysis and RT-PCR
3.1 Biochemical Analysis o f  Micromass Culture o f Embryonic Chick 
Chondrocytes
3.1.1 Preparation of Micromass culture
Micromass cultures of 17-day embryonic chick sternal chondrocytes were established as 
described by Daniels et al (1996). 17-day chick sterna were dissected free from the 
chick bodies and collected in a small Petri dish supplemented with DMEM 10 % FCS 
medium. The samples were washed three times in DMEM serum free medium. Three 
regions (caudal, middle and cephalic) were identified and cut out from the sterna. The 
tissues were individually placed in a separate universal tube containing 5ml of freshly 
made collagenase and trypsin. The tubes were incubated at 37°C for 1.5 to 2 hours. The 
contents of each tube were filtered through a 40pm Strainer filter. The flow-through cell 
suspension was collected in sterilized 15ml tubes which were subsequently centrifuged 
at 1800 rpm for 5 minutes to pellet the cells. The supernatant was carefully removed and 
discarded. The resulting cell pellet was resuspended in 5ml of DMEM 10 % FCS 
medium and then re-centrifuged. The same procedure was repeated three times to 
ensure complete removal of enzymes. The cell pellet was then resuspended in 5ml of 
DMEM-Serum free medium and the number of cells counted using a hemacytometer 
slide. The cell concentration was adjusted to 2xl07cells/ml (2><105 cells/1 Opl) with 
DMEM 10 % FCS medium.
The tubes containing the cells were then inverted a number of times to obtain a good 
homogenous mixture. Aliquots (lOpl) of the cell suspension were pipetted out from the 
tubes and dispensed carefully and slowly in dot form (2 xio5 cells) onto the centre of a 
culture dish. Care was taken not to introduce air bubbles into the dots, as these could 
reduce the interaction and the biological contact between cells and the extracellular 
matrix which might be formed between the chondrocytes in each single dot. After 
incubating for 6 hours at 37°C in a humidified atmosphere of 5% CO2, 50 % of the 
dishes were flooded slowly with 3ml of pre-warmed DMEM 10% FCS from the edge. 
The other 50 % of dishes were flooded with pre-warmed DMEM 10% FCS containing 
cyclopamine at a final concentration of 1 Opg/ml, and incubated as described above. The 
medium was replaced every day with fresh DMEM 10%FCS medium for normal
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culture and DMEM 10% FCS containing Cyclopamine for the treated culture 
throughout the experiment period (8 days).
For the biochemistry assays the micromass dots of the three different phenotypes of 
chondrocytes were removed from the surface of the dishes without digestion and 
collected separately in eppendorf tubes for the assays. Whereas, the micromasses of all 
three types of chondrocytes (proliferative, prehypertrophic and hypertrophic) which 
were used for the RT-PCR, were harvested and digested every 24 hour. The total RNA 
of each different population of chondrocytes was isolated using RNeasy Mini Kit 
(Qiagen).
3.1.2 Analysis of Sulphated Glycosaminoglycans by DMMB Assay 
The Dimethylmethlene blue (DMMB) assay was used to measure the production of 
sulphated GAGs (i.e chondroitin-4-sulphate) in both micromass dots and that released 
into the culture media. Dimethylmethlene blue is a metachromatic dye used originally in 
histochemical detection of sulphated GAGs and then it was developed to be used as an 
analytical assay. In this assay a reduction of sample volumes was used and analysis was 
carried out on a 96 well plate.
3.1.2.1 Preparation of Dimethylmethlene Blue (DMMB) Reagent
The GAG measurement procedure was carried out using the methods as described by 
Little et al, (1999). Dimethylmethlene blue (32mg) was dissolved in 20ml of ethanol at 
room temperature overnight with stirring. The dissolved DMMB was added to a 
solution containing 1500 ml of double distilled H2O. NaOH (1M) (56 ml) and formic 
acid (98%) (7ml) were added to the DMMB solution, which was then made up to 2 
liters with ddFLO. The solution was stirred for 2 hours. Aliquot (1ml) was taken from 
the solution and its absorbance was measured at 525 nm wavelength. DMMB binds to 
the sulphated groups of GAGs to form a chromophore which appears pink. This pink 
coloration is readily absorbed at the 525nm wavelength. The DMMB dye was stored in 
a lightproof bottle at room temperature.
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3.1.2.2 Digestion of Micromass
The suspensions of the three different phenotypes of chondrocyte were cultured 
separately as 10 pi dots in 60mm Petri dishes and 15 dots of micromass were cultured in 
each dish. The micromass culture was incubated at 37°C and at 5% air CO2 for 6 hours 
and then 3ml of DMEM 10 % FCS medium were added gently to the culture. The 
micromass culture was incubated for 8 days and one Petri dish of each phenotype was 
collected daily and used for the DMMB assay. The medium of the three different 
phenotypes (Caudal, Middle and Cephalic) were collected separately and stored at-20°C 
for the assay whereas the micromass dots were washed twice with PBS. The micromass 
was carefully removed and put in a sterile eppendorf tube. The tubes were immersed in 
liquid nitrogen and stored at -80°C for DMMB analysis. The frozen micromass dots 
were digested using the non-specific proteinase papain. Dots were dissolved in 1ml 
digestion buffer (20mM sodium phosphate pH6.8, ImM EDTA and 2mM DTT) 
containing 300pg papain. Samples were incubated at 60°C for 60 minutes and any 
partially digested samples were incubated for longer. Iodoacetamide was added to give 
a final concentration of lOmM to alkylate the reactive sulphydryl groups generated 
through DTT treatment. Samples were further diluted 3-5 times with 50mM Tris/HCl 
(pH 8.0).
3.1.2.3 Measurement of GAG Content
The standards and samples (40 pi) were pipetted gently in triplicate into a 96- well plate 
and then 200pi of DMMB dye added into each well and mixed gently by pipetting up 
and down three times. The plate was read immediately using a plate reader at a 
wavelength of 525 nm; further dilution was required with some of the samples that were 
outside the standard curve limit. These samples were diluted in their respective buffer. 
A serial dilution was prepared using whale chondroitin-4-sulphate with standards 
ranging from 0 to 70pg/ml. All standards were made up using the same buffer as real 
samples (i.e for conditioned media-DMEM and for micromass extract- dilution buffer).
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3.1.3 Analysis of Hydroxyproline Production in the Micromass Culture
This method was used to measure the hydroxyproline content produced in the 
micromass culture samples.
3.1.3.1 Preparation of Hydroxyproline Reagents
The hydroxyproline measurement procedure was carried out using the method as 
describes by Woessner (1976).
1) Concentrated HC1.
2) Stock Buffer (500ml) 28.5g sodium acetate trihydrate
18.75g tri sodium citrate dehydrate 
2.75g Citric acid 
200ml Propan-2-ol
These chemicals were dissolved in 250ml of ddH20 first followed by the propan-2- 
ol, and then it was made up to 500ml with ddH20.
3) Diluent (100ml) 100ml propan-2-ol
50ml ddH20
4) Oxidant 0.7g chloramine T
10 ml ddH20  
50ml stock buffer
5) Colour reagent 7.5g dimethylamino benzaldehyde
11.25ml perchloric acid (60%)
Hydroxyproline standards l-10pg/ml in ddH20. This can be prepared in bulk and 
stored aliquots at -20°C.
Reagents 1, 2 and 3 were prepared in advance and stored at room temperature. 
Reagents 4 and 5 used to prepare prior to use and were stored at 4°C overnight.
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3.1.3.2 Digestion of Micromass Dots
The micromass dots that were collected daily from the culture were hydrolysed in 400pl 
of concentrated HC1 with the same volume of ddH20 for 24 hours giving a final 
concentration of 6N HC1 at 110°C. The samples were dried using a vacuum centrifuge 
at full speed overnight to remove all the HC1 from the samples. Hydrolysed samples 
were resuspended in 400pl of ddH20 (using the same volume of HCL that was used) 
and were used immediately for the hydroxyproline assay.
3.1.3.3 Measurement of Hydroxyproline Content
The standards and samples (30pl) were pipetted gently in triplicate into a 96- well plate 
and then 70pl of diluent were added into the wells and mixed gently three times. 50pl of 
oxidant was added into the wells and mixed gently. The 96 well plate was then mixed 
on a plate shaker at room temperature for 5-10 minutes. Colour reagent (125pl) was 
added into the wells and the plate shaken for 5 minutes. The plate was then incubated in 
a water bath at 70°C for 10-30 minutes until samples went a peach colour. The plate 
was read immediately using a plate reader (Labsystem Multiscan MS 
Spectrophotometer) at a wavelength of 540nm. Further dilution was required with some 
of the samples that gave readings outside the limits of the standard curve 1-10 pg/ml. 
These samples were diluted in ddH20. The 96-well plate was read immediately after the 
incubation at 70°C. All standards were made up using ddH20 as the real samples
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3.1.4 Analysis of Proteins Content in the Micromass Culture
The protein content of samples was measured using Bio-Rad protein assay. Samples 
were collected every 24 hours for 8 days. In this analysis the micromass dots were 
washed three times in PBS and removed carefully by scraping the dots from the surface 
of the dish culture. The micromass dots of different cell phenotypes were collected 
separately in eppendorf tubes. The samples were stored at -80°C until they were used 
for this assay after 8 days.
3.1.4.1 Preparation of Protein Assay Reagents
One part of the Bio-Rad protein assay dye was diluted with 4 parts of ddthO. The 
diluted dye was filtered through a Whatman (110mm) filter paper.
3.1.4.2 Dissolving of Micromass Dots
The micromass samples were thawed on the bench top for 10 minutes at room 
temperature. Fifty pi of the dissolving buffer (50 mM NaFkPO^ 300 mM NaCl and 
0.5% Titron X-100, pH 8.0) were added to each sample. The samples were vortexed for 
one minute and incubated in a water bath at 37°C for 30-60 minutes. The samples were 
vortexed three times during the incubation until the content of each sample was clear 
and had become homogenous. One part of the concentrated sample was diluted with 4 
parts of the dissolving buffer. The diluted samples were then used for the protein assay. 
A serial dilution was prepared using 50mM NaH2P0 4 , 300mM NaCl, and 0.5 % Triton 
X-100 stock, with BSA standards ranging from 0.05mg/ml to 7mg/ml. All standards 
were made up using ddH2 0 .
3.1.4.3 Measurement of Protein Content in the Micromass Culture
The standard and sample solution (lOpl) was pipetted separately into 96-well plate. The 
diluted dye reagent (200pl) was added to each well. The samples and reagent were 
mixed thoroughly by a multi-channel pipette. The plate was incubated at room 
temperature for 10 minutes and then the plate was read using a plate reader at a 
wavelength of 595nm.
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3.1.5 Statistical Analysis
Data of three replicate samples from each type of tissues (caudal, middle and cephalic) 
for each group of treatment (cyclopamine treated and non-treated) were statistically 
analysed using paired tests in MINITAB. This computerised software allows test for 
normality to be carried out using the Anderson-Darling test as described by Fry, (1993). 
The parametric Paired t test was used to determine if the mean difference, treated and 
non-treated groups, is significantly different from zero (Fry, 1993).
3.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
3.2.1 Isolation of RNA from Micromass Culture
Micromass dots were digested in collagenase / trypsin for 1 hour. The cells were 
pipetted into 15ml tubes and were centrifuged at 1800xg for 5 minutes, the cell pellet 
was resuspended in 5ml of DMEM-10 % FCS medium and the tubes were centrifuged 
at the same speed for another 5 minutes. This process was then repeated three times. 
The three different types of chondrocytes were then counted with a haemocytometer 
slide. Using the manufacture’s recommended protocol (Qiagen) the number of cells 
used for RNA isolation was (3-4x 106). The pellets were lysated in 350pl of RLT buffer 
and vortexed for 30 seconds. The lysate was pipetted directly onto a QIA shredder spin 
column placed in a 2ml collection tube and the columns were centrifuged for 2 minutes 
at maximum speed. One volume of 70 % (v/v) ethanol was added to the homogenized 
lysate and mixed well by pipetting. The lysate (700pl) was then applied to a RNeasy 
mini column placed in a 2 ml collection tube. All tubes were closed gently and were 
centrifuged in microcentrifuge for 15 seconds at 8000xg (>10,000rpm) and the flow­
through was discarded.
During this procedure, DNase digestion was performed by using the RNase-Free DNase 
kit (Qiagen). RW1 buffer (350pi) was pipetted into the RNeasy mini column which was 
centrifuged for 15 seconds at 10,000 rpm to wash, and then the flow-through was 
discarded. The columns were placed on the bench at room temperature and lOpl of 
DNase I stock solution (see RNase-Free DNase kit’s hand book; Qiagen) were added to 
70pl of RDD buffer and the mixture was mixed gently by inverting the tube. The DNase
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I incubation mix (80pl) was directly applied on the RNeasy silica-gel membrane, and 
then the columns were placed on the bench top at room temperature (20-30°C) for 15 
minutes. After the 350pl of RW1 buffer were pipetted into RNeasy mini columns, they 
were centrifuged for 15 seconds at 10,000 rpm. The flow-through and collection tubes 
were discarded and the columns were transferred into new 2ml collection tubes, and 
500jnl of RPE buffer were pipetted onto the RNeasy columns. The tubes were closed 
gently and were washed by centrifuging the tubes for 15 seconds at 10,000 rpm, and the 
flow-through was discarded. Another 500pi of buffer RPE were pipetted onto the 
columns, and then the tubes were centrifuged once again for another 2 minutes at the 
same speed. The columns were placed into new collection tubes and they were 
centrifuged for 1 minute, in order to eliminate any possibility of buffer RPE carryover. 
The tubes were transferred to 1.5ml RNase DNase free collection tubes and 30-50 pi of 
RNase-ffee water were applied directly onto the RNeasy silica-gel membrane. The tubes 
were closed gently and then were centrifuged for 1 minute at 10,000 rpm to elute the 
RNA. The concentration of the RNA samples was calculated using the 
spectrophotometer at the absorbance of 260nm and 280nm.
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3.2.2 cDNA Synthesis by Reverse Transcription-PCR
The RNA was reversed transcribed to cDNA by mixing the listed reagents as follows:
Reagents Amount
5x MMLV RT buffer lOpl
Random primers (Promega) lul
dNTPs 25mM (Promega) lpl
RNase inhibitor (Promega) 0.5pl
MMLV reverse transcriptase (Promega) 0.5pl
RNA sample (lpg/pl) 2 pi
DNase and RNase free water (Sigma) 34pl
Total 50pl
Table 3.1: Preparation of RT product (cDNA) for RT-PCR
The reaction mixture was incubated in the 9700 thermal cycler (Applied Biosystem) 
according to the following sequence:
25°C for 10 minutes —► 45°C for 60 minutes —► 95°C for 10 minutes.
The RT-Product was used immediately for PCR reactions or stored at -80°C until 
required.
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3.2.3 Preparation of Reverse Transcription-PCR Reaction
The reagents were added in the following order:
Reagents Amount I
RT product 0.5pl
1 OxPCR buffer (Promega) 5pl I
MgCb 1.5mM (Promega) 3 pi
Forward primer (50pg/ml) lpl
Reverse primer (50pg/ml) lpl
dNTPs lOmM (Promega) lpl
Taq polymerase (Promega) 0.25pl
DNase and RNase free water (Sigma) 36.75 pi
Total 50 pi
Table 3.2: Standard preparation of RT-PCR reaction
The PCR reaction was cycled at:
95°C for 2 minute —► [95°C for 30seconds, At (X)* °C for lminute, 75°C for 
30seconds] x 35cycles —> 75°C; 5minutes, 4°C ac
(* the appropriate annealing temperature, see Table 3.3)
The primer pairs used in the RT-PCR experiment were chick Ihh, chick SAP, chick type 
X collagen, chick patched, chick PTHrP and chick GAPDH. Sequences of the primers 
used are listed in Table 3.3.
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Primers Sequence 5' to 3' Annealingtemperature
Product 
size of 
cDNA
Chick Ihh
F o r w a r d 5C A T  C A T  C T T  C A A  G G A  C G A  G G A  G A A  C 3
58 224
R e v e r s e 'T A C  T T G  T T G  C G G  T C C  C T G  T C T  G A C 3
Chick SAP
F o r w a r d 5G C C  T T G  T T A  T C G  G A G  A C C  A C A  G 3
55 360
R e v e r s e 5T T T  G G T  T T C  T G G  G A C  C G C  A G 3
Chick Type 
X collagen
F o r w a r d 5A G C  A G G  A G C  A A A  T C A  A G C 3
55 340
R e v e r s e SC A G  A G G  A A T  A G A  G A C  C A T 3
Patched
F o r w a r d 5 G T G  G A A  G T T  G G T  G G A  C G A  G T 3
60 280
R e v e r s e 5 C A T  G T A  C T C  T G C  T G G  C C T  G A 3
GAPDH
F o r w a r d 5A A G  G C T  G A G  A A C  G G G  A A A  C T T  G 3
58 560
R e v e r s e 5T C A  A C A  A C A  G A G  A C A  T T G  G G G  G 3
PTHrP
F o r w a r d 5C C T  A A G  C C T  G C T  A C C  A A C  A C 3
58 260
R e v e r s e 5 G C T  C G C  C T C  T T T  T T C  T T C  T C 3
Table 3.3: Forward and reverse sequences of the primers used in this project.
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3.3 Results
3.3.1 Optimization of the Reverse Transcription Polymerase Chain Reaction (RT- 
PCR)
The present study used RT-PCR to study the effect of cyclopamine on the expression of 
SAP, type X collagen, Ihh, PTHrP and Patched. GAPDH was also used as a house 
keeping gene throughout this project. A series of PCR cycles were primarily carried out 
using a set of the appropriate primers in order to determine the optimum number of PCR 
cycles required for the study. Figure 3.1 shows the intensity of the DNA products 
obtained by varying the number of PCR cycles in the experiment. The results showed 
that the intensity of the PCR products at cycle 30 is similar to that at cycle 40. 
Therefore, cycle 30 was used in all subsequent PCR reactions in order to ensure that the 
results obtained from different PCR reactions can be compared and that the reaction 
products still fall within the experimental phase of DNA amplification. Jemtland et al 
(2003) also reported that the optimum number of PCR cycles for use in their study of 
the expression pattern of various genes was 30 cycles. The present study also included 
additional test to determine the optimum amount of cDNA required for the subsequent 
experiments. Figure 3.2 shows results obtained from PCR analyses with various 
concentrations of DNA template. The test indicated that the appropriate concentration 
that still produced a well defined band of high density was 0.5pg/pl of cDNA. 
Therefore, this concentration of cDNA was used throughout the study.
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M 20 25 30 35 40 -RT dH20
603 - J
310 "H 
118 “►
Figure 3.1: Agarose gel showing that there is a gradual increase in the amount of 
GAPDH PCR product from 20 cycles to 40 cycles with an increment of 5 cycles. 
M = X174 DNAJHae III Marker.
M 0.5 1 1.5 2 pg/pl -RT dH20
Figure 3.2: Agarose gel illustrating various amount of cDNA used in PCR reaction of 
GAPDH. 0.5 pi of the cDNA was used as an optimum amount of template into the PCR 
reaction. M = XI74 UNAJHae III Marker.
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3.3.2 Expression of Type X collagen, Ihh, SAP, Patched and PTHrP in 
Cyclopamine Treated and Untreated Micromass Dot Cultures at Different Time 
Points
In this study the expression of different genes has been studied in the micromass culture 
of 17-day chick chondrocytes isolated from the sternum tissue. The effect of 
cyclopamine (a drug that block the hedgehog signalling pathway) on changes in 
expression pattern of six different genes was also examined. These genes included: 
GAPDH, type X collagen, Ihh, Patched, PTHrP and SAP.
The expression analysis of these genes was studied in three different phenotypes of 
chondrocytes: proliferative (caudal region), prehypertrophic (middle region) and 
hypertrophic (cephalic region). The cells (2xl05 cells) were cultured using micromass 
technique. Cyclopamine treated and untreated cultures were established. The micromass 
dots were grown in small culture dishes, each contained 15 dots. One dish of each 
phenotype of chondrocytes was harvested daily from the cyclopamine treated and 
untreated cultures for RNA isolation. Examination by microscopy revealed that, some 
of the chondrocytes that had separated from the edges of the micromass dots had 
differentiated and became fibroblasts.
In order to prevent the samples from being contaminated with RNA from fibroblasts, 
the micromass dots cultures were carefully removed from the culture dishes using 
sterile forceps. Each isolated sample was transferred into sterile RNA/DNA free tubes, 
and then the RNA was isolated and reverse transcribed for the analysis of gene 
expression using the RT-PCR. The experiment that used the fibroblast free cultures was 
repeated three times The PCR results obtained from the first set of experiments are 
shown in Figures 3.3, 3.4 and 3.5 and those from the other two sets of experiments are 
shown in Appendix (Figures A.6, 7, 8, 9, 10 and 11). In addition, an experiment using 
micromass dots cultures that contain fibroblasts was also included in the study. This 
experiment was done only once to ascertain whether the inclusion of the fibroblasts 
affected the gene expression pattern and the results obtained from this experiment are 
shown in Figure 3.6. The results indicate that the patterns of expression of GAPDH, 
Type X, Ihh, SAP and PTHrP in the cultures without fibroblasts (Figures 3.3, 3.4 and
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3.5) are similar to those in the cultures containing fibroblasts (Figure 3.6). However, 
there are variations in the pattern of Patched expression in these cultures. For example, 
in all cultures (caudal, middle and cephalic tissues) containing fibroblast, Patched was 
detected at all time points (Figure 3.6). With regard to those cultures containing no 
fibroblast, the pattern of Patched expression was variable depending on the types of 
cultures. The cultures of caudal region showed Patched expression from day 5 onward 
(Figure 3.3) whereas those of the middle region expressed Patched from day 0 to day 5 
(Figure 3.4). In the cultures of cephalic region, Patched was only detected from day 0 to 
day 4 (Figure 3.5).
It is also noteworthy that the cultures containing no fibroblasts showed some variations 
in the expression pattern of Ihh, Patched and PTHrP, noticeably those treated with 
cyclopamine (see Appendix, Figures A.6, 7, 8, 9, 10 and 11). For example, in one set of 
the experiments using treated caudal region of the tissue (Figure A.6), Ihh showed no 
expression until day 4 whereas in the other (Figure A.9) it was detected at day 3. 
Furthermore, the expression of PTHrP in these tissues was found to be less pronounced 
from day 3 in the former set of the experiments (Figure A.6) whereas in the latter 
(Figure A.9), there was no reduction in the level of PTHrP expression until day 5. 
There were also changes in the level of PTHrP expression in the middle region of the 
tissue (Figures A.7 and A. 10). In one experiment (Figure A10), PTHrP was no longer 
detected at day 2 but in the other (Figure. A.7), its expression was still found up to day 
4. Changes in the level of Patched expression pattern were obvious in both the treated 
and untreated cephalic region (Figure A.8 and A.l 1). One set of the experiments using 
the untreated samples (Figure A8), Patched was found up to day 2 whereas its 
expression was not detected until day 5 (Figure A ll).
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3.3.3 RT-PCR Analysis of Micromass Dot Cultures of Chondrocytes without 
Fibroblasts
3.3.3.1 Chondrocytes Isolated From Caudal Region of Sternum
Figure 3.3A represents one of the three sets of experiments being carried out. This 
representative figure shows the expression patterns of GAPDH, Type X collagen, Ihh, 
SAP, Patched and PTHrP in the untreated cultures of caudal chondrocytes without 
fibroblasts from 0 to 7 days. The intensity of GAPDH expression appears somewhat 
similar at all different time points (0, 1, 2, 3, 4, 5, 6 and 7 days). Type X collagen and 
Ihh were not expressed throughout the period of cultures. SAP showed the same levels 
of expression from time 0 up to day 4 and more intense expression from day 5 up to day 
7. However, the expression of Patched and PTHrP was somewhat variable, depending 
on the time points. Most noticeable was the difference in the expression intensity of 
Patched; the chondrocytes did not express Patched until their culture reached day 5. 
PTHrP showed similar expression levels from time 0 up to day 3 but its expression 
gradually became less pronounced from day 4 to day 7. The expression of GAPDH, 
Type X collagen, Ihh, SAP, Patched and PTHrP showed a similar pattern in other two 
sets of experiments (see Table 3.4 and Appendix).
Figure 3.3B illustrates the typical results obtained from the analysis of cyclopamine 
treated cultures of chondrocytes. Cyclopamine appeared to have no effect on GAPDH 
as the treated cultures showed similar levels of expression at all time points. However, 
there were striking differences in the expression levels of other genes. Type X collagen 
showed no expression in the cultures until day 4 when a faint band appeared and the 
expression became gradually more intense from day 5 up to day 7. The chondrocytes 
started to show Ihh and Patched expression at day 3 and the intensity increased 
thereafter. SAP expression was obtained at time 0 but there was no SAP expression at 
other time points. And similarly PTHrP was expressed from time 0 but its expression 
started to decrease at day 2 and no bands appeared after day 4. The other two sets of 
experiments showed similar results (see Table 3.4 and Appendix, Figures A.6 and A.9).
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(A ) Days
0 1 2 3 4 5 6 7
GAPDH
Type X
Patched
PTHrP
GAPDH
TypeX
Patched
PTHrP
Figure 3.3: Agarose gel of PCR products showing the typical observation out of 3 sets 
of experiments. The expression of different genes in the untreated and treated 
micromass cultures of the caudal region of the sternum of 17 day chick embryos. RNAs 
were isolated form individually collected chondrocyte micromass with out any 
surrounding cells. Every 24 hours the RNA was isolated from a 7 day culture period and 
was used for the RT-PCR analysis. Lane 0 = 0 time point. Lanes 1 - 7 = RNA isolated at 
days 1, 2, 3, 4, 5, 6 and 7 respectively.
(A) Untreated.
(B) Treated with cyclopamine.
(0) RNA was extracted from freshly isolated chondrocytes.
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Gene Untreated Treated I
GAPDH No change in expression No change in expression
Type X collagen No expression Expression at day 5, 6 and 7
Ihh No expression
Expression at day 4, 5, 6 and 
7
SAP
Expression from the time 0 to 
day 7
No expression
Patched Expression at day 5, 6 and 7
Expression from day 3 to 
day 7
PTHrP
High expression from the time 0 
and gradually decreased to day 7
High expression at the time 0 
and then gradually 
decreased to day 4
Table 3.4: Summary of the expression of different genes obtained by the RT-PCR in 
the caudal region of the treated and cyclopamine treated samples
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3.3.3.2 Chondrocytes Isolated from Middle Region of Sternum
As shown in Figure 3.4A GAPDH and type X collagen show similar expression levels 
at all different time points (0, 1, 2, 3, 4, 5, 6 and 7). However, there were noticeable 
variations in the intensity of expression of the other genes. Indian hedgehog showed 
low level of expression from time 0 to day 3 but the expression became more intense at 
day 4 and thereafter. In contrast, SAP expression was intense from time 0 to day 3 and 
its expression became less intense thereafter. The Patched expression was pronounced 
from time 0 to day 4 and decreased thereafter. On the other hand, the expression of 
PTHrP appeared strong from time 0 to day 3 and the bands started to lose their intensity 
at day 4 but the levels of expression remained similar at day 5 up to day 7.
As shown in Figure 3.4B the levels of GAPDH expression in the cyclopamine treated 
cultures were similar at all time points. Other genes showed remarkable variations in the 
expression intensity. Noticeably, SAP showed only a strong band of expression at time 
0 and no expression at the other time points. PTHrP also showed a strong band at time 
0 but the expression became much less at day 2 and no band was observed from day 3. 
Patched showed strong bands from time 0 until day 4 and the bands became less intense 
at other time points.
The above results are representative and summarised in Table 3.5. Those from other two 
sets of experiments are shown in Appendix, Figures A.7 and A. 10.
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GAPDH
TypeX
Patched
PTHrP
(B)
GAPDH
TypeX
Ihh
SAP
Patched
PTHrP
Figure 3.4: Agarose gel of PCR products showing the typical observation out of 3 sets 
of experiments. The expression of different genes in the untreated and treated 
micromass cultures of the middle region of the sternum of 17 day chick embryos. RNAs 
were isolated form individually collected chondrocyte micromass with out any 
surrounding cells. Every 24 hours the RNA was isolated from a 7 day culture period and 
was used for the RT-PCR analysis. Lane 0 = 0 time point. Lanes 1 - 7 = RNA isolated at 
days 1, 2, 3, 4, 5, 6 and 7 respectively.
(A) Untreated.
(B) Treated with cyclopamine.
(0) RNA was extracted from freshly isolated chondrocytes.
Days
0 1 2 3 4 5 6 7
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Gene Untreated Treated 1
GAPDH No change in expression No change in expression 1
Type X collagen Expression at all time points Expression at all time points 1
Ihh
Gradually increased in Gradually increased in
expression from day 3 to day 7 expression from day 1 to day 7
High expression from the time 0
SAP and then gradually decreased to 
day 7
No expression
High expression from the time 0 High expression from the time
Patched and then gradually decreased to 0 and then gradually decreased
day 7 to day 7
High expression from the time 0 High expression at time 0,1 1
PTHrP and then gradually decreased to and suddenly decreased from
day 7 day 2
Table 3. 5: Summary of the expression of different genes obtained by the RT-PCR in 
the Middle region of the treated and cyclopamine treated samples
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3.3.3.3 Chondrocytes Isolated from Cephalic Sternum
Reverse transcription -PCR analysis of the cephalic region of both, the cyclopamine 
treated and untreated sternum, shows that all 3 genes (GAPDH, Type X collagen and 
Ihh) were expressed and the levels of their expression were somewhat similar 
throughout the time points (Figure 3.5A). The remaining genes (SAP, Patched and 
PTHrP) exhibited significant variations in the intensity of expression, depending on the 
time points. In the untreated samples, SAP was expressed at time 0 but the bands of 
expression started to loose their intensity from day 1 and then no further expression was 
recorded as from day 6. The pattern of decreasing levels of expression was also 
observed in Patched and PTHrP. The Patched expression was intense from day 1 and 
the intensity of its expression was gradually reduced from day 4. In the treated samples, 
SAP and PTHrP expression was recorded at time 0 but showed no further bands from 
day 1 to day 7. In contrast, Patched did not show up until day 2 and its expression 
started to increase gradually from day 5 right through to day 7 (Figure 3.5 B).
The above results represent one set of the experiments and summarised in Table 3.6. 
The other two sets of experiments also showed similar results that are presented in 
Appendix, Figure A.8 and A. 12.
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(A )
0
Days 
3 4
GAPDH
TypeX
Patched
PTHrP
(B) Days
0 1 2 3 4 5 6 7
GAPDH
TypeX
Patched
PTHrP
Figure 3.5: Agarose gel of PCR products showing the typical observation out of 3 sets 
of experiments. The expression of different genes in the untreated and treated 
micromass cultures of the cephalic region of the sternum of 17 day chick embryos. 
RNAs were isolated form individually collected chondrocyte micromass with out any 
surrounding cells. Every 24 hours the RNA was isolated from a 7 day culture period and 
was used for the RT-PCR analysis. Lane 0 = 0 time point. Lanes 1 - 7 = RNA isolated at 
days 1, 2, 3, 4, 5, 6 and 7 respectively.
(A) Untreated.
(B) Treated with cyclopamine.
(0) RNA was extracted from freshly isolated chondrocytes.
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Gene j Untreated Treated
No change in expressionGAPDH I No change in expression
Type X collagen I Expression at all time points Expression at all time points I
I Gradually increased in
Ihh
expression from day 3 to day 7
Gradually increased in 
expression from day 1 to day 7
SAP
High expression from the time 0 [ 
and then gradually decreased to No expression 
day 5
Patched
High expression from the time 0 
and then gradually decreased to 
day 7
High expression from the time 1 
0 and then gradually decreased 
to day 7
PTHrP
High expression from the time 0 
and then gradually decreased to 
day 7
High expression at time 0 and 1 
suddenly non expression from 
day 1
Table 3.6: Summary of the expression of different genes obtained by the RT-PCR in 
the cephalic region of the treated and cyclopamine treated samples
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GAPDH
TypeX
IHH
SAP
Patched
PTHrP
GAPDH
TypeX
IHH
SAP
Patched
PTHrP
Days
0 1 2 3 4 5 6 7
(C)
0
Days 
3 4
GAPDH
TypeX
Patched
PTHrP
Figure 3.6: PCR reaction products of different regulatory genes in the untreated 
micromass culture of 17 day chick embryo. The RNA used in these reactions was 
isolated from the whole micromass culture containing the dedifferentiated fibroblasts. 
Lane 0 = 0 time point. Lanes 1 - 7 = RNA isolated at days 1, 2, 3, 4, 5, 6 and 7 
respectively.
(A) Caudal region (B) Middle region (C) Cephalic region
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3.3.4 Glycosaminoglycans (GAGs) and Collagen synthesis
3.3.4.1 Effect of Cyclopamine on the Levels of GAGs Released into the Micromass
Medium during 8 Days Culture
The experimental results and the statistical analysis are shown in Table 3.7
The controls taken from caudal, middle and cephalic regions showed a gradual increase 
in the levels of GAG release into the medium throughout the period of culture from day 
2 to day 8. The same pattern of GAG release was also observed in the cyclopamine 
treated samples. Furthermore, the levels of GAG release are significantly higher 
(P<0.05) in the cyclopamine treated than those in the control samples taken from both 
the caudal and middle regions. However, the levels of GAG release were significantly 
(P<0.05) less in the cyclopamine treated than those in the control samples taken from 
the cephalic region.
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Caudal Samples
Day
Untreated
(pg/ml)
mean
SE
Treated
(pg/ml)
mean
SE P Value
2 0.38 ± 0.006 14.33 ±0.012 0.02
4 12.26 ±0.015 31.69 ± 0.002 0.01
6 45.64 ± 0.002 52.51 ± 0.007 0.03
8 63.42 ±0.004 60.28 ± 0.003 0.031
Middle samples
Day
Untreated
(M g/m l)
Mean
------
SE
Treated
(pg/ml)
mean
SE P Value
2 10.87 ± 0.001 21.86 ± 0.005 0.010
4 23.24 ± 0.003 28.42 ±0.001 0.020
6 26.52 ± 0.002 29.88 ± 0.002 0.047
8 30.49 ± 0.001 43.47 ± 0.006 0.006
Cephalic samples
Day
Untreated
(Hg/ml)
Mean
SE
Treated
(pg/ml)
mean
SE P Value
2 7.43 ± 0.001 2.93 ±0.005 0.040
4 12.19 ± 0.003 9.49 ± 0.006 0.044
6 21.22 ±0.012 11.71 ± 0.001 0.049
8 31.90 ± 0.005 18.15 ±0.017 0.048
Table 3.7: The release of GAGs by three different regions of the 17 day chick 
embryonic sternum into the medium of the treated and untreated micromass 
cultures. SE = Standard error, replicate number (n) = 3
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3.3.4.2 Effect of Cyclopamine on the Levels of GAGs Production in the Micromass 
Mass during 8 Days Culture
The results and the statistical analysis are summarised in Table 3.8 
In the untreated (control) caudal sample, the level of GAG production constantly 
increased throughout the period of culture (8 days). The production of GAG in this 
sample increased from 27.26 pg/mg of protein on day 2 to 100.17 pg/mg of protein on 
day 8 (Table 3.8). In the cyclopamine treated sample, the production of GAG also 
increased constantly throughout the same period of culture from 34.30 pg/mg of protein 
on day 2 to 103.15 pg/mg on day 8. Increases in the level of GAG production have also 
been observed throughout the period of cultures in the cyclopamine treated and 
untreated middle region. The level of GAG production in the untreated middle region 
reached 6.67 pg/mg on day 2 and gradually increased to 70.65 pg/mg of protein on day 
8 (Table 3.8). The production of GAG in the cyclopamine treated middle region showed 
a similar pattern; it reached 19.07 pg/mg of protein on day 2 and increased to 
93.93pg/mg on day 8 (Table 3.8). A similar pattern of increasing levels of GAG 
production was also found in the cephalic tissue, either treated or untreated. The level of 
GAG production in the untreated sample of the cephalic region was at 9.38 pg/mg of 
protein on day 2 and peaked at 55.47 pg/mg of protein on day 8 (Table 3.8). In the 
treated cephalic region, the level of GAG production was found to be 3.20 pg/mg on 
day 2 and gradually increased to 14.39 pg/mg on day 8 (Table 3.8).
Statistical analysis of the data shows that the levels of GAG production in the 
cyclopamine treated sample were significantly (P<0.05) higher than those in the 
untreated taken from both caudal and middle regions (Table 3.8). However, the cephalic 
region showed a reverse trend, that is the levels of GAG production in the cyclopamine 
treated sample were significantly less (P<0.05) as compared to those in the control 
samples (Table 3.8). Furthermore, it is interesting to note that the levels of GAGs 
produced by the cephalic region were less than those in the middle and caudal regions 
regardless of whether the samples were treated or untreated by cyclopamine.
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Caudal Samples
Day
Untreated
(Hg/mg)
mean
.r .............
SE
Treated
(Pg/mg)
mean
SE P Value
2 27.26 ± 0.003 34.30
±0.001 0.038
4 49.24 ± 0.003 73.63 ± 0.003 0.0096 86.64 ±0.011 108.56 ± 0.006 0.020
8 100.17 I ± 0.009 103.15 ± 0.006 0.032 I
Middle samples
Day
Untreated
(Hg/mg)
mean
SE
Treated
(Pg/mg)
mean
SE P Value
2 6.67 ± 0.003 6.67 ± 0.003 0.035
4 32.35 ± 0.004 32.35 ± 0.003 0.004
6 61.73 ± 0.003 61.73 ± 0.001 0.008
8 70.65 I ± 0.003 70.65 I ± 0.002 0.010 1
Cephalic samples
Day
Untreated
(Hg/mg)
mean
SE
Treated
(Hg/mg)
mean
SE P Value
2 9.38 ± 0.002 3.20 ±0.001 0.036
4 17.82 ± 0.003 7.42 ± 0.003 0.035
6 41.58 ± 0.003 11.24 ± 0.003 0.005
8 55.47 ± 0.003 14.39 ± 0.007 0.008
Table 3.8: Shows the amount of GAGs production in the mass of the treated and 
untreated micromass cultures during one week culture and the P value between the 
three different regions of the 17 day chick sternal chondrocytes. SE = Standard 
error, replicate number (n) = 3
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3.3.4.3 Effect of Cyclopamine on the Levels of GAGs Production in the Micromass 
Mass after Two Weeks in Culture
In the results shown in Table 3.9 the micromass cultures were grown for two weeks. 
This was to examine and investigate the phenotype of the chondrocytes in the 
micromass culture. In the cartilaginous tissue the undifferentiated and mature 
chondrocytes are responsible for ECM synthesis which can be examined by measuring 
the production of GAGs and hydroxyproline. From the result obtained from the 8 days 
culture period it was necessary to examine if the chondrocytes can maintain their 
chondrocytic phenotype beyond the initial period of culture ie 8, Therefore the culture 
period was extended to 14 days, and the micromass mass were analyses at three 
different time points (12, 13 and 14 days) during the second week of culture.
In the experimental results are shown in Table 3.9. In the absence of cyclopamine, all 
three regions of the sternum (caudal, middle and cephalic) showed a gradual increase in 
the levels of GAG production throughout the period of cultures from day 12 to day 14. 
In the presence of cyclopamine, the levels of GAG production by all treated cultures 
gradually decrease during the same period. The amount of GAG found in the treated 
caudal and middle regions was significantly (P<0.05) higher than that in the untreated 
samples. In contrast, the levels of GAG in the treated cephalic region were found to be 
significantly (P<0.05) lower than those in the untreated samples.
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Caudal Samples
Day
Untreated
(pg/mg)
mean
SE
Treated
(pg/mg)
mean
SE P Value
12 113.42 ±0.011 77.78 ±0.010 0.005
13 118.14 ± 0.003 90.81 ± 0.003 0.001
14 123.97 ± 0.007 101.19 I ± 0.009 0.001
Middle samples
Day
12
Untreated
(pg/mg)
mean
| Treated 
SE (pg/mg) 
I mean
I
SE P Value 
1 I
102.31 I ±0.013 81.88 ± 0.007 0.073
13 108.69 ±0.006 87.95 ± 0.006 0.046
14 112.31 I ±0.002 90.46 ± 0.004 0.040
Cephalic samples
Day
Untreated
(pg/mg)
mean
SE I Treated(Mg/mg)
mean
SE P Value
12 48.13 ± 0.003 34.14 ± 0.007 0.013
13 70.56 ± 0.003 33.30 ± 0.006 0.004
14 83.54 ± 0.001 I 43.97 ± 0.003 0.002 I
Table 3.9: Shows the amount of GAGs production in the mass of the treated and 
untreated micromass cultures during two weeks culture and the P value between the 
three different regions of the 17 day chick sternal chondrocytes. SE = Standard 
error, replicate number (n) = 3
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3.3.4.4 Effect of Cyclopamine on the Release of Collagen in the Micromass Mass 
during 8 Days Culture Period
The results and the statistical analysis are summarised in Table 3.10 
Collagen synthesis was measured by analysis of hydroxyproline. In all untreated 
samples, the levels of hydroxyproline production constantly increased throughout the 
period of culture (8 days). The production of hydroxyproline in the caudal region 
increased from 0.12 pg/mg of total protein on day 2 to 13.73 pg/mg of total protein on 
day 8. The level of hydroxyproline production in the untreated middle region reached 
2.55 pg/mg of total protein on day 2 and gradually increased to 12.44 pg/mg of total 
protein on day 8 (Table 3.10). A similar increasing pattern of hydroxyproline 
production was also found in the untreated cephalic tissue. The hydroxyproline 
production in the untreated sample of the cephalic region was at 0.91 pg/mg of total 
protein on day 2 and peaked at 4.13 pg/mg of total protein on day 8.
In the cyclopamine treated caudal and middle regions, the production of hydroxyproline 
also increased constantly throughout the same period of culture. The level of 
hydroxyproline found in the treated caudal started from 2.50 pg/mg of total protein on 
day 2 increased to 20.08 pg/mg of total protein on day 8. The level of hydroxyproline 
production in the cyclopamine treated middle region reached 0.31 pg/mg of total 
protein on day 2 and increased to 8.81 pg/mg of total protein on day 8. However, a 
similar increasing pattern of hydroxyproline production was also found in the treated 
cephalic tissue but only up to day 6 after which this level dropped to 1.85 pg/mg of total 
protein on day 8 (Table 3.10).
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Caudal Samples
Day
Untreated
(Hg/mg)
mean
SE
Treated
(pg/mg)
mean
SE P Value
2 0.12 ± 0.001 2.50 ± 0.003 0.039
4 5.41 ± 0.002 9.70 ±0.001 0.004
6 7.77 ± 0.003 12.99 ± 0.002 0.009
» 13.73 ± 0.003 20.08 ± 0.001 0.026 I
Middle samples
Day
Untreated
(Hg/mg)
mean
SE
Treated
(Mg/mg)
mean
SE
'
P Value
2 2.55 ± 0.001 0.31 ± 0.001 0.001
4 3.44 ± 0.001 4.01 ± 0.001 0.004
6 5.83 ±0.001 8.26 ± 0.008 0.030
8 8.81 ± 0.002 12.44 I ± 0.008 0.009
Cephalic samples
Day
Untreated
(Hg/mg)
mean
SE
Treated
(Mg/mg)
mean
SE P Value
2 0.91 ± 0.004 0.11 ± 0.002 0.012 1
4 2.99 ± 0.001 1.47 ± 0.009 0.047
6 3.05 ± 0.001 2.39 ± 0.002 0.006
1 8 4.13 ± 0.001 1.85 ± 0.001 0.019 1
Table 3.10: Shows the amount of hydroxyproline released into the mass of the 
treated and untreated micromass cultures during one week culture and the P value 
between the three different regions of the 17 day chick sternal chondrocytes. SE = 
Standard error, replicate number (n) = 3
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3.3.4.5 Effect of Cyclopamine on the Release of Collagen in the Micromass Mass 
after Two Weeks of Culture
The experimental results and the statistical analysis are summarised in Table 3.11. In 
the absence of cyclopamine, all three regions of the sternum (caudal, middle and 
cephalic) showed a gradual increase in the levels of hydroxyproline production 
throughout the period of cultures from day 12 to day 14. In the presence of 
cyclopamine, the levels of hydroxyproline production by all treated cultures gradually 
increase throughout the same period of cultures. The amount of hydroxyproline found 
in the treated caudal and middle regions was significantly (P<0.05) higher than that in 
the untreated samples (Table 3.11). In contrast, the levels of hydroxyproline in the 
treated cephalic region were found to be significantly (P<0.05) lower than those in the 
untreated samples (Table 3.11).
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Caudal Samples
Untreated T reated
Day (pg/mg) SE (pg/mg) SE P Value
mean mean
12 17.50 ± 0.009 28.03 ± 0.001 0.047
13 23.80 ±0.001 29.08 ± 0.003 0.024
14 26.62 ± 0.003 |______34.55 ± 0.002 0.024 J
Middle samples
Untreated Treated
Day (pg/mg) SE (Hg/mg) SE P Value
mean mean
12 11.68 ± 0.003 18.95 ± 0.001 0.039
13 14.37 ± 0.001 21.95 ± 0.001 0.014
14 18.30 I ± 0.003 27.28 I ± 0.002 0.025 I
Cephalic samples
Untreated Treated I |
Day (Hg/mg)
mean
SE (Mg/mg)
mean
SE P Value I
12 4.03 ± 0.001 3.03 ± 0.005 0.048
13 7.02 ± 0.002 4.28 ± 0.001 0.009
14 7.93 ± 0.001 4.75 | ± 0.001 0.011 I
Table 3.11: Shows the amount of hydroxyproline released into the mass of the 
treated and untreated micromass cultures during two weeks culture and the P value 
between the three different regions of the 17 day chick sternal chondrocytes. SE = 
Standard error, replicate number (n) = 3
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Summary o f the Biochemistry Analysis Results
> The culture medium of the treated caudal and middle micromass dots 
contains high level of GAGs as compared to that of the untreated samples.
> The level of GAGs in the culture medium of the treated cephalic micromass 
dots is less than that in the untreated samples.
^  The level of GAGs was high in the caudal and middle micromass dots grown 
in the cyclopamine containing medium for 8 days as compared to that in the 
untreated samples.
^  The level of GAGs was low in the cephalic micromass dots grown for 8 days 
in the medium containing no cyclopamine as compared to that in the 
untreated samples.
^  The level of GAGs in the two weeks cultures of the treated caudal, middle 
and cephalic regions was less than that in the untreated samples.
^  The level of hydroxyproline production was generally higher in the one 
week cultures of the treated caudal and middle regions except that at day 2.
^  The level of hydroxyproline in the one week culture of the treated cephalic 
region was less than that in the untreated samples.
^  The level of hydroxyproline was high in the two weeks culture of the treated 
caudal and middle regions as compared to that in the untreated samples.
^  The level of hydroxyproline in the two weeks culture of the treated cephalic 
region was less than that in the untreated samples.
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3.4 Discussion
In the previous experiments (see Chapter 2), histological and in situ hybridisation 
methods demonstrated that most of the chondrocytes in the caudal region of the sternum 
showed a phenotype similar to the cells of the proliferative zone of the tibia whereas 
those in the middle region appeared to be similar to the prehypertrophic chondrocytes, 
and those in the cephalic region are similar to the hypertrophic chondrocytes in the tibia 
(Gibson, 1997; 1998). Furthermore, the results obtained from these experiments have 
shown that small acidic protein (SAP) was predominantly localised in the proliferative 
chondrocytes although low intensity of expression was also observed in the 
prehypertrophic and hypertrophic cells. While type X collagen was only detected in the 
hypertrophic chondrocytes, Ihh was found in both the prehypertrophic and hypertrophic 
cells. Studies made in earlier years have reported that the prehypertrophic and 
hypertrophic phenotypes also showed the presence of PTHrP and patched (van der 
Eerden et al., 2000).
Since cyclopamine, a plant steroidal alkaloid, is known to have the ability to inhibit cell 
receptor signalling, its inhibitory effect on the expression of SAP, Ihh, PTHrP, Patched 
and type X collagen was examined in the present study using 17 day old chick sternum. 
Much attention was focused on whether the non expression of SAP affects the 
expression pattern of the other genes of interest. The results obtained from this study 
could be used, not only to confirm the above results but also to ascertain whether SAP 
interacts with Ihh, PTHrP, Patched and type X collagen, all of which are known to be 
involved in the chondrocyte differentiation. Three different phenotypes of chondrocytes 
were isolated from their respective (caudal, middle and cephalic) regions of the sternum 
and grown in an appropriate culture system.
It has been well established that cyclopamine inhibits cellular response to hedgehog 
(Hh) signal by blocking its signalling pathway (Kindblom et al, 2002). In a number of 
tissues, deregulation of the Hh signalling pathway can inhibit cell differentiation and 
promote tumorigenesis (Altaba et al., 2004). However, the effect of deregulating Hh 
signalling on tumour growth can be reversed by cyclopamine treatment (Altaba et al., 
2004). According to Sanchez et al (2004), blocking the pathway of Hh with
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cyclopamine inhibits cell proliferation and differentiation. Furthermore, Qualtrough et 
al (2004) have demonstrated that cyclopamine treatment resulted in decreased cell yield 
and induction of apoptosis in vivo and that no evidence of necrotic cell death was 
observed in treatment of cell lines, which suggested that cyclopamine is not toxic.
In order to determine the appropriate culture system for use throughout this study, 
different types of cultures were initially tested: monolayer, organ and micromass dots. 
The test showed that in the monolayer culture system, the cells were differentiated into 
fibroblasts after a few days in culture. Moreover, attempts to isolate RNA from the 
organ culture proved very difficult if not impossible and often resulted in RNA 
degradation. The latter culture system in which the cells were grown in micromass dots 
was found to have several advantages over the former two: (1) it was easy to extract a 
high quality RNA from the cells; and (2) the cells were surrounded by their extracellular 
matrix, thus maintaining their in vivo environment. Furthermore, in this system the cells 
were found to maintain their chondrocytic phenotype and since they were densely 
packed together in dots, this facilitated the interaction and signalling pathway between 
these cells and the ECM (Swalla et al, 1986; Archer et al, 1992).
This culture system was initially developed to study chondrogenesis in the limb bud 
(Ahrens et al, 1977; Daniels et al, 1996). This system allowed the formation of a three 
dimensional, multilayered organisation of closely associated cells with pericellular and 
extracellular matrix (ECM) entrapped to potentiate differentiation. The sequence of 
chondrogenic events within the micromass culture recapitulates the sequence observed 
in vivo. According to Daniels et al (1996), the micromass faithfully reproduces three 
basic concepts in developmental biology: pattern formation, morphogenesis, and 
differentiation in vitro. Since the micromass dot culture system was found to offer 
several advantages over that of monolayer and organ system, it was used throughout the 
present study.
This study used reverse transcription polymerase chain reaction (RT-PCR) method to 
examine the effect of cyclopamine on the expression of type X collagen, Ihh, SAP, 
Patched and PTHrP in all three regions of the sternum: caudal, middle and cephalic. The
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results obtained from the RT-PCR study indicate that cyclopamine has an effect on all 
five genes: type X collagen, Ihh, SAP, Patched and PTHrP (Figures 3.3, 3.4 and 3.5). 
However, the response of these genes to cyclopamine varied depending on the duration 
of the treatment and cell phenotypes (proliferative, prehypertrophic and hypertrophic). 
In the absence of cyclopamine, the proliferative chondrocytes showed no expression of 
type X collagen and Ihh (Figure 3.3 A). However, these cells expressed type X collagen 
and Ihh following exposure to cyclopamine (Figures 3.3 B, 3.4 B and 3.5 B). 
Furthermore, all untreated proliferative chondrocytes showed high levels of SAP 
expression whereas there was no SAP expression in any treated cells throughout the 
time points of the cultures. These findings suggest that cyclopamine has a strong 
inhibitory effect on SAP expression in the three different phenotypes of chondrocytes 
(Figures 3.3B, 3.4B and 3.5B).
The present study also revealed that the proliferative cells and those at early stage of 
differentiation exhibited high levels of PTHrP expression in all cyclopamine-free 
cultures whereas those exposed to cyclopamine showed a significant reduction in the 
levels of PTHrP expression. This inhibitory effect was only observed after a prolonged 
exposure to cyclopamine after 3 days of culture. Furthermore, the PCR analysis of 
prehypertrophic chondrocytes in the middle region of the sternum revealed that while 
cyclopamine had no significant inhibitory effect on the expression of type X collagen 
and Ihh, it completely knocked out that of SAP and PTHrP (Figures 3.3 B & 3.4 B and
3.5 B). In the untreated and treated cultures, no significant variation in the levels of 
expression of Patched was observed. The results obtained from the PCR analysis of the 
hypertrophic chondrocytes in the cephalic region indicate that cyclopamine did not 
inhibit the expression of type X collagen, Ihh and Patched whereas it showed a strong 
inhibitory effect on SAP and PTHrP (Figures 3.3 B & 3.4 B and 3.5 B). The detection 
of PTHrP expression in the untreated caudal cells seems to confirm an earlier report that 
PTHrP was immunostained in proliferating chondrocytes (Moseley et al, 1991).
Earlier studies using tibia indicated that these genes coordinate the rate of chondrocyte 
proliferation and determine the time when the cells should leave the proliferative stage 
to begin differentiation (Kobayashi et al, 2002; Maclean et al, 2005). As suggested by
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Vortkamp et al (1996) Ihh and PTHrP are the major regulators of chondrocyte 
proliferation and differentiation, and they work together in a negative feedback loop. 
Moreover, earlier studies using growth plate have shown that cyclopamine inhibited 
PTHrP expression by blocking Ihh signalling which directly affects the expression of 
PTHrP in the chondrocytes (Kim et al, 1998; Chen et al, 2002). It has been further 
suggested that the non expression of PTHrP could cause the chondrocyte to become 
hypertrophic (Nakase et al, 2001). Under normal conditions, the signal of Ihh activates 
the release of PTHrP and this signalling process happens through the Ihh receptors such 
as Smoothened (Smo) and Patched. In the presence of cyclopamine, the Ihh response is 
inhibited and also affected the balance between active and inactive forms of Smo 
(Taipale et al, 2000). Therefore examining the expression of Smo will also be 
important in supporting the current conclusion.
In the present study, high levels of SAP expression were found in all untreated caudal 
cultures in which type X collagen and Ihh were absent. In contrast, in the cyclopamine 
treated caudal samples, SAP was knocked out completely as early as day 1 whereas type 
X collagen and Ihh were highly expressed after a longer exposure to cyclopamine. SAP 
expression was inhibited by cyclopamine, not only in the caudal region where the cells 
were proliferative but, also in the middle and cephalic regions in which the cells 
underwent differentiation. These findings indicate that the blocking of HH signalling 
may either affect SAP mRNA stability or inhibit SAP gene expression. PTHrP also 
showed similar sensitivity to cyclopamine in all cell phenotypes. The fact that SAP 
expression was of very low intensity in all the untreated cephalic cultures seems to 
confirm that SAP was downregulated as soon as the chondrocytes became hypertrophic. 
This observation confirms the results of the in situ hybridisation studies presented in 
chapter 2, which showed that SAP was expressed in the prehypertrophic rather than 
hypertrophic cells of the sternum (Chapter 2).
According to Webster’s finding (1999), SAP may be a transcription factor since its 
secondary structure is a basic-Helix-loop-Helix. This bHLH structure is known to be 
one of the other transcription factors structures. This observation suggests that SAP 
would play an important role as a transcription regulator which either binds to other
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transcription factors or upregulates the transcription of other gene(s) (Figure 3.7). The 
present study shows that under normal culture conditions (no cyclopamine treatment), 
SAP and PTHrP were highly expressed in the caudal (proliferative) and middle 
(prehypertrophic) regions of the sternum. However, the results also show that following 
cyclopamine treatment, the expression of SAP was completely inhibited in these regions 
and that of PTHrP was gradually downregulated. It was also noted that there was 
increasing Ihh expression soon after PTHrP expression was switched off; the middle 
region in particular showed high levels of Ihh expression. These observations suggest 
that cyclopamine may induce a chain of events in these regions where the inhibition of 
SAP was found to be followed by the downregulation of PTHrP expression. If this is the 
case, SAP may be involved in the transcription of PTHrP and indirectly affects the Ihh- 
PTHrP feed back loop. This could be investigated using a PTHrP promoter- reporter 
gene construct in transfected cells treated with various amount of SAP. The results 
obtained from the present study seem to confirm the observations in earlier studies that 
cyclopamine has the ability to inhibit cell response and signalling pathways (Incardona 
et al 1999; Chen et al 2002; Qualtrough et al 2004).
The PCR results presented in this study have revealed that SAP, Ihh and PTHrP are all 
expressed in the same region (prehypertrophic) of the embryonic sternum and that the 
non expression of either SAP or PTHrP or both results in the up regulation of Ihh in this 
region. This observation suggests that SAP may function in the same way as PTHrP in 
that it interacts with Ihh in a negative feedback loop. The fact that the up regulation of 
Ihh expression was followed by the down regulation of that of PTHrP seems to indicate 
for the very first time that the Ihh/PTHrP negative feedback loop has taken place in the 
embryonic sternum. Since this feedback loop has only been reported in the growth plate 
of mouse tibia, the results obtained from both the in situ hybridisation and PCR analyses 
confirm that SAP was specifically localised and highly expressed in the proliferative 
and prehypertrophic regions of the embryonic sternum. SAP was also shown to interact 
in a negative feedback fashion with Ihh, one of the endochondral ossification regulators. 
These findings seem to support the hypothetical view that SAP may play a part in 
endochondral ossification process.
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As far as Patched is concerned, the present study showed no major variations in its 
expression between the untreated and treated cultures (Figures 3.3, 4, 5, 6, 7 and 8). 
PCR analysis of the hypertrophic chondrocytes in the cephalic region indicates that 
cyclopamine did not inhibit the expression of Patched. However, cyclopamine has 
previously been reported to have the ability to disrupt the action of Patched, one of the 
Ihh receptors. Patched has been shown to be one of the downstream targets of Ihh 
signalling (Kamenetsky et al, 2002) and both the present study and earlier reports 
showed that Patched was expressed in proliferative as well as in mature 
(prehypertrophic and hypertrophic) chondrocytes. This interesting observation required 
further examination to study the possible mechanism and function of SAP, Patched and 
Smo in endochondral ossification.
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Figure 3.7: Diagram summarising the expected involvement of SAP within the Ihh 
signalling pathway. In the presence of Cyclopamine, the Ihh signalling pathway is 
inhibited, and as a result its receptors such as Patched (Patch) and Smoothened (Smo) 
are deactivated. The deactivation of Smo signal inhibits the expression of Gli in the 
nucleus and consequently the Ihh target genes are also affected, mainly PTHrP. SAP has 
been predicted to be a transcription factor (Webster, 1999). Cyclopamine is shown in 
the present study to inhabit the expression of SAP and PTHrP. These observations may 
suggest that SAP could be a transcription factor for either Gli target genes or the PTHrP 
gene.
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The present study also examined the effect of cyclopamine on the production of 
glycosaminoglycans (GAGs) and collagen by various types of chondrocytes using the 
DMMB staining and hydroxyproline assay methods as described in the ‘Materials and 
Methods’. Changes in the level of GAGs and hydroxyproline productions may be used 
as an indicator for cell maturation since it is well known that proliferative chondrocytes 
produce more ECM and collagens as compared to the hypertrophic cells.
In the absence of cyclopamine, the production of GAGs and collagen in the caudal, 
middle and cephalic regions was found to increase constantly throughout the 14 days 
period of cultures. The caudal produced more GAGs and hydroxyproline than the 
middle and cephalic regions. Comparing the middle and cephalic regions shows that the 
former produced more GAGs and hydroxyproline than the latter. The caudal region has 
been demonstrated by the in situ hybridisation (Chapter 2) to contain proliferative 
chondrocytes. The fact that the levels of production of GAGs and hydroxyproline in this 
region were much higher than those in the other two regions indicates that the 
proliferative chondrocytes underwent active mitotic division as well as actively 
synthesised the structural components of the extracellular matrix (ECM), namely GAGs 
and collagens. A slowdown in the production of GAGs and hydroxyproline in the 
middle region suggests that early cell differentiation took place in this region. The 
cephalic region where the cells reached full differentiation stage to become 
hypertrophic, showed a further decline in the production of GAGs and hydroxyproline, 
resulting in decreased ECM yield.
In the presence of cyclopamine, the levels of GAGs and hydroxyproline in the caudal 
and the middle increased throughout the same period of cultures. However, differences 
were noted in the levels of GAGs and hydroxyproline production between the 
cyclopamine treated and untreated cultures and these variations depended on the regions 
from which the chondrocytes were isolated. The analysis of the 8 days cultures shows 
that the levels of GAGs and hydroxyproline produced in the treated caudal and middle 
were significantly (P<0.05) higher than those in the untreated culture. Except that in day 
8 the GAGs production was significantly (P<0.05) less in the treated caudal region. By 
contrast, the levels of GAGs and hydroxyproline produced in the cyclopamine treated
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cephalic region were significantly (P<0.05) lower than those in the untreated samples 
and these significant differences were observed throughout the 8 days and 14 days 
period (Tables 3.7, 3.8, 3.9. 3.10 and 3.11). A decrease in the production of GAGs and 
hydroxyproline in the treated cephalic samples could suggest that cyclopamine affects 
the production of the extra cellular matrix and the synthesis of type X collagen which is 
known to be the major collagen synthesised by the hypertrophic chondrocytes.
GAGs and collagen are found highly abundant in vertebrate embryos. These structural 
components of the extracellular matrix interact with a wide variety of proteins in 
performing major developmental functions. The present study shows that under the 
influence of cyclopamine, the chondrocytes at the early stage of proliferation and 
prehypertrophy (caudal and middle samples) increased the production of GAGs 
(Figure3.8) whereas those at the later stage of the processes (two weeks cultures) 
showed a decrease in GAGs production (Figure3.9). This decline in GAGs production 
in the later days of culture may be due to the fact that the proliferative and 
prehypertrophic cells differentiated into hypertrophic chondrocytes and therefore they 
produced less GAGs. The present study has also suggested that cell maturation may be 
regulated by the Ihh/PTHrP loop and that it can be affected by cyclopamine treatment. 
In the caudal region in particular, the cells do not usually express type X collagen as this 
collagen is specific to hypertrophic chondrocytes. The fact that this type X gene was 
found by the PCR analysis to be expressed in the cyclopamine treated caudal region 
seems to suggest that in the presence of cyclopamine, the proliferative cells accelerate 
the process of differentiation; thus the cells became hypertrophic or matured earlier than 
normally expected. In addition, the results obtained from the RT-PCR analysis showed 
that the expression of PTHrP which has been reported to be expressed in the 
proliferative and the prehypertrophic chondrocytes (Nakase et al, 2001) is gradually 
decreased in the caudal and middle regions in the present of cyclopamine. This fact 
further supports the notion that chondrocytes from these two regions become 
hypertrophic more rapidly. This finding is confirmed by the reduced production of 
GAGs in these two regions during two weeks of culture when the cells were exposed to 
longer treatment of cyclopamine.
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With regard to the cephalic region where the cells already reached a fully differentiated 
stage, cyclopamine was found to reduce the production of GAGs and hydroxyproline: 
The levels of GAGs production were significantly (P<0.05) less than those observed in 
the controls. It is apparent that the production of GAGs and hydroxyproline in the 
hypertrophic region was affected by the cyclopamine treatment. However, the levels of 
GAGs and hydroxyproline produced appeared to increase gradually with time in both 
cyclopamine treated and untreated cephalic cultures. This shows that cyclopamine was 
not toxic to the cells. There was no morphological evidence of cell death in these 
cyclopamine treated culture. The decline in the production of GAGs and hydroxyproline 
in the cephalic region indicates a continuing slowdown in the synthesis of GAGs and 
collagens, resulting in less production of extracellular matrix. These observations seem 
to support the findings reported by Qualtrough et al (2004) that treatment of cell lines 
by cyclopamine induced decreased cell yield and apoptosis in tumour cells and that it 
did not cause cell death by necrosis.
Regardless of whether the cells were treated or not with cyclopamine, the levels of 
GAGs and hydroxyproline in the caudal and middle regions were always found to be 
much higher than those in the cephalic region; this observation suggests that the 
proliferative and prehypertrophic chondrocytes were more actively involved in the 
production of the extracellular matrix components than the hypertrophic cells. In 
another word, the synthesis of GAGs and hydroxyproline was down regulated as soon 
as the chondrocytes became fully differentiated or matured cells
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4 Introduction
In this project it has been mentioned that the biological functions of the novel Small 
Acidic Protein (SAP) is not yet known. The main aim of the work presented in this 
chapter is therefore to investigate the biological functions of SAP especially focused on 
its involvement in the process of chondrocyte maturation in chondrocyte culture and 
embryonic limb development. This study was carried out using the avian Replication 
Competent ALV LTR with a Splice acceptor (RCAS).
The RCAS vector has been developed by Hughes et al, (1987) and used successfully by 
a rapidly expanding number of groups to assess the biological function of gene directly 
in ovo. This proviral vector is derived from the Rous Sarcoma Virus (RSV) which has a 
unique Clal restriction sites in place of the region normally encoding the src onco 
genes, into which foreign DNA fragments of up to approximately 2.4 kb can be 
inserted. This proviral vector can be efficiently transfected into cultured chick embryo 
fibroblast (CEFs) using standard techniques, and supernatant containing infectious 
viruses easily collected and concentrated to yield high-titer viral stocks, that can then be 
used to infect chick embryos of susceptible strains. Alternatively, transfected CEF cells 
can be grafted directly into host embryos. The viral surface glycoprotein encoded by the 
env gene primarily determines the host range specificity of the virus. Avian specific 
vectors are currently available that contain env genes derived from subgroups A, B and 
D (Figure 4.1) (Hughes et al., 1987). More recently, modified RCAS vectors containing 
env gene derived from murine leukaemia viral glycoprotein have also been generated 
that can infect (but not replicate in) mammalian cells efficiently thus making it possible 
to also use the RCAS system for gene transfer in mice (Barsov et al., 1999). Strains of 
chicken exist that differ in their susceptibility to infection with viruses of different 
RCAS subgroups. C, A and B cells are resistant to infection with A and B subgroup 
viruses and there are cells which are not resistant to any of the five subgroups. It is 
possible to graft infected cell pellets derived from a sensitive strain into the limb bud of 
an insensitive strain. This provides a convenient way to generate a local source of 
transgene expression while avoiding subsequent spread of the virus following 
application of the graft. The replication-competent avian vectors are able to carry out all 
the functions of the virus life cycle in addition to encoding an additional transcript of
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the inserted transgene. It is also therefore possible for the virus to spread from cell to 
cell after the initial infection following injection into the embryo. This can result in a 
widespread infection in the host embryo and therefore broad missexpression of the 
transgene following the initial injection.
The gene of interest (SAP) was copied using the RT-PCR and cloned into the RCAS 
vector and over-expressed in vitro using 17-day embryonic chick chondrocytes.
SD SA SA
LTR 1H1 
1 gag
pol env GeneX
Subgroup 1
variable
LTR
region Cla I
Kpn I Sal I
Cla I
Figure 4.1: RCAS retroviral vector. Avian leukaemia virus long terminal repeat (LTR) 
sequences (red shading) flank the retroviral gag, pol and env genes and the site used to 
insert the transgene (gene X). The Kpnl- Sail sites were used to insert envelops genes of 
different subgroups (A, B and E). The Clal sites used to insert the transgene. SD, splice 
donor, SA splice acceptor.
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4.1 M aterials & M ethods
4.1.1 Preparation of RCAS Vector
The RCAS vector used in this project was cloned into competent XL-1 E.Coli as 
follows:
The XL-1 blue competent cells were thawed on ice for 15 minutes and then 150p,l of 
cell suspension mixed gently with 1 pi of RCAS vector (50ng) by flicking the tube for 4- 
5 times. The tube was placed on ice for 20 minutes, followed by a heat-shock incubation 
in a pre-warmed water bath without shaking for exactly 45 seconds at 50°C. The tubes 
were returned immediately to ice and left for 10 minutes. SOC medium (200pl) was 
added into the tube containing the cells. The tube was incubated at room temperature 
for 25 minutes. The content of the tube was then spread on two Luria broth (LB) 
Ampicillin agar plates, incubated at room temperature for 30 minutes, and then 
overnight at 37°C.
On the following day colonies were picked up and inoculated separately into 5 ml of 
freshly prepared sterile LB medium. The tubes were incubated with continuous 
shacking (250 rpm) at 37°C over night.
4.1.2 Isolation of RCAS Plasmids from the Competent Cells XL-1
This procedure was done using the plasmid mini prep (Qiagen), all buffers used are 
included in the kit.
After overnight incubation 1.5 ml of each culture was transferred into a sterile 
DNase/RNase free eppendorf microcentrifuge tube. The remaining cultures of the tubes 
were frozen in liquid nitrogen and then stored at -80°C for future use. All 1.5ml tubes 
containing the cells were centrifuged in a microcentrifuge for 5 minutes at 10,000 rpm. 
The resulting supernatant in each tube was discarded and the bacterial pellet 
resuspended in 250pl of PI buffer. P2 buffer (250pl) was added gently into the tubes 
which were then inverted 4-5 times. Buffer N3 (350pl) was added into the solution, and 
the tubes were inverted immediately 4-6 times and centrifuged for 10 minutes at 
13,000rpm.
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The supernatants were pipetted onto QIAprep spin columns and centrifuged for 60 
seconds. The flow-through was discarded. The QIAprep spin columns were washed by 
adding 0.5ml of PB buffer and centrifuged for 60 seconds. The resulting flow-through 
was again discarded and the QIAprep spin columns were washed by adding 0.75ml of 
PE buffer and centrifuged at full speed (13,000 rpm) for 60 seconds. The same 
procedure was repeated again at the same speed to remove residual wash buffer. The 
QIAprep spin columns were placed into fresh DNase/RNase free 1.5ml microcentrifuge 
tubes, and then the DNA was eluted by adding 40pi of EB buffer (lOnM Tris-Cl, pH 
8.5) to the centre of each QIAprep spin columns. The columns were left on the bench 
surface at room temperature for 1-2 minutes. They were then centrifuged at maximum 
speed 13,000 rpm for 1 minute. The DNA concentration of RCAS plasmid was 
measured by using a DNA/RNA spectrophotometer.
4.1.3 Cutting RCAS Plasmid with C/a/Restriction Enzyme
The chicken SAP open reading frame was inserted into the RCAS plasmid using the 
Clal restriction sites. Briefly, 50ng of the plasmid was restricted with 2ml of Clal 
according to the following Table:
Reagents Amount
Buffer C (Promega) 5 pi
BSA (Promega) 0.2 pi
RCAS plasmid (50ng) 2 pi
Clal restriction enzyme 2 pi
dH20 10.8 pi
Total 20 pi
Table 4.1: Cutting RCAS plasmid 
The reaction was incubated overnight at 37°C.
In order to examine that the restriction enzymes were cut the plasmid, the cut plasmid 
and uncut plasmids were run on 1% agarose gel, see (Figure 4.3)
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4.1.4 Dephosphorylation of the Cut RCAS Plasmid
Dephosphorylation of linearised plasmids is a method employed to prevent the majority 
of plasmids simply recircularising during the ligation step. It is especially useful when 
both protruding termini of the linearised plasmid have been cut with the same enzyme 
(sticky ends) but is also used in blunt-ended ligations. The cut RCAS plasmid was 
dephosphorylated using alkaline phosphates as follows:
Reagents Amount 1
Alkaline phosphates 4 pi
Buffer supplied 4 pi
Cut RCAS plasmid 3 pi
dH20 9 pi
Total | 20 pi |
Table 4.2: Dephosphorylation of the cut RCAS plasmid 
The reaction was incubated at 37°C for 1 hour.
4.1.5 Isolation of RNA from the Sternal Chondrocytes
The 17 day chick sterna were dissected from the chick embryo bodies and rinsed twice 
with DMEM serum free medium to remove all blood contamination. The sterna were 
chopped into small pieces of tissue and digested in collagenase/trypsin for 2 hour at 
37°C. The resulting suspension was then filtered through a falcon cell strainer. The 
suspension was centrifuged at 1800 rpm for 5 minutes at room temperature. The cell 
pellet was resuspended in 5ml of DMEM-10% FCS and the tubes were centrifuged at 
the same speed for another 5 minutes. This process was repeated three times. The pellets 
were lysed in 350pl of RLT buffer and vortexed for 30 seconds. The lysate was pipetted 
directly onto a QIAshredder spin column placed in a 2ml collection tube and the 
columns were centrifuged for 2 minutes at maximum speed. One volume of 70% 
ethanol was added to the homogenized lysate and mixed well by pipetting. The lysate 
mixture (700pl) was then applied to a RNeasy mini column placed in a 2ml-collection 
tube. All tubes were closed gently and were centrifuged in a microcentrifuge for 15 
seconds at 10,000rpm and the flow-through was discarded.
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During this procedure, DNase digestion was performed by using the RNase-Free DNase 
kit (Qiagen). Aliquots (350pl) of RW1 buffer were pipetted into the RNeasy mini 
column and they were centrifuged for 15 seconds at 10,000 rpm to wash and then the 
flow-through was discarded. The columns were placed on the bench at room 
temperature and lOpl of DNase I stock solution (see RNase-Free DNase kit’s hand 
book; Qiagen) were added to 70pl of RDD buffer and the mixture was mixed gently by 
inverting the tube. The DNase I incubation mix (80pl) was directly applied on the 
RNeasy silica-gel membrane, and then the columns were allowed to stand at room 
temperature (20-30°C) for 15 minutes. After the 350pl of RW1 buffer were pipetted into 
RNeasy mini columns, they were centrifuged for 15 seconds at 10,000 rpm. The flow­
through and collection tubes were discarded and the columns were transferred into new 
2ml collection tubes and 500pi of RPE buffer were pipetted onto the RNeasy columns. 
The tubes were closed gently and were washed by centrifugation for 15 seconds at 
10,000 rpm, and the flow-through was discarded. The mini columns were further 
washed with another 500pl of RPE buffer and centrifuged for another 2 minutes at the 
same speed. The columns were placed into new collection tubes and they were 
centrifuged for 1 minute to eliminate any possibility of buffer RPE carryover. The tubes 
were transferred to 1.5ml RNase DNase free collection tubes and 30-50 pi of RNase- 
free water were applied directly onto the RNeasy silica-gel membrane. The tubes were 
closed gently and then centrifuged for 1 minute at 10,000 rpm. The RNA isolated from 
the 17 day chick embryo was used for preparing cDNA using the RT-PCR as described 
in chapter 3 (Table 3.1).
4.1.6 RT-PCR Reaction of the Open Reading Frame of SAP Fragment
In order to be able to clone the open reading frame of SAP gene into RCAS viral vector 
we designed a pair of primers that amplify the open reading frame of SAP sequence. 
These primers were designed to have Clal restriction sites (ATCG) attached to the end 
of each (forward and reverse) primer. These primers amplify a fragment of 557 bp of 
the open reading frame SAP gene. Also, a 6xHis-tag sequence was added to the C- 
terminal of the reverse primer. The 6xHis-tag would be useful in subsequent 
immunolocalisation of the recombinant SAP in transfected chondrocytes using the 
6xHis-tag antibody.
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SAP forward primer with Clal restriction site:
Clal Site SAP forward
5’ TTA A ■ ■  A TGA GCT CGG CCC GGG AGT G 3 
SAP reverse primer with Clal restriction site and 6xHis-tag sequence:
Clal Site 6xHis-Taq SAP reverse
5’ TATA | H i  ATTA GTG GTG GTG GTG ATG ATG TGA ACC ACT GCT TTA
AC ‘
The PCR reaction was cycled at:
95°C for 2 minute —► [95°C for 30seconds, At* 55 °C for 1 minute, 75°C for 
30seconds] x 30cycles —► 75°C; 5minutes, 4°C oc
This PCR reaction was repeated for 30 cycles.
* The optimum annealing temperature of open reading frame SAP primers in the PCR 
reaction.
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4.1.7 Ligation of the Open Reading Frame SAP Fragment into RCAS Vector
The ligation of SAP open reading frame cDNA, using the RCAS viral vectors was 
prepared as follows:
The tube containing the RCAS vector was briefly centrifuged and placed on ice. The 
ligation reaction mixtures were set up as shown in Table 4.3. To give a maximum 
number of transformants, the tubes were incubated at room temperature for 24 hours.
Reagents Amount 1
2 X ligation buffer 2 pi I
Cut RCAS vector 2 pi
SAP cDNA 2 1*1 I
T4 ligase 1 Pi I
dH20 3 pi
Total 10 pi
I
Table 4.3: standard protocol for RCAS vector ligation reaction
4.1.8 Transformation of RCAS-SAP Vectors into XL-1 Blue Cells
High-efficiency competent cells (XL-1 blue E.Coli strain) were used for the 
transformation of RCAS vector containing SAP open reading frame fragment. The XL- 
1 competent cells were thawed on ice for 15 minutes. The tube containing the ligation 
reaction was centrifuged to collect the contents at the bottom of the tube. The competent 
cells were mixed gently by flicking the tube for 4-5 times, and lOOpl of these cells was 
added into ligation tube and mixed gently. The tube was placed on ice for 20 minutes, 
followed by a heat-shock incubation in a pre-warmed water bath without shaking for 
exactly 45 seconds at 50°C. The tube was returned immediately to ice and left for 10 
minutes. SOC medium (200pl) was added into the tube containing the cells which was 
transformed with ligation reaction; the tube was incubated at room temperature for 25
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minutes. The content of tube was spread on the top of two Luria broth (LB) agar 
plates and incubated at room temperature for 30 minutes, and then over night at 37°C.
4.1.9 Isolation of RCAS-SAP Plasmids from the XL-1 Competent Cells
After over night incubation, 20 colonies were selected (10 colonies from each plate) for 
the isolation of RCAS plasmids containing SAP open reading frame fragment with Clal 
sites. All these selected colonies were inoculated separately in fresh 2ml of LB-broth 
containing Ampicillin (lOOpg/ml). All tubes containing cultures were grown overnight 
at 37°C with continuous shaking (300 rpm). After the incubation period (16 hours); 1.5 
ml of each culture was transferred into a sterile DNase/RNase free tube. The remaining 
cultures were kept at 4°C for future use. All prepared tubes containing the cells were 
centrifuged in a microcentrifuge for 5 minutes at 10,000 rpm. The resulting supernatant 
in each tube was discarded.
For isolating the RCAS plasmids from the XI-1; Wizard plus SV Mininprep DNA 
purification system kit (Promega) was used. The bacterial pellets were resuspended 
thoroughly in 250pl of cell resuspension solution. The cell lysis solution buffer (250pl) 
was added gently into each sample and the tubes were inverted 4-5 times. Alkaline 
protease solution (lOpl) was added into each tube and the samples were inverted 4 times 
to mix. All samples were placed onto 1.5ml rack and incubated at room temperature for 
5 minutes. Neutralization solution (350pl) was added into the samples and the tubes 
were inverted again 4 times. All samples were centrifuged at top speed (13,000 rpm) for 
10 minutes at room temperature. During the centrifuging process the spin columns 
provided with the kit were inserted into collection tubes. The resulting cleared lysate 
were decanted into the spin columns. The tubes were then centrifuged at full speed for 1 
minute at room temperature and the flowtrough was discarded. The columns were 
reinserted into the collection tubes followed by adding 750plof wash solution (ethanol 
added) into each column. The columns were centrifuged at full speed for 2 minutes at 
room temperature. All columns were transferred to sterile 1.5ml microcentrifuge tubes. 
50pl of nuclease-free water were added to the spin columns and centrifuged at full 
speed for 1 minute at room temperature. The columns were discarded and the RCAS- 
SAP plasmids (DNA) were stored at -20°C.
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4.1.10 Cutting RCAS-SAP Plasmids with Clal Restriction Enzyme
In order to check that the RCAS plasmids isolated from 20 different colonies contained 
the open reading frame SAP fragment. All 20 samples were cut with Clal restriction 
enzyme. This cutting procedure should release SAP fragment (557 bp) from the RCAS 
vector. This cutting producer was prepared as illustrated in Table (4.5)
Reagents 1 Amount 1
10 x buffer (Promega) 2 pi
Spermidine (lOOmM/pl) lpl
Clal enzyme lOu/pl (Promega) lpl
(IH2O (Sigma) 6pl
DNA samples (RCAS) lOpl
Total 20pl
Table 4.5: cutting RCAS plasmid with Clal restriction enzyme
The reaction mix was prepared for 20 samples. All samples were centrifuged briefly for 
30 seconds and incubated for 2 hours at 37°C. The reaction was stopped by incubating 
the samples at 65 °C for 5 minutes. Aliquots lOpl of each sample were mixed with 3 pi 
of loading dye and run on 1% agarose gel. Samples number 9 and 17 were selected for 
the PCR reaction with SAP open reading frame primer. These two samples were the 
only samples that gave bands of 557 bp on the agarose gel. The sizes of these two bands 
were the same size as that of the SAP fragment inserted into the RCAS vector. These 
two samples (plasmids 9 and 17) were then used as template for the PCR reaction with 
SAP full length primers to make sure that they give the exact size of SAP open reading 
frame fragment (Figure 4.3).
160
Chapter 4 Over expression of SAP
4.1.11 PCR Reactions of the RCAS-SAP Plasmids with SAP Open Reading Frame 
Primers
The two selected samples (9 and 17) were used as a template for the PCR reactions. The 
primers used in this reaction were the SAP open reading frame primers (Table 4.6) these 
primers were originally used to amplify the SAP open reading frame fragment.
| Primers Sequence
Forward 5 TTA A ATCG A TGA GCT CGG CCC GGG AGT G J 1
| Reverse y TATA ATCG ATTA TGA ACC ACT GCT TTA AC
Table 4.6: SAP primers sequence
The reaction was prepared as follow:
Reagents Amount I
lOx PCR buffer 5pl 1
Mgcl2 (25mM/pl) 3 pi
dNTPs (lOmM/pl) lpl
Forward SAP primer (50mM/pl) lpl
Reverse SAP primer (50mM/ml) lpl
cDNA (RCAS plasmid; 1:20 dilution) lpl
Taq polymerase 0.25pl
dH20  (Sigma) 37.75 pi
Total 50 pi
Table 4.7: PCR reaction of SAP open reading frame fragment
The reaction was run for 30 cycles and the annealing temperature used was 55°C, and 
15 pi of the PCR products of each sample (SAP 9 and SAP 17) were mixed with 3 pi of 
lading dye and run on 1.5% agarose gel. The 174 DNA///ae III DNA marker (lOpl ) 
was run beside the two samples (Figure 4.4).
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4.1.12 Termination of the Correct Orientation of SAP Open Reading Frame 
Fragment Cloned into RCAS Vector by using RT-PCR
After SAP full length fragment was generated and cloned successfully into the RCAS 
vector. It was necessary to determine the correct orientation of the cloned sequence. 
This determination was done by designing two forward and reverse primers for RCAS 
vector just before the cloning site of the vector.
The two samples (9 and 17) which contain the correct size of SAP were used again as 
templates for the PCR reactions. In this PCR reaction, two different pairs of primers 
were used (SAP primers) which is shown in Table 4.6 and (RCAS primers) illustrated in 
Table (4.9)
Primers Sequence
Forward 5 ACG CTT TTG TCT GTG TGC TGC ' J
Reverse 3 ’ ATC TCT GCA ATG CGG AAT TCA GTG ' 3
Table 4.9: Primers of RCAS plasmid
4.1.13 PCR Reaction of SAP and RCAS Primers
The protocol of the PCR reaction used in this experiment was exactly as shown in Table 
4.7. However, in this reaction two pairs of primers (SAP and RCAS) were used into this 
PCR reaction. These primers were used with the two DNA samples (9 and 17). The use 
of these primers into the PCR reaction was as shown in diagram (4.2). The PCR 
reaction was run for 30 cycles and the optimum annealing temperature of both SAP and 
RCAS primers was 58°C.
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(A)
Tube 9 A 
SAP (F) & RCAS (F)
Tube 9 C 
RCAS (F) & RCAS (R)
Sample No: 9 
3 separate PCR reactions
Tube 9 B 
SAP (F) & RCAS (R)
(B)
Tube 17 A 
SAP (F) & RCAS (F)
Tube 17 C 
RCAS (F) & RCAS (R)
Sample No: 17 
3 separate PCR reactions
Tube 17 B 
SAP (F) & RCAS (R)
Figure 4.2: A diagram shows the experimental design of the PCR reactions using the 
SAP and RCAS primers.
(A) Shows the forward and reverse primers used into three different PCR reactions of 
samples 9.
(B) Shows the forward and reverse primers used into three different PCR reactions of 
samples 17.
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4.1.14 Sequencing RCAS Plasmid Containing SAP Open Reading Frame Sequence
The PCR results obtained from the experiment in section 4.1.13 has led to determine the 
RCAS plasmid that has to be sequenced. RCAS plasmid No: 9 was selected to be the 
correct sample for sequencing. ABI Prism Bigdye terminator cycle sequencing ready 
reaction kit was used for sequencing the RCAS plasmid. The reaction was prepared as 
follow:
Reagent Quantity |
Terminator ready reaction mix 4.0pl
Template (RCAS plasmid) 500 ng 5 pi
Primer (3.2pmol) lpl I
dH20 3.6 pi
Total lOpl
Table 4.10: Preparation of the sequencing mixture of the PCR reaction
The primers that were used for sequencing included SAP and RCAS forward and 
reverse primers are listed in Table 4.11
Primers Sequence
P*
<
Forward 5 TTA A ATCG A TGA GCT CGG CCC GGG AGT G ‘J
W Reverse y TATA ATCG ATTA TGA ACC ACT GCT TTA AC ‘J
<n
<
Forward 5' ACG CTT TTG TCT GTG TGC TGC ' J
UQC Reveres 5 ’ ATC TCT GCA ATG CGG AAT TCA GTG ' J
Table: 4.11: Primers used for sequences the RCAS plasmid containing the SAP
fragment
The master mix was made for three sequencing reaction. The contents of each tube were 
mixed well and spin briefly.
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4.1.15 Cycle sequencing of RCAS Plasmid on the Gene Amp PCR System 9700
The tubes were placed in the PCR thermal cycler and the following PCR cycle was 
repeated for 25 cycles.
Rapid thermal ramp to 96°C; (96 °C for 10 seconds), Rapid thermal ramp to 55°C; 
(55°C for 5 seconds), Rapid thermal ramp to 60°C; (60°C for 4 minutes).
Rapid thermal ramp at 4°C and was hold until purification process.
4.1.16 Precipitation of the PCR Sequencing Reaction of RCAS Plasmid Containing 
the Open Reading Frame of SAP Fragment
The contents of all three different PCR reactions were centrifuged briefly for 10 
seconds. Double dH2 0  (40pl) was added separately into each tube. The reaction mix of 
each tube was transferred individually into fresh 1.5 ml DNA/RNA free tubes. NaAc 
pH 5.2 (5pi) was added into each reaction followed by adding 125 pi of 95 % ethanol. 
The content of each tube was mixed and vortex briefly and then incubated at room 
temperature for 20 minutes. The reactions were centrifuged at full speed (13,000 rpm) 
for 15 minutes. The supernatants were removed carefully and 175pl of 70% ethanol 
were added gently into each reaction. The tubes were centrifuged at full speed for 2 
minutes. The 70% ethanol was removed slowly and the tubes were air dry at room 
temperature for 20-30 minutes.
4.2 Preparation o f primary cell line
One dozen of eggs were incubated at 37°C until day 10 (approximately stage 36). The 
embryos were removed from the eggs and laid in a 10-cm Petri dish. The limbs and 
heads were removed using a sterile razor blade and eviscerated with forceps. The 
remained embryo trunks were collected in a fresh 10-cm Petri dish and minced 
thoroughly with a razor blade (this step was important as it greatly increase the 
efficiency at which the trypsin solution dissociates the cells). The chopped embryos 
were collected into Erlenmeyer flask containing 10ml of 0.25% trypsin, ImM EDTA 
solution (Gibco). The contents was shaken gently for 60 minutes on a rotator, also the 
flask was shaken by hand every few minutes. When the small chunks of tissue were 
disappeared the flask was taken off the rotator and left on the bench surface for a few
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minutes until all big chunks of tissue were settled. The supernatant was transferred to a 
50ml centrifuge tube (Falcon sterile plastic tube). Another 50ml of fetal calf serum 
(FCS) were added into the suspension and mixed gently for a few seconds. The mixture 
was left to stand for 5 minutes in the tissue culture hood to allow any remaining tissue 
chunks to settle. The suspension mixture was decanted into a fresh 50ml tube and 
centrifuged at 1000 rpm for 5 minutes. The supernatant was removed and the cells were 
resuspended in 10ml of 100% FCS, the mixture was spun again, and resuspended in 
DMEM supplemented with 10% FCS and 2% chicken serum (Sigma).
The number of cells in the suspension was counted using a conventional 
haemocytometer. The entire preparation was plated onto the appropriate number of 
1 0 cm tissue culture dishes at three different concentrations: 1 0 7cell/dish, 1 0 6cells/dish 
and 3 x 105 cells/dish. The cultures were monitored daily until they began to recover and 
started to divided very rapidly. As soon as the healthiest dishes became close to 
confluent, it was taken and harvested. The cells were harvested by adding 0.10% trypsin 
for 15 minutes. The enzyme was removed and the cells were rinsed with two washes of 
PBS, another 1ml of 0.10% trypsin was added for a few minutes. As soon as the cells 
began to lift off the dish and separated, 3ml of DMEM supplemented with 10% FCS 
and 12% DMSO were added to the solution and mixed gently until the cells clumps 
were disappeared. An aliquot amount of 0.5ml was placed into 1.5ml sterilized tubes 
and all tubes were put on dry ice and were stored at -80°C.
4.3 Transfection o f Viral Supernatant Production
Two tubes of the frozen chicken fibroblast cell line stock were thawed on ice. The cells 
were plated onto 10cm dishes and cultured overnight in 10ml DMEM (supplemented 
with 10%FCS and 2% CS and Penicillin-streptomycin solution, Gibco-BRL). After 
overnight incubation the cells reached approximately 70-80% confluence, 10ml of fresh 
medium were added to the culture 4 hours before the transfection. RCAS-transgene 
plasmid DNA (lOpl) were diluted with distilled water to a final volume of 450pl, 
followed by adding 50pl of 2.5 M CaCE. The solution and was mixed well and 
incubated at room temperature for 20-30 minutes. After this incubation period, the DNA
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(RCAS plasmid) solution was added drop wise onto the dish of the cells while slowly 
swirling the medium in the plate. The culture was incubated overnight at 37°C.
The following day, the cells were confluent and split to two 15cm dishes. The cultures 
were incubated overnight again. Next day a small aliquot of the 0.1 % trypsin was 
added into each culture and the cultures were incubated for 30 minutes. The cells were 
rinsed and washed twice with completed DMEM medium and the cells were plated on a 
24-well cell culture plate. In order to confirm that the transfection procedure was 
successful, after a day of culture these cells were stained with the 3C2 monoclonal 
antibody (mAh), which recognizes the viral MA antigene.
167
Chapter 4
4.4 Results and Discussion
Over expression of SAP
Uncut Cut M
9,416 bp
Figure 4.3: Gel electrophoresis photos showing the uncut (lane 1) and the RCAS 
plasmid cut with Clal restriction enzyme (lane 2) plasmids. M = lambda Hind III 
marker.
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(A)
M Uncut 1 2 3 4 5  6 7 8  9  10
564 bp
(B)
M Uncut 11 12 13 14 15 16 1 7  18 19 20
5 6 4 b p
Figure 4.4: Agarose gel showing the uncut plasmid (RCAS) and the 20 samples of cut 
RCAS plasmid containing the open reading frame SAP sequence (557bp). All samples 
were cut with Clal restriction enzyme to release the inserted open reading frame 
sequence of SAP. Lanes 1-20 are RCAS plasmids isolated from different colonies. Only 
two samples lanes 9 and 17 showed the corrected size of the inserted gene SAP whereas 
the other samples showed different sizes of inserts. These sizes are not equal to the SAP 
open reading frame sequence therefore they were not containing the correct insert 
(SAP).
(A) Showing the uncut and cut RCAS plasmids. Sample 9 is showing the correct 
size of SAP fragment.
(B) Showing the uncut and cut RCAS plasmids. Sample 17 is showing the correct 
size of SAP fragment.
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Figure 4.5: Gel electrophoresis showing RT-PCR products of SAP open reading 
frame fragment. The cDNA used in this PCR reaction were samples 9 and 17 of the 
RCAS plasmids containing SAP open reading frame sequence. Two bands of 
samples 9 and 17 showing the correct size of the insert.
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CGG AGC TGA GCT GAC TCT GCT GGT GGC CTC GCT CTA CCA CTG 
TGG C ATCG ■ ^ ■ ■ ■ ■ ■ ■ ■ ■ C G  CAG GCT CGC CAC GGC 
CTC AAG CGA GCG GCC TCT CCC GAC GGC TCC GGC AGC TGG CAG 
GCG GCG GAC CTC GGC AAC GAG GAG AGG AAG CAG AAG TTC CTG 
AGG CTG ATG GGC GCG GGG AAG AAA GAA CAT ACT GGC CGC CTT 
GTT ATC GGA GAC CAC AGA TCA ACC TCT CAC TTC AGG ACA GGG 
GAA GAA GAC AAG AAA ATG AAT GAA GAA CTG GAG TCT CAG TAC 
CAG CAG AGC ATG GAC AGC ACG ATG TCT GGA CGA AAC CGG CGC 
CAT TGT GGA CTG GGT TTC AGT GAG TTT CAG GAA GGT GAA GAG 
GAG GCA GCT GGG CAT TCC TCT GAC CAT GAG AGT TCA GAG GAC 
TCC GAA AGT GGC TCT GAT TCA GAG CAA GAT GAA TCT GCA GAG 
GAA CTG CAA GCT GCT GAA AAA CAC GAT GAA GCT GCG GTC CCA 
GAA AAC AAA AAG GAA GCA AAA AGC AAT TAT AAA ATG ATG TTT
TAA T CGAT
G CGA TGT ACG GGC CAG ATA TAC GCG TAT CTG AGG GGA CTA GGG 
TGT GTT TAG GCG AAA AGC GGG GCT TCG GTT GTA CGC GGT TAG 
GAG TCC CCT CAG GAT ATA GTA GTT TCG CTT TTG CAT AGG GAG
Figure 4.6: The sequence of RCAS plasmid containing the open reading frame of 
SAP fragment. Assession number: C R 3 5 3 8 2 2 .
I 1 Clal restriction sites 
H  SAP forward and reverse primers 
BM 6 xHis-Tag sequence 
ATG Start code 
TAA Stop code
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The present study aims to investigate the effect of over expression of SAP in vitro in 
embryonic chick using an avian viral vector (RCAS A). All preparative procedures used 
throughout this project are described in detail in the section ‘Materials and Methods’. A 
brief account of the main preparative steps is also described in this section as required.
First of all, a small amount of RCAS vector (donated by Dr. I. Khan, Cardiff School of 
Biosciences) was cloned into XL-1 E.Coli competent cells which were then allowed to 
grow for 24 hours. Some of the colonies were collected under sterile conditions 
following the 24 hours culture, and incubated overnight in LB medium. The RCAS 
plasmids were isolated from these cells, lpl and 5 pi of the plasmids were run on 1% 
agarose gel along side with 5 pi of lambda Hind III marker. This RCAS plasmid was 
then cut with Clal restriction enzyme to create a Clal restriction site in which the open 
reading frame of SAP fragment should fit. The cut and uncut RCAS plasmids were run 
side by side on agarose gel with the uncut one used as a control. As shown in Figure. 
4.3, the cut RCAS plasmid appears as a single band and is about 9.4 kb.
Following dephosphorylation of the cut RCAS with Alkaline phosphatase, the ligation 
of SAP open reading frame cDNA was performed using the avian viral vector (RCAS 
A). The RCAS vector containing the SAP open reading frame fragment was then 
transformed with XL-1 competent cells and spread on the top of two Luria broth (LB) 
agar plates. After an overnight incubation, 20 colonies were selected (10 colonies from 
each plate) from the isolation of RCAS plasmids containing the SAP open reading 
frame fragment with Clal sites. All these selected colonies were inoculated separately in 
fresh 2ml of LB-broth. In order to check that the RCAS plasmids that were isolated 
from 20 different colonies contained the open reading frame SAP fragment, all 20 
samples were cut with Clal restriction enzyme. This cutting procedure should release 
SAP fragment (557 bp) from the RCAS vector. As shown in Figure. 4.4, two samples 
(lane 9 and lane 17) show a band at 557 bp, the same size as that of SAP fragment 
inserted into the RCAS vector. These samples (SAP 9 and SAP 17) were used as 
template for the PCR reaction with SAP primers. The PCR was run for 30 cycles and 
the reaction products were mixed with loading dye and run on agarose gel along side 
with 174 DNAJHae III DNA marker. As shown in Figure. 4.5, the two bands show the 
correct size of the insert.
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After the SAP open reading frame fragment was generated and cloned successfully into 
the RCAS vector, it was necessary to determine the correct orientation of the cloned 
sequence. This was done by designing two forward and reverse primers for the RCAS 
vector. The two samples (9 and 17) which contained the correct size of SAP were used 
again as templates for the PCR reactions. In this case, two different pairs of primers 
were used (SAP primers) and (RCAS primers) with their respective DNA. The PCR 
reaction was run for 30 cycles. The resulting sequence reveals the open reading frame of 
cloned SAP fragment and confirms that the gene was cloned into the RCAS vector at 
the correct orientation as shown in Figure. 4.6. This open reading frame of cloned SAP 
fragment was used to transfect the sternal chondrocytes.
The chondrocyte cell lines were prepared as described in detail in the ‘Materials and 
Methods’. In brief, the embryos were removed from chicken eggs (12 in total) after 10 
day incubation. With the limbs and heads removed, the remaining embryo trunks 
minced, chopped and trypsinised. Following a succession of resuspension in FCS 
followed by DMEM and centrifugation steps, the number of cells in the suspension was 
counted using a conventional haemocytometer and plated onto culture dishes at three 
different concentrations (107cell/dish, 106cells/dish and 3 xlO5 cells/dish).. The 
confluent cells were harvested, trypsined, washed in PBS, mixed with supplemented 
DMEM. As required, the cells were plated, cultured overnight in 10ml supplemented 
DMEM and used for transfection. After the cells reached approximately 70-80% 
confluence, diluted RCAS-transgene plasmid DNA solution was added. After an 
overnight incubation, the cells were trypsinised, washed with DMEM medium and 
plated on a 24-well cell culture plate. After 24 hours culture, these cells were stained 
with the 3C2 monoclonal antibody (mAb). This antibody binds to the transfected 
chondrocytes and gives a blue colour which can be used as an indication for a 
successful transfection. However, the results had shown no blue colour. This indicates 
that the chondrocytes were not successfully transfected with RCAS/SAP vector .
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A number of factors may contribute to this unsuccessful transfection. It is generally 
known that cells become infected by retroviruses as a result of the interaction that takes 
place on the surface of the cells between the viral envelope glycoprotein and a related 
receptor. This interaction ultimately causes the viral membrane to fuse with the 
membrane of the target cell. As a result of this fusion, the virion core enters the 
cytoplasm of the target cell. Different retroviral envelopes recognise different receptors 
on the surface of the host cells. For example, the avian sarcoma-leukosis virus (ASLV) 
family that included RCAS, ALV and RSV vectors have a variety of envelop 
subtypes such as A-J and A-E. According to Bates et al (1993), the cellular receptor for 
the A envelope is tva, a protein that is related to an LDL receptor repeat. Amongst these 
vectors, that of RCAS was found to replicate efficiently in avian cells. Since most 
chicken strains contain endogenous pro-viruses that are closely related to the family of 
avian sarcoma leukosis virus (ASLV), these pro-viruses are also related to the RCAS 
vectors that originate from ASLV. Consequently, this can lead to recombination 
between the RCAS vector and these endogenous viruses. This problem has been 
previously reported by Hughes (2004).
Furthermore, it has been generally acknowledged that there are potential problems when 
designing inserts for RCAS vectors. Some of these problems are as follows: (1) 
whereas some sequences contain direct repeats or duplicate other regions of the vector 
genome, the others can interfere with the expression of the full length viral genome; (2 ) 
there are also sequences that are too large for the vector as well as those that are toxic 
for the host cells when expressed; (3) it is difficult to use the RCAS vectors to express 
genes that are toxic and/or interfere with cell growth; (4) cells that are made to express 
proteins that are toxic or interfere with cell growth, will be overgrown by cells that 
don’t express these proteins; and (5) attempts to use the RCAS vectors to express toxic 
proteins often result in the loss of the inserted gene.
Another potential problem is that viral passage can lead to the loss of inserted 
sequences. When the cells are not fully infected by an RCAS vector, proviral DNA also 
becomes unstable.
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The RCAS (Replication Competent ALV LTR with a Splice acceptor) vector was used 
in the present study because it has been reported to offer the following advantages over 
the replication-defective vectors: (1) there is no problem with recombination between 
the vector and the inserted sequences; (2 ) there is no need to provide a selectable marker 
or select infected cells; (3) The RCAS contains a short sequence that can be recognise 
by an antibody (4) because a replication-competent vector spreads rapidly, it will infect 
all the cells in a culture dish in a short time. However, it is apparent in the present case 
that the cells have not been successfully transfected with the use of RCAS vectors. One 
of the possible causes is that the inserted gene may be toxic to the cells that are 
supposed to express SAP, but instead encourages the overgrowth of those that do not 
express this protein. This consideration suggests using a different cell line. As a rule of 
thumb, the host cell must be in a healthy state if viral replication is to be efficient. 
Furthermore, retroviral vectors can efficiently transfer the genes they carry into the 
genome of the host cells, only if retroviral integration is efficient.
The RCAS-SAP vector can be used to infect chondrocyte culture and therefore over 
expression SAP in these cells. The high level of SAP expression can be monitored using 
an anti 6 xHisTag antibody. This will show whether the newly expressed recombinant 
SAP is localised mainly within the nucleus. Thus confirming SAP is a nuclear protein, 
the expected results from such investigation would be a reduction in the maturation rate 
of infected chondrocytes. The expected changes between the normal and infected 
cultures are summarised as follows:
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Infected
Alkaline phosphatase ^
Type X Collagen
Mineral deposition 
(Alizarin red staining)
MMP 13 I
GAGs and Hydroxyproline I
Slow down cell 
Maturation
Normal
t
t
t
t
1
Mature faster
with time
with time
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5 General Discussion
The skeleton develops through two mechanisms, intramembranous and endochondral 
ossification. The former, during which mesenchymal cells develop into osteoblasts, is 
involved in the formation of flat bones as well as the appositional growth of most long 
bones. The latter is responsible for the development of most other bones. Endochondral 
ossification involves a two stage mechanism, whereby cells (chondrocytes) form a 
matrix template for example the growth plate, in which cellular events eventually lead 
to the replacement of the cartilage template by newly formed bone. This process 
requires careful coordination of proliferation, cell differentiation and the deposition of 
bone. Many regulatory genes have been shown to take part in the coordination of 
chondrocyte proliferation and differentiation (Vortkamp 1999). Ihh and PTHrP are 
implicated in this coordination. Earlier studies using murine tibial growth plate 
indicated that these genes coordinate the rate of chondrocyte proliferation and determine 
the time when the cells should leave the proliferative stage to begin differentiation 
(Kobayashi et al., 2002; Maclean et al., 2005). As suggested by Vortkamp et al (1996), 
Ihh and PTHrP are the major regulators of chondrocyte proliferation and differentiation, 
and they work together in a negative feedback loop.
The detection of high Ihh expression in the prehypertrophic cells by the present 
investigation adds further evidence to support the findings of several previous studies 
that Ihh is exclusively produced by prehypertrophic chondrocytes (Bitgood et al., 1995; 
Koyama et al, 1996; Lanske et al., 1996; St-Jacques et al., 1999 Seth et al., 2000; 
Colnot et al., 2000). The localisation of Ihh in the embryonic chick sternum and tibial 
sections obtained from the present investigation together with those of the earlier 
studies support the observation that Ihh is involved in the early stages of chondrocyte 
differentiation and that Ihh plays two important roles in chondrocyte proliferation, a 
direct stimulator and a regulator of this process. First of all, Ihh stimulates perichondrial 
cells to produce PTHrP through its receptor (Patched) and then co-ordinates with the 
PTHrP to regulate the rate of chondrocyte proliferation as well as the timing for cell 
differentiation (Long et al., 2001; Karp et al., 2000; St-Jacques et al., 1999; Lanske et 
al., 1998; Vortkamp et al., 1996). The Ihh/PTHrP interaction prevents the cells from 
reaching maturation. Interestingly, there are recent reports that the Ihh/PTHrP
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interaction takes place in a negative feedback fashion. (Yoshida et al, 2001; Kindblom 
et al, 2002 Karp et al., 2000, Vortkamp, 1999, St-Jacques et al, 1999 Bitgood et al, 
1995). One typical example of the Ihh/PTHrP negative feedback interaction is that in 
fetal bone, Ihh stimulates the periarticular cartilage to express PTHrP, which then acts 
on the prehypertrophic chondrocytes to inhibit cell differentiation (Kindblom et al, 
2002; Vortkamp, 1999). Vortkamp (1996) remarked that in the postembryonic growth 
plate, postproliferative chondrocytes secreted Ihh which increased secretion of PTHrP 
to slowdown hypertrophy and that consequently; the slowing down of hypertrophy will 
reduce the production of cells that secreted Ihh.
A novel gene product recently identified as a Small Acidic Protein (SAP), has also been 
suggested to play a part in endochondral ossification. Embryonic cartilaginous tissue or 
growth plate of tibia has been extensively used in most of the earlier studies on 
endochondral ossification and in particular the development of the cartilage growth 
plate. Another type of cartilaginous tissue, the embryonic chick sternum has also been 
used to study bone development in recent years but to a lesser extent. While in most 
cases, both the sternum and tibia have been used to localise type X collagen, a well 
known marker of chondrocyte hypertrophy, the latter has been an important model 
system in the elucidation of the Ihh/PTHrP negative feedback loop in the regulation of 
endochondral ossification. SAP has so far not been extensively studied especially its 
involvement in chondrocyte maturation. This Small Acidic Protein was first reported in 
quail (Gong et al, 1997) and then later in chick (Webster, 1999). SAP has also been 
reported in cells from mammalian tissues including the human heart, brain, liver and 
placenta. As reported by Webster (1999), the SAP gene is short in quail, chick and 
human. The chick mRNA is 758 nucleotides in length including the poly- A tail and the 
predicted peptide is 173 amino acids long. The mRNA and peptide sequences are highly 
conserved amongst different species. Sequence comparisons revealed that it shares 92% 
and 60% nucleotide homology and 95% and 74% amino acid identity with the quail and 
human SAP sequence respectively. Comparison of the human and chick genomic 
sequences indicated remarkable conservation of the gene structure. Both human and 
chick SAPs are coded for by 5 exons with highly conserved exon/intron boundaries. 
This high level of evolutionary conservation suggests that SAP has an important 
biological function. Previous studies by Webster (1999) have suggested that SAP may
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reside within the nucleus and together with the predicted basic-helix-loop-helix 
secondary structure. This structure is one of the four forms transcription factors (see 
Chapter 3) SAP may function as a transcription regulator either by binding other nuclear 
proteins or directly to DNA. Although the molecular structure of SAP has been partially 
characterized and differential display PCR screen has shown that SAP gene expression 
is down regulated in hypertrophic chondrocytes in vitro, the localisation of SAP mRNA 
in the growth plate of the tibia and sternum has not yet been studied. Moreover, there 
has been little insight into what role SAP plays in the process of endochondral 
ossification.
The sternum has not been widely used in the studies of the bone development of 
cartilage growth plate. This observation has prompted the inclusion of both tissues in 
the present work. My project aims to examine the biological roles of SAP in 
endochondral ossification in particular the regulation of its expression. The 
experimental approaches employed in my project include in situ hybridisation, RT-PCR 
and biochemical analysis of the embryonic chick sternum and tibia in vivo. The 
experimental findings are summarised as follows:
❖ ISH showed that SAP was down regulated in the cephalic region of the 
embryonic sternum of the sternum.
❖ ISH showed that SAP was expressed in the proliferative and prehypertrophic 
zones f  the tibia.
❖ ISH showed that SAP was expressed in the caudal and middle regions of the 
sternum.
❖ ISH showed that SAP was down regulated in the hypertrophic zone in the 
tibia.
❖ ISH showed that Ihh was expressed in the middle and cephalic region of 
sternum.
❖ ISH showed that Ihh was expressed in the prehypertrophic zone of the tibia.
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❖ RT-PCR showed that type X expressed in the middle and cephalic regions of 
the untreated micromass culture.
❖ RT-PCR showed that type X collagen was expressed in the cyclopamine 
treated caudal chondrocytes micromass cultures.
❖ RT-PCR showed no differences in Ihh expression between the treated and 
untreated cultures.
❖ RT-PCR showed that SAP was expressed predominantly in the caudal and 
middle micromass cultures.
❖ RT-PCR showed that SAP expression was strongly suppressed in the 
cyclopamine treated micromass cultures.
❖ RT-PCR showed that PTHrP expression was inhibited in the treated 
micromass culture.
❖ RT-PCR showed that there was no difference in the expression pattern of 
Patched within the treated and untreated cultures.
♦> GAGs production was reduced in the treated micromass culture from all 
three different regions.
❖ Collagen biosynthesis was reduced in the treated micromass culture from all 
three different regions.
From a cellular/developmental perspective, tibia and sternum show a close similarity as 
confirmed by the present histological studies. The embryonic chick sternum is 
composed of three characteristic zones (caudal, middle and cephalic) distinguishable by 
their respective chondrocyte phenotypes: proliferative, prehypertrophic, and
hypertrophic.
The present in situ hybridisation studies have shown for the very first time that SAP is 
predominantly localised in the proliferative chondrocytes although low intensity of 
expression is also observed in the prehypertrophic and hypertrophic cells. This pattern
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of SAP expression is observed in both, sternum and tibia. Ihh is highly expressed in the 
prehypertrophic chondrocytes in both tissues and the expression continues throughout 
this transitional zone where the majority of cells are stained strongly, but the reactivity 
becomes less pronounced throughout the hypertrophic zone. Unlike SAP and Ihh, type 
X collagen is found to accumulate exclusively in the hypertrophic chondrocytes zone in 
these tissues.
In this project, in situ hybridisation was used initially to examine the expression pattern 
of SAP in vivo. Indian hedgehog and type X collagen mRNA localisations were used to 
define the boundaries of the prehypertrophic and hypertrophic zones respectively, since 
these are well known markers for cell maturation in cartilage. Also their expression 
domains have been clearly defined by other investigators. In the present study it was 
interesting to note that SAP is expressed in the prehypertrophic chondrocytes where Ihh 
is expressed suggesting that a possible functional link between SAP and Ihh. Therefore 
subsequent investigations were designed to examine any possible interactions between 
SAP and the Ihh/PTHrP feedback loop.
The expression of SAP was then investigated using RT-PCR. The PCR studies revealed 
that under normal culture conditions, the proliferative cells show high level of SAP, 
PTHrP and Patched expression but do not express Ihh and type X collagen. However, 
when treated with cyclopamine, these cells exhibited the reverse trend. In other words, 
the proliferative chondrocytes no longer express SAP and PTHrP but started to express 
Ihh and type X collagen. It is interesting to note that the response of the proliferative 
chondrocytes to cyclopamine with respect to the expression of SAP, Ihh and PTHrP 
varies depending on the duration of the treatment and cell phenotypes. Cyclopamine has 
a strong inhibitory effect on SAP and PTHrP expression not only in the proliferative but 
also in the prehypertrophic as well as hypertrophic chondrocytes. This inhibitory effect 
is observed throughout the duration of the experiments. By contrast, cyclopamine did 
not inhibit the expression of Ihh and type X collagen in the prehypertrophic 
chondrocytes and hypertrophic chondrocytes; instead, it up regulated the expression of 
these genes in the proliferative chondrocytes in which they are not normally expected to 
be expressed. The present study is consistent with the earlier observations that 
cyclopamine has the ability to inhibit cell response to Ihh receptor signalling (Incardona
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et al., 1999; Chen et al., 2002; Qualtrough et al., 2004). Moreover, earlier studies using 
murine growth plates have shown that cyclopamine inhibited PTHrP expression by 
blocking Ihh signalling which directly affects the expression of PTHrP in the 
chondrocytes (Kim et al., 1998; Chen et al., 2002). In addition, it has been reported that 
the missexpression of PTHrP in mouse limbs could cause the chondrocytes to become 
prematurely hypertrophic (Nakase et al., 2001). Taken together, it is concluded that 
there is a strong possibility that SAP is an integral part of the Ihh/PTHrP regulation in 
endochondral ossification.
Cyclopamine is shown to have no significant inhibitory effect on Patched expression. 
This is an unexpected finding since Patched is also a downstream target gene of the Hh 
signalling pathway. This observation may also suggest that the cyclopamine used in 
these experiments was not effective in blocking Ihh signalling. However, the effect of 
cyclopamine on PTHrP suggests that the Ihh signalling pathway was indeed inactivated. 
Further experiments examining the expression of other Hh signalling downstream 
targets such as the Gli proteins (Gli 1, 2 and 3) and Smo would be important to ascertain 
the effect of cyclopamine on the Ihh pathway in this system. Although a slight 
difference in the intensities of the Patched PCR products was observed with or without 
cyclopamine treatment, it was not possible to determine whether such changes are 
significant. Quantitative PCR would be a more suitable approach to examine any 
quantitative changes in the expression of the hedgehog target genes. Due to time 
constraint and problems with the primers and probes at the time, this approach was 
considered but not implemented. On the other hand, cyclopamine has previously been 
reported to have the ability to disrupt the Hh signalling (Kamenetsky et al., 2002). 
Therefore the premise that cyclopamine has inhibited the Hh-signalling pathway in the 
present cell culture system was adopted.
It is evident from the PCR studies that SAP and PTHrP are expressed by the 
proliferative chondrocytes and that their expression is down regulated when the cells 
start to differentiate. In this project a concomitant up regulation of Ihh with the down 
regulation of SAP and PTHrP expression has been observed. These findings confirmed 
that Ihh expression was up regulated when chondrocytes leave the proliferative phase. 
Another interesting observation is that SAP, Ihh and PTHrP are shown to be
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simultaneously expressed in the middle (prehypertrophic) region of the embryonic 
sternum and that the reduced expression of either SAP or PTHrP or both resulted in the 
up regulation of Ihh in this region. This observation tentatively suggests that SAP may 
function in the same way as PTHrP in that it inhibits cell maturation. The findings seem 
to support the hypothetical view that SAP may play a part in the endochondral 
ossification process, either involving in the transcription of PTHrP directly or indirectly 
affecting the Ihh/PTHrP feedback loop. This could be further investigated using a 
PTHrP promoter-reporter construct to examine whether there is a transcriptional control 
of PTHrP gene expression by SAP. It can also be studied in a SAP missexpression 
system that the over expression of SAP may lead to the up-regulation of PTHrP.
In the presence of cyclopamine, the levels of GAGs and hydroxyproline increased 
throughout the same period of cultures. However, differences were noted in the levels of 
GAGs and hydroxyproline production between the cyclopamine treated and untreated 
cultures and these variations depended on the regions from which the chondrocytes 
were isolated. The analysis of the micromass cultures shows that the levels of GAGs 
and hydroxyproline produced in the treated caudal and middle were significantly higher 
than those in the untreated cultures. By contrast, the levels of GAGs and hydroxyproline 
produced in the cyclopamine treated cephalic region were significantly lower than those 
in the untreated samples. This decrease of hydroxyproline in the cephalic samples could 
suggest that cyclopamine affect the synthesis of type X collagen which is know to be 
the major collagen synthesised by the hypertrophic chondrocytes. The levels of GAGs 
and hydroxyproline in all cyclopamine treated cultures were significantly less than those 
in the untreated samples with an exception that the day 1 2  of the middle region showed 
no significant difference in the levels of GAGs produced between the treated and 
untreated cultures
GAGs and hydroxyproline are found highly abundant in vertebrate embryos. These 
structural components of the extracellular matrix closely associate with a wide variety 
of proteins in performing major developmental functions. The present study shows that 
under the influence of cyclopamine, only the chondrocytes at the early stage of 
proliferation or differentiation ( 8  days cultures) increased the production of GAGs 
whereas those at the later stage of the processes (14 days cultures) showed a decline in
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their production. Since the cell proliferation process was shown to be regulated by the 
Ihh/PTHrP loop (Vortkamp 1996; 1999), the present study has also suggested that this 
process may be regulated by the Ihh/PTHrP loop and that it can be affected by 
cyclopamine treatment. In the caudal region in particular, the cells do not usually 
express type X collagen as this collagen is specific to hypertrophic chondrocytes. The 
fact that this type X gene was found by the PCR analysis to be expressed in the 
cyclopamine treated caudal region seems to suggest that in the presence of cyclopamine, 
the proliferative cells accelerated the process of differentiation; thus the cells became 
hypertrophic or matured earlier than normally expected. In addition, the results 
obtained from the RT-PCR analysis showed that the expression of PTHrP which has 
been reported to be expressed in the proliferative and the prehypertrophic chondrocytes 
(Nakase et al, 2001) is gradually decreased in the caudal and middle regions in the 
present of cyclopamine. This fact further supports the notion that chondrocytes from 
these two regions become hypertrophic more rapidly. This finding is confirmed by the 
reduced production of GAGs in these two regions during two weeks of culture when the 
cells were exposed to longer treatment of cyclopamine.
With regard to the cephalic region where the cells already reached a fully differentiated 
stage, cyclopamine was found to reduce the production of GAGs and hydroxyproline: 
the levels of GAGs production were significantly (P<0.05) less than those observed in 
the controls. It is apparent that the production of GAGs and hydroxyproline in the 
hypertrophic region was affected by the cyclopamine treatment. However, the levels of 
GAGs and hydroxyproline produced appeared to increase gradually with time in both 
cyclopamine treated and untreated cephalic cultures. This shows that cyclopamine was 
not toxic to the cells. There was no morphological evidence of cell death in these 
cyclopamine treated cultures. The decline in the production of GAGs and 
hydroxyproline in the cephalic region indicates a continuing slowdown in the synthesis 
of GAGs and collagens, resulting in reduced extracellular matrix production.
Regardless of whether the cells were treated or not with cyclopamine, the levels of 
GAGs and hydroxyproline in the caudal and middle regions were always found to be 
much higher than those in the cephalic region; this observation suggests that the
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synthesis of GAGs and hydroxyproline was down regulated as soon as the chondrocytes 
became fully differentiated.
From this study, it is apparent that several important areas require further investigation. 
In addition to the future experiments mentioned earlier, one of the urgent issues is to 
examine whether cyclopamine affects SAP gene transcription or SAP mRNA stability 
which resulted in the low levels of SAP PCR product. Transcriptional control of SAP by 
cyclopamine could be ascertained by performing nuclear run on assays. Also in order to 
confirm that SAP is a nuclear protein, an antibody could be raised to localized SAP in 
the nucleus. As an adequate amount of purified SAP is not available, it is planed to raise 
an antibody to a syntactic peptide in the future. Alternatively, the SAP 6 x-HisTag fusion 
protein can be localised in the chondrocytes transfected with RCAS. More recently, 
other investigators in the laboratory have shown that over expression of human SAP in 
chick chondrocytes inhibited mineralisation in vitro in monolayer cultures. These 
observations further support the hypothesis that SAP regulates cell maturation by 
inhibiting this process and that SAP is an integral part of the Ihh/PTHrP loop. In 
addition, the expression of SAP could be directly modulated using siRNA of SAP. This 
would enable a variable gene knockdown to be achieved and the effect on 
mineralisation to be monitored.
Throughout this project, I have adopted the assumption that the Ihh/PTHrP signalling 
loop also operates in the embryonic chick sternum since the developmental sequence of 
chondrocytes in this tissue is almost identical to that of the tibial growth plate. The 
results from my RT-PCR investigation showed fluctuations of the mRNA levels of key 
components of the Ihh/PTHrP loop i.e: Ihh, PTHrP. Also when PTHrP expression was 
inhibited by the treatment of cyclopamine, type X collagen expression was up regulated. 
These observations suggest that the Ihh/PTHrP loop also operate in the developing 
chick sternum. This negative feedback loop has only been reported previously in the 
tibia. However, this is evidence circumstantial and definitive demonstration of the 
existence of the Ihh/PTHrP loop in the embryonic chick sternum requires a series of in 
situ hybridisation studies using serial sections from the different anatomical regions of 
the sternum.
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Figure A.6: Agarose gel of PCR products showing the expression of different genes 
in the untreated and treated micromass cultures set 2 of the caudal region of the 
sternum of 17 day chick embryos. RNAs were isolated form individually collected 
chondrocyte micromass with out any surrounding cells. Every 24 hours the RNA 
was isolated from a 7 day culture period and was used for the RT-PCR analysis. 
Lane 0 = 0 time point. Lanes 1 - 7 = RNA isolated at days 1, 2, 3, 4, 5, 6 and 7 
respectively.
(A) Untreated.
(B) Treated with cyclopamine.
(0) RNA was extracted from freshly isolated chondrocytes.
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Figure A.7: Agarose gel of PCR products showing the expression of different genes 
in the untreated and treated micromass cultures set 2 of the middle region of the 
sternum of 17 day chick embryos. RNAs were isolated form individually collected 
chondrocyte micromass with out any surrounding cells. Every 24 hours the RNA 
was isolated from a 7 day culture period and was used for the RT-PCR analysis. 
Lane 0 = 0 time point. Lanes 1 - 7 = RNA isolated at days 1, 2, 3, 4, 5, 6 and 7 
respectively.
(A) Untreated.
(B) Treated with cyclopamine.
(0) RNA was extracted from freshly isolated chondrocytes.
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Figure A.8: Agarose gel of PCR products showing the expression of different genes 
in the untreated and treated micromass cultures set 2 of the cephalic region of the 
sternum of 17 day chick embryos. RNAs were isolated form individually collected 
chondrocyte micromass with out any surrounding cells. Every 24 hours the RNA 
was isolated from a 7 day culture period and was used for the RT-PCR analysis. 
Lane 0 = 0 time point. Lanes 1 - 7 = RNA isolated at days 1, 2, 3, 4, 5, 6 and 7 
respectively.
(A) Untreated.
(B) Treated with cyclopamine.
(0) RNA was extracted from freshly isolated chondrocytes.
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Figure A.9: Agarose gel of PCR products showing the expression of different genes 
in the untreated and treated micromass cultures set 3 of the caudal region of the 
sternum of 17 day chick embryos. RNAs were isolated form individually collected 
chondrocyte micromass with out any surrounding cells. Every 24 hours the RNA 
was isolated from a 7 day culture period and was used for the RT-PCR analysis. 
Lane 0 = 0 time point. Lanes 1 - 7 = RNA isolated at days 1, 2, 3, 4, 5, 6 and 7 
respectively.
(A) Untreated.
(B) Treated with cyclopamine.
(0) RNA was extracted from freshly isolated chondrocytes.
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Figure A.10: Agarose gel of PCR products showing the expression of different 
genes in the untreated and treated micromass cultures set 3 of the middle region of 
the sternum of 17 day chick embryos. RNAs were isolated form individually 
collected chondrocyte micromass with out any surrounding cells. Every 24 hours 
the RNA was isolated from a 7 day culture period and was used for the RT-PCR 
analysis. Lane 0 = 0 time point. Lanes 1 - 7 = RNA isolated at days 1, 2, 3, 4, 5, 6 
and 7 respectively.
(A) Untreated.
(B) Treated with cydopamine.
(0) RNA was extracted from freshly isolated chondrocytes.
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Figure A .ll: Agarose gel of PCR products showing the expression of different 
genes in the untreated and treated micromass cultures set 3 of the cephalic region of 
the sternum of 17 day chick embryos. RNAs were isolated form individually 
collected chondrocyte micromass with out any surrounding cells. Every 24 hours 
the RNA was isolated from a 7 day culture period and was used for the RT-PCR 
analysis. Lane 0 = 0 time point. Lanes 1 - 7 = RNA isolated at days 1, 2, 3, 4, 5, 6 
and 7 respectively.
(A) Untreated.
(B) Treated with cyclopamine.
(0) RNA was extracted from freshly isolated chondrocytes.
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